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Chapter 1  
 
Introduction 
 
 
 
The degree to which animals recognize and react to external stimuli thoroughly depends on the 
availability and complexity of their neural systems. While the rudimentary nervous tissue of 
Caenorhabditis elegans (C. elegans) enables some perception of environmental stimuli and 
subsequent adaptation, only the formation of a complex central nervous system (CNS) unlocks the 
superior cognitive power enjoyed, among others, by mammals (Arendt et al., 2016; Galizia and 
Lledo, 2013; Hobert, 2010; Metaxakis et al., 2018). Along its evolutionary refinement, the nervous 
system increased the number and diversity of its constituent cells, developed functionally specialized 
anatomical structures such as the hippocampus, and equipped itself with dazzling sensory arrays 
such as the retina. Among the many distinct cell types present in the brain, glia have evolved as 
morphologically and functionally distinct from neurons, and a tremendous increase of their 
abundance as well as a diversification of their physiological functions can be observed along the 
evolution of neural systems (Bullock and Horridge, 1965; Hartline, 2011; Verkhratsky et al., 2017; 
Zhang, 2001). 
Astroglial cells in particular exhibit a dynamic phylogenetic expansion of their numbers as well as 
their cellular complexity (Andriezen, 1893; Leuba and Garey, 1989; Nedergaard et al., 2003; 
Oberheim et al., 2009; Oberheim et al., 2006; Vasile et al., 2017). For instance the nervous system of 
C. elegans maintains a 1:6 ratio of glia to neuron (50 glial cells for 302 neurons), whereas in adult 
human brains, astrocytes outnumber neurons and constitute the majority of neural cells (1.4 
astrocyte per neuron) (Chaboub and Deneen, 2012; Freeman, 2010; Nedergaard et al., 2003; 
Sofroniew and Vinters, 2010; Vasile et al., 2017; von Bartheld et al., 2016). Moreover, species 
specific quantitative relations between neurons and astrocytes in adult individuals remain relatively 
constant, fluctuating only within minimal ranges (Bandeira et al., 2009; Brizzee and Jacobs, 1959; 
von Bartheld et al., 2016). This implies that astrocyte to neuron ratios correlate with varying levels of 
cognitive ability along the phylogenetic tree, but remain stable within a species, indicating that the 
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relative amount of neurons and astroglia may partly define brain performance (von Bartheld et al., 
2016). Thus the increased functional competence of the mammalian brain is not to be attributed 
exclusively to neurons (Nedergaard et al., 2003; Robertson, 2014). In fact, advanced cognitive 
abilities are likely the result of precise cooperation between neurons and numerically superior 
astrocytes, which appears to execute important role in various facets of brain physiology (Clarke and 
Barres, 2013; Nedergaard et al., 2003; Oberheim et al., 2009; Oberheim et al., 2006; Robertson, 
2013, 2014).  
 
1.1 Physiological functions of astrocytes  
 
Although glial cells were first described in the 19th century by Rudolf Virchow, they were once 
thought to provide little more than structural support for neurons (the term glia derives from the 
ancient Greek word for glue) (Distler et al., 1991; Meyer and Kaspar, 2017; Oberheim et al., 2012). 
Along the 20th century however, it became increasingly clear that astrocytes are involved in a wide 
range of critical physiological functions in the brain, of which we would like to draw a short and non-
exhaustive list here.  
One of the roles of astrocytes is to provide metabolic support for surrounding neurons, chiefly 
through glycolysis. This is possible because unlike most neurons, astrocytes extend processes that 
form endfeet in apposition to local blood vessels, enabling direct transport of glucose from the 
bloodstream through glucose transporter 1 (GLUT 1) and through the blood-brain barrier (Maher et 
al., 1994). In addition, astrocytes are the only type of brain cell known to store glucose in the form of 
glycogen in significant amounts (Brown and Ransom, 2007), and therefore are uniquely positioned to 
store as well as supply energy to the brain. The mechanisms by which astrocytes provide energy to 
neurons are summarized in what is known as the astrocyte-neuron lactate shuttle hypothesis 
(Pellerin and Magistretti, 1994). According to this hypothesis, glucose and glycogen are metabolized 
into lactate by astrocytes and shuttled to neurons in an activity-dependent manner. Indeed, 
astrocytes express glutamate receptors and transporters, enabling them to adjust the rate of lactate 
secretion to match the global level of neurotransmitter release in nearby neurons. Although various 
aspects of this elegant hypothesis are still a matter of debate, its central tenet has received a 
considerable degree of experimental support since its inception (Pellerin and Magistretti, 2012).  
Another function of astrocytes is to maintain synaptic and extracellular homeostasis, according to 
the tripartite synapse hypothesis (Perea et al., 2009). While a typical synapse of the CNS is composed 
of a presynaptic and postsynaptic neuronal element, this hypothesis posits that each synapse is also 
enwrapped by the processes of a single astrocyte. These astrocytic endfeet are equipped with 
glutamate receptors and transporters, enabling astrocytes to sense glutamate release and 
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participate in the reuptake of neurotransmitter (Rose et al., 2017). These cells are therefore well 
positioned to contribute to the regulation of synaptic transmission. In addition, astrocytes express 
membrane-bound, inward rectifying K+ channels and adenosine triphosphate (ATP) dependent 
Na+/K+ pumps, allowing them to rapidly buffer the increase in extracellular potassium consecutive 
to neuronal firing (Simard and Nedergaard, 2004). Furthermore, astrocytes play a central role in 
regulating the water content of the CNS through aquaporin 4 (AQP4) channels located on astrocytic 
processes contacting local blood vessels (Simard and Nedergaard, 2004).  
Finally, together with microglia and fibroblasts, astrocytes play an important protective role after 
brain damage through a process known as reactive astrogliosis (Sofroniew, 2009). Following 
neuronal death consecutive to inflammation, focal ischemia or brain injury, astrocytes become 
proliferative, adopt a hypertrophic morphology and increase glial fibrillary acidic protein (GFAP) 
expression. Reactive astrocytes migrate towards the site of damage and begin a process of 
encapsulation, culminating in the formation of a glial scar that insulates the site of injury from 
surrounding, healthy tissue (Sofroniew, 2009).  
Additional roles of astrocytes that will not be discussed here include trafficking of molecules through 
the blood-brain barrier (Abbott et al., 2006), regulation of extracellular pH (Obara et al., 2008) and 
modulation of blood flow in relation to general levels of neuronal activity (Iadecola and Nedergaard, 
2007). These multifaceted roles of astrocytes clearly speak for their importance to CNS function, well 
beyond that of mere “glue” (for more exhaustive reviews, see (Sofroniew and Vinters, 2010; 
Verkhratsky et al., 2017)). The functions of astrocytes described here are further enhanced by the 
fact that these cells form a functional syncytium (Scemes and Spray, 2004). In the cerebral cortex, 
the processes of astrocytes do not overlap extensively, instead the cortical parenchyma is tiled with 
a juxtaposition of individual astrocytes, each covering their individual domain. However, the 
extremities of neighbouring astrocytes are coupled by gap junctions enabling the passage of small 
signaling molecules, ions and travelling Ca²+ waves (C. Charles et al., 1991), and which among other 
things expands the K+ buffering capacity of the astrocytic network (Scemes and Spray, 2004). This 
anatomical organization increases the potency of an already versatile cell type, and is obviously 
underpinned by the establishment of an appropriate ratio of astrocytes to neurons during brain 
development.         
 
1.2 Development of neurons 
 
The development of astrocytes has altogether received less attention than the development of 
neurons, however both processes share at least some common mechanisms (Chaboub and Deneen, 
2013; Molofsky and Deneen, 2015). It is therefore useful to appreciate astroglial development with 
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respect to neuronal development, which we will shortly introduce here, focusing on cortical 
neurogenesis (Figure 1).  
Neurons are born from radial glial cells (RGCs) which themselves descend from neuroepithelial cells 
(NECs) (Hartfuss et al., 2001; Rakic, 1982; Sahara and O'Leary, 2009). NECs are neural stem cells 
(NSCs) that proliferate between E8.5 and E12.5, expanding their pool by symmetric division 
(Martynoga et al., 2012; Nguyen et al., 2018). At the onset of neurogenesis (E10.5-E11.5), NECs 
begin expressing astroglial markers (e.g. glutamate aspartate transporter (GLAST) or brain lipid-
binding protein (BLBP)) as well as adherens junctions, turning into RGCs (Dehay and Kennedy, 2007; 
Gotz and Huttner, 2005; Kriegstein and Alvarez-Buylla, 2009; Martynoga et al., 2012; Sahara and 
O'Leary, 2009). RGCs reside in the ventricular zone (VZ) and possess a short apical process contacting 
the ventricular surface (or apical surface, AS) as well as a long process contacting the pial surface 
(PS) (Arai and Taverna, 2017; Gotz and Huttner, 2005; Kriegstein and Alvarez-Buylla, 2009). These 
RGCs divide asymmetrically, producing deep layer neurons and other RGCs during early 
neurogenesis (E10-E14) (Kriegstein et al., 2006; Tuoc et al., 2013b). Preferentially during late 
neurogenesis, RGCs use asymmetric division to self-renew and produce basal (intermediate) 
progenitors (BPs) (Kriegstein et al., 2006; Pontious et al., 2008). BPs temporarily proliferate in 
subventricular zone (SVZ) before differentiating into superficial layer neurons (Kriegstein et al., 2006; 
Pontious et al., 2008).  
Regardless of the modalities of their birth, successive generations of neurons migrate into the 
developing cortical plate (CP), either radially following the scaffold of radial glial fibers or by soma 
translocation (Marin-Padilla, 1978; Miyata et al., 2001). This mode of migration results in a peculiar 
pattern in the fully developed cortex: indeed, successive cohorts of migrating neurons form the 
familiar pattern of cortical layers, whereby each generation of excitatory neurons occupies a distinct 
layer in the cortex (Angevine and Sidman, 1961; Guy and Staiger, 2017; Rakic, 1974). Early born 
neurons occupy the deeper layers of the cortex, while late born neurons migrate past their 
predecessors to form the supragranular layers, shaping an inside-out pattern of cortical lamination 
(Angevine and Sidman, 1961; Rakic, 1974). A key feature of cortical layers that has greatly facilitated 
the study of neuronal development is the fact that individual layers can be identified by layer-
specific markers (Guy and Staiger, 2017; Molyneaux et al., 2007; Popovitchenko and Rasin, 2017). 
For example, layer II/III neurons can be readily identified by expression of regulator of G protein 
signaling 8 (RGS8) (Gold et al., 1997; Wagener et al., 2010). Layer IV neurons, on the other hand, 
express high levels of RAR-related orphan receptor β (RORβ), and layer V is characterized by 
expression of coup-TFI interacting protein 2 (CTIP2) (Leid et al., 2004; Schaeren-Wiemers et al., 
1997). In addition, BPs that give birth to neurons can be identified by their high expression of T-box 
brain protein 2 (TBR2) (Pinto et al., 2008; Tuoc et al., 2013b). The availability of such specific markers 
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of given developmental stages in the neuronal lineage has considerably helped our understanding of 
neuronal development. Alas, the same cannot be said of the development of the astroglial lineage.    
 
 
 
 
 
 
Figure 1 | Development of neurons and astrocytes in mouse cortex. Top left: schematic illustration of a 
coronal section through a developing mouse brain illustrating the three known germinal zones for 
astrocytes and neurons. Bottom: schematic depiction of cortical neurogenesis and astrogliogenesis in 
chronological order. The area illustrated corresponds to the inset at the top left. Briefly, cortical 
development begins with the self-renewal of embryonic NECs, which then differentiate into RGCs 
overexpressing astroglial markers (e.g. GLAST). RGCs begin producing neurons around E11.5 by direct 
neurogenesis. In later stages, RGCs produce neurons through indirect neurogenesis, by generating BPs 
that reside and proliferate in SVZ. Proliferating BPs eventually differentiate into neurons that migrate into 
the CP. Astrogliogenesis begins after neurogenesis, around E17.5 when RGCs (refered to as astrocytic 
RGCs) overexpress astroglial TFs (e.g. NFiA),detach form the surface of VZ in the form of AGPs, and then 
migrate, proliferate transiently, and finally differentiate into the mature astrocytes. The expression of 
mature astrocyte markers (e.g. GFAP) is believed to be triggered by neuron-derived cytokines. AGPs, 
astroglial progenitors; BPs, basal progenitors;  CP, cortical plate; NECs, neuroepithelial cells; SVZ, 
subventricular zone; RGCs, radial glial cells; VZ, ventricular zone. 
 
 
1.3 Development of astrocytes 
 
As described above, our understanding of astrocyte physiology has dramatically improved over the 
last few decades (Khakh and Sofroniew, 2015). Similarly, our contemporary view of neuronal 
6 
 
development appears rather exhaustive (Chaboub and Deneen, 2012; Gallo and Deneen, 2014; Kwan 
et al., 2012; Martynoga et al., 2012). However, our knowledge of astrocyte development and its 
molecular control has evidently lagged behind (Chaboub and Deneen, 2013; Sloan and Barres, 2014; 
Yang et al., 2013). Accordingly, we have very little knowledge of the transcription factors (TFs), or 
epigenetic regulation involved in even the simplest steps of astrogliogenesis (Freeman, 2010; 
Molofsky et al., 2012). This is partly due to the fact that unlike neurons, no single known molecular 
marker permits unambiguous identification of the distinct stages of astroglial development 
(Chaboub and Deneen, 2013; Molofsky et al., 2012). This regrettable situation arises from the fact 
that astroglial development has not enjoyed the same degree of attention as neuronal development, 
as these cells were long believed to provide little more than passive and structural support to 
neurons (Molofsky et al., 2012). In fact, the very idea that distinct stages of development should be 
characterized by the expression of a unique combination of markers derives from studies on 
developing neurons and oligodendrocytes, but it is not clear whether the same logic must apply to 
astroglial development (Chaboub and Deneen, 2013; Molofsky and Deneen, 2015). For instance, 
similarly to neurons, astrocytes are known to derive from RGCs of VZ that differentiate towards 
astrocytes through the process of migrating and transiently amplifying astroglial progenitor or 
premature astrocyte (which we will henceforth refer to as AGPs) (Kriegstein and Alvarez-Buylla, 
2009; Schitine et al., 2015; Schiweck et al., 2018). RGCs express a set of markers that are persistently 
found at all above listed stages of astroglial development, (such as BLBP or GLAST), making it difficult 
to rely on these markers to identify distinct developmental steps (Gotz and Barde, 2005; Molofsky 
and Deneen, 2015; Molofsky et al., 2012).  
In spite of these difficulties, investigations of astroglial development have met with some success, 
and depict an overall diverse and complex process whereby astroglial cells originate from several 
areas and periods in time (Bayraktar et al., 2014; Minocha et al., 2017; Schiweck et al., 2018). 
Accordingly, lineage tracing experiments indicate that during embryonic development, forebrain 
astrocytes arise from three main germinal regions, namely VZ of cortex as well as medial and lateral 
ganglionic eminences (MGE and LGE respectively; Figure 1) (Bayraktar et al., 2014; Minocha et al., 
2017; Tsai et al., 2012). Generally, astrogliogenesis is considered to begin once neurogenesis is 
complete, which is estimated to occur between E16.5 and E18.5 in mouse cortex (Ge et al., 2012; 
Miller and Gauthier, 2007; Minocha et al., 2017; Molofsky and Deneen, 2015). The source of 
astroglial cells lies with RGCs of VZ, which begin producing neurons around E11.5, then switch to 
production of astroglia instead (Costa et al., 2009; Schiweck et al., 2018). In the spinal cord, this 
switch in cellular fate is accompanied by the upregulated expression of TFs: nuclear factor I A (NFiA) 
and SRY-box 9 protein (SOX9) in RGCs, and this has traditionally been generalized to cortex (Chaboub 
and Deneen, 2013; Deneen et al., 2006; Kang et al., 2012; Nagao et al., 2016). Both of these TFs were 
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shown to be indispensable and sufficient for the initiation of astrogliogenesis (Molofsky et al., 2012). 
There are several processes through which RGCs generate astroglia (Ge and Jia, 2016; Kriegstein and 
Alvarez-Buylla, 2009). The best known of these processes begins when RGCs delaminate and migrate 
out of germinal zones by soma translocation after retracting their apical and subsequently basal 
processes (Kriegstein and Alvarez-Buylla, 2009; Noctor et al., 2008; Voigt, 1989). This corresponds to 
a change in the morphology of the differentiating cell, which turns from a bipolar, RGC-like towards 
a multipolar, astroglial-like morphology (Kriegstein and Alvarez-Buylla, 2009). Once outside of 
germinal zones, at least a fraction of these cells proliferate and become what can be considered 
transiently amplifying AGPs, which ultimately differentiate into astrocytes (Gallo and Deneen, 2014; 
Ge and Jia, 2016; Kriegstein and Alvarez-Buylla, 2009; Namihira and Nakashima, 2013). Another 
process begins when RGCs divide asymmetrically to generate AGPs which then migrate radially 
outside of VZ (Molofsky and Deneen, 2015; Schitine et al., 2015). In both these cases the 
identification of AGPs is possible solely because of their localization, as these cells express the same 
set of astroglial markers as their progenitors, RGCs (Guillemot, 2007; Minocha et al., 2015). Another 
known source of cortical mature astrocytes lies in the postnatal SVZ, which also spawns AGPs that 
migrate out of their germinal zone into the cortex before proliferating and differentiating locally (Ge 
and Jia, 2016; Molofsky and Deneen, 2015; Schitine et al., 2015; Schiweck et al., 2018; Tien et al., 
2012). Importantly, some locally multiplying AGPs also express markers typical for mature astrocytes 
despite their proliferative capacities (Ge et al., 2012; Tabata, 2015). Collectively, these processes 
begin between E16.5 and E18.5 and continue well into early postnatal life (for the sake of simplicity, 
we will henceforth consider that they start at E17.5) (Schiweck et al., 2018). It is generally 
considered that RGCs constitute the main source of cortical AGPs in embryonic and early postnatal 
life, while SVZ-descending AGPs become increasingly important at later times (Ge and Jia, 2016; 
Kriegstein and Alvarez-Buylla, 2009). But regardless of their place and time of origin, AGPs 
proliferating and differentiating locally constitute the main source of mature astrocytes and enable 
the expansion of astroglial population in postnatal forebrain (Bandeira et al., 2009; Gallo and 
Deneen, 2014; Ge and Jia, 2016; Ge et al., 2012; Schiweck et al., 2018). 
The molecular events governing transient proliferation of astroglia are not well known, despite their 
impressive 6 to 8 fold increase observed during postnatal development and achieved through 
symmetric divisions (Bandeira et al., 2009; Ge and Jia, 2016). Most studies on the topic addressed 
aberrant astroglial overproliferation in a pathological context, such as formation of gliomas or 
reactive astrogliosis (Gallo and Deneen, 2014). However, what knowledge exists highlights the role 
of the mitogen activated protein/ extracellular signal-regulated kinase (MAP/ERK) signaling pathway, 
potentially dependent on epidermal growth factor receptor (EGFR) activation (Li et al., 2012; 
Molofsky and Deneen, 2015; Tien et al., 2012). For instance, it was shown in spinal cord that AGPs 
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proliferate upon upregulation of ERK1/2 and its upstream B-Raf Serine/Threonine-protein (BRAF) 
(Tien et al., 2012). Similarly, constitutively active MEK1 was shown to stimulate proliferation of GFAP 
-positive premature cortical astrocytes (Li et al., 2012). In addition some reports have implicated the 
sonic hedgehog (SHH) signaling pathway in the initiation of AGPs proliferation (Gallo and Deneen, 
2014; Wallace and Raff, 1999). Overall, much remains to be elucidated about the molecular signaling 
pathways orchestrating astroglia proliferation in the context of normal brain development (Molofsky 
and Deneen, 2015; Tien et al., 2012).                                                        
The process of terminal differentiation implies that cells exit the proliferation cycle and turn into 
functional, quiescent astrocytes (Ge and Jia, 2016; Kriegstein and Alvarez-Buylla, 2009; Molofsky and 
Deneen, 2015). Although the molecular mechanisms underlying this phenomenon are not fully clear, 
neuron-derived cytokines are known to promote the expression of markers typical for adult astroglia 
(Barnabe-Heider et al., 2005; Kanski et al., 2014). Markers commonly used to identify this 
developmental stage include GFAP, acyl-CoA synthetase bubblegum family member 1 (ACSBG1) or 
glutamine synthetase (GS), however their reliability is somewhat questionable as they have also 
been found in proliferative astroglia (Chaboub and Deneen, 2013; Gallo and Deneen, 2014; Tabata, 
2015).  
Finally, the germinal zone in which astroglia are born determines their ultimate allocation: cells 
derived from cortical VZ populate the cortex and corpus callosum, those born in LGE migrate to the 
striatum and piriform cortex, and astrocytes descending from MGE-born progenitors are allocated to 
ventral pallidum and striatum (Bayraktar et al., 2014; Tsai et al., 2012).  
The diverse origins of mature astrocytes briefly described here raises difficult questions. On the one 
hand, it is remarkable that cells born from various mechanisms differentiate into a cell type, the 
astrocyte, which integrates into a unified network that performs coherent physiological functions 
(Molofsky and Deneen, 2015; Sofroniew and Vinters, 2010). On the other hand, because 
astrogliogenesis begins after neurogenesis is complete, it is impressive that the various processes 
that give birth to mature astrocytes can coordinate to maintain a proper numerical ratio of astrocyte 
to neurons (Miller and Gauthier, 2007). This raises the question of the molecular events deciding 
upon cell fate and numbers. Is there a universal molecular factor that drives progenitors born at 
various places and time towards a common fate, and does this factor control the proliferation of 
progenitors and ultimately the number of mature astrocytes born from them?     
 
1.4 Chromatin remodeling BAF complex  
 
The process of cellular differentiation, from progenitor to fully mature and differentiated cell can be 
understood as a sequence of activation of one or several gene expression programs (Sokpor et al., 
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2017). A key aspect in the activation or repression of genetic programs is the process of chromatin 
remodeling, by which chromatin can be opened into the accessible euchromatin or closed in the 
form of heterochromatin, respectively enabling or preventing the binding of TFs necessary for the 
initiation of transcription (Coskun et al., 2012; Hirabayashi and Gotoh, 2010; Juliandi et al., 2010; 
Narayanan and Tuoc, 2014a; Ronan et al., 2013; Sokpor et al., 2017; Watson and Tsai, 2017). A 
crucial chromatin regulator is the ATP-dependent SWItch/Sucrose Non-Fermentable (mSWI/SNF), 
better known as BRG1/BRM-associated factor (BAF), a multi-subunit chromatin remodeling complex, 
henceforth referred to as BAF complex (Ho and Crabtree, 2010; Wang et al., 1996).  
 
 BAF complex from the biochemical side 
Biochemically, the BAF complex is a conglomerate of 15 or more different protein subunits, 
comprising core and peripheral elements (Ho and Crabtree, 2010; Kadoch and Crabtree, 2015; 
Lessard et al., 2007; Wu et al., 2007). The core subunits of the BAF complex include the ubiquitous 
BAF47 as well as two scaffolding subunits, BAF170 and/or BAF155, providing structural support for 
the assembly of the entire BAF complex (Mashtalir et al., 2018; Narayanan et al., 2015; Phelan et al., 
1999; Sokpor et al., 2017). In addition, the BAF complex core also comprises one of two ATPase 
subunits, brahma related gene 1 (BRG1) or brahma (BRM) (Ho and Crabtree, 2010; Lessard et al., 
2007; Wang et al., 1996). Peripheral subunits (also referred to as variant subunits) bind to the core 
subunits, and exhibit far greater diversity (Ho and Crabtree, 2010; Mashtalir et al., 2018). As a result 
of this diversity, it is believed that hundreds of possible permutations exist in assembling discrete 
BAF complexes (Narayanan and Tuoc, 2014a; Ronan et al., 2013; Sokpor et al., 2017). Because 
distinct subunits possess various protein domains (including but not limited to, DNA binding domains 
as well as bromo- and chromodomains, etc.), the properties of the BAF complex as a whole is a 
reflection of its particular subunit composition (Ho and Crabtree, 2010; Sokpor et al., 2017; Yoo and 
Crabtree, 2009). Accordingly, BAF complex interacts with TFs, coactivators, corepressors and histone 
modifiers in a manner that depends on its assembly (Ho and Crabtree, 2010; Narayanan et al., 2015; 
Narayanan and Tuoc, 2014a; Wu, 2012). This structural and functional diversity is presumed to 
endow the BAF complex with the ability to regulate gene expression profiles in a cell lineage-specific 
manner (Ho and Crabtree, 2010; Sokpor et al., 2017). For example, in embryonic stems cells (ESCs), 
proliferation and pluripotency are associated with the presence of a BAF complex comprising BRG1, 
BAF60a/b, BAF155 and BAF250a but not BRM, BAF60c, BAF170 and BAF250b (Ho et al., 2009; Kaeser 
et al., 2008; Kidder et al., 2009; Sokpor et al., 2017). In another example, neuronal progenitors 
express BAF45A and BAF53A, which is replaced by BAF45B and BAF53B as progenitors leave mitosis 
and differentiate into neurons (Ho and Crabtree, 2010; Olave et al., 2002; Yoo et al., 2009). 
Interestingly, the BAF53B subunit is a key regulator of activity-dependent dendritic morphogenesis 
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in neurons (Wu et al., 2007). From a mechanistic point of view, it is plausible that all possible 
combinations of the BAF complex share a similar mode of action, namely the utilization of energy 
derived from the hydrolysis of ATP by its core subunits BRG1 or BRM to orchestrate structural 
changes within the chromatin by direct alteration of histones and nucleosomes (Cairns, 2007; 
Hargreaves and Crabtree, 2011; Yoo and Crabtree, 2009). 
 
 The role of BAF complex in regulation of developmental processes  
As described above, the diverse subunit composition of the BAF complex enables it to play various 
roles in a cell lineage dependent manner, with wide ranging implications for embryonic development 
and tissue formation (Lessard et al., 2007; Matsumoto et al., 2006; Nguyen et al., 2016; Tuoc et al., 
2013a). Unsurprisingly, the BAF complex has also been implicated in numerous pathologies, such as 
developmental disorders and several forms of cancer (Alfert et al., 2019; Kadoch et al., 2017; Sokpor 
et al., 2017).  
Over the last few years, several studies have investigated the involvement of BAF complex in 
neuronal development in more detail (Sokpor et al., 2017). The most telling illustration of its 
importance comes from phenotype analysis of conditional mutant mice in which BAF complex 
expression is entirely lost (Narayanan et al., 2015). This can be achieved by simultaneous deletion of 
BAF155 and BAF170, which causes the dissociation of the entire BAF complex, followed by 
ubiquitination and subsequent degradation of its constituent subunits, effectively obliterating any 
BAF-complex dependent remodeling of chromatin (Narayanan et al., 2015). When the loss of BAF 
complex is triggered in the telencephalon at E8.5, shortly before the onset of neurogenesis, the 
telencephalon entirely fails to develop (Narayanan et al., 2015). When activated at E10.5 in cortex, 
the deletion of BAF complex results in hypotrophic and underdeveloped cortical structures 
(Narayanan et al., 2015). These results highlight the importance of BAF complex integrity for proper 
brain development.  
The role of BAF complex has also been studied with respect to cellular proliferation and 
differentiation during neurogenesis (Sokpor et al., 2017). Several reports indicate that NSCs 
(including NECs and RGCs) express a BAF complex variation whose composition is characteristic of 
their type, the NSC/neuronal progenitor - npBAF complex (Chen et al., 2012; Ho and Crabtree, 2010; 
Lei et al., 2015; Li et al., 2010; Meng et al., 2018; Oh et al., 2008). Among the subunits composing 
this cell-type specific BAF complex, BRG1, BAF45A/D, BAF53A and BAF55A are known to be 
indispensable for NSCs proliferation (Lessard et al., 2007; Matsumoto et al., 2006; Staahl et al., 
2013). Furthermore, the composition of the BAF complex in RGCs determines whether these cells 
engage in direct or indirect modes of neurogenesis, that is, by directly generating neurons or by 
producing intermediate progenitors (Tuoc et al., 2013b). Two of the core subunits have been 
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implicated in this phenomenon, BAF170 and BAF155 (Tuoc et al., 2013b). More precisely, direct 
neurogenesis is favoured when BAF170 is incorporated into the BAF complex, whereas the 
dominance of BAF155 promotes indirect neurogenesis (Tuoc et al., 2013b). In addition, the BAF 
complex has been implicated in various other neurodevelopmental processes, such as neuronal 
migration, dendritic morphogenesis, neuronal subtype determination and even adult neurogenesis 
(Lessard et al., 2007; Ninkovic et al., 2013; Olave et al., 2002; Petrik et al., 2015; Tuoc et al., 2017; 
Wiegreffe et al., 2015; Woodworth et al., 2016; Wu et al., 2007).  
Overall, these wide ranging effects of BAF complex on neural development clearly identify it as a 
potential molecular switch capable of orienting progenitors born at different places and time 
towards a common fate.        
 
BAF complex in regulation of gliogenic switch and astrocyte differentiation 
Although BAF complex is known to have a profound effect on neurogenesis, only few studies have 
investigated its involvement in astrogliogenesis. What studies exist have relied on deletion of a 
single BAF complex subunit, have investigated the effect of BAF complex outside of the forebrain, or 
during adult gliogenesis rather than in embryonic development. As a result the interpretation of 
these studies in the context of embryonic forebrain astrogliogenesis is haphazard at best.  
For example, Matsumoto and colleagues have investigated the effects of Nestin-Cre driven deletion 
of BRG1 on embryonic astrogliogenesis in the cortex and spinal cord (Matsumoto et al., 2006). The 
loss of BRG1 caused an apparent loss of astrogliogenesis. This was possibly due to a precocious 
exhaustion of the progenitor pool. Another study examined the role of BRG1 deletion in adult 
neurogenesis. Surprisingly the study found that deletion of BRG1 in adult NSCs abolishes production 
of neurons and directs differentiation towards astroglia (Ninkovic et al., 2013). These contradictory 
findings raise the possibly that BRG1 plays different roles in embryonic versus adult astrogliogenesis. 
Finally, a previous study from our laboratory (Tuoc et al., 2017) investigated the role of BAF170 in 
adult neurogenesis and found that deletion of this subunit from adult NSCs in dentate gyrus (DG) 
leads to the depletion of their pool, and promotes terminal differentiation towards astrocytes.       
Although these studies are insufficient to establish what role the BAF complex as a whole plays in 
embryonic astrogliogenesis, some hints can be found elsewhere in the literature. For example, it has 
been suggested that BAF complex interacts with the nuclear corepressor complex (N-CoR) through 
some of its subunits (Underhill et al., 2000). N-CoR was shown to repress astrogliogenesis: indeed, 
NSCs deprived of N-CoR are unable to proliferate in vitro, and their differentiation to GFAP-
expressing astroglial cells is enhanced (Hermanson et al., 2002). Furthermore, another chromatin 
remodeler, the polycomb repressive complex (PcR) has been shown to repress neurogenesis, and 
thus indirectly enabling astrogliogenesis (Hirabayashi et al., 2009). Interestingly, it is known that BAF 
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complex can evict PcR from its binding site on chromatin, through which it could potentially 
antagonize its repression of neurogenesis and putative enhancement of astrogliogenesis 
(Hirabayashi et al., 2009; Kadoch et al., 2017).   
Overall, the existing literature on the involvement of BAF complex on astrogliogenesis is scarce and 
insufficient to come to a satisfying conclusion. However, the importance of BAF complex on 
neurogenesis, and the evidence described here led us to anticipate that BAF complex potentially also 
exerts a powerful regulatory effect on astrogliogenesis.  
 
1.5 Aims and approaches 
 
The literature reviewed so far clearly indicates that astrocytes play indispensable roles in the 
function of the CNS. Because astrocytes form a connected network, it is crucial that they are 
generated in appropriate numbers during development to ensure full coverage of the cerebral 
parenchyma as well as minimal overlap between individual astrocytic domains. These requirements 
are challenging and imply that the number of astrocytes generated must keep pace with the number 
of neurons born previously, as neurogenesis typically precedes astrogliogenesis. Adding to that 
complexity, we have described that cells of the astroglial lineage are born at various locations (MGE, 
LGE and cortical VZ), both pre- and postnatally, and yet this diverse developmental landscape must 
culminate in the establishment of an integrated network of mature astrocytes. These observations 
raise the question of the molecular events guiding astroglial development and led us to wonder 
about the existence of a unique molecular regulator capable of guiding progenitors born at various 
time and places towards a common fate as well as ensuring the formation of an appropriate number 
of mature astrocytes with respect to the existing neuronal population. Such a molecular mechanism 
may involve the powerful chromatin remodeling BAF complex, which is already known to exert 
control over proliferation and differentiation in the neural lineage.  
Therefore, in the present thesis, we investigated the role of BAF complex in astroglial and neuronal 
lineages. To this end, we first investigated the expression of several BAF subunits (namely; BRG1, 
BAF155, BAF170, BAF60a and BAF250a) in both lineages using immunohistochemistry in distinct 
areas of perinatal brain tissue. Progenitors of the astroglial lineage were identified by combined 
expression of NFiA and GLAST together with careful analysis of their localization with respect to 
known germinal zones. This approach enabled us to identify unique BAF subunit expression 
dynamics characteristic of astroglial cells, which clearly differed from the neuronal lineage.   
Subsequently, we investigated the function of BAF complex in astrogliogenesis. To this end, we used 
a double conditional knockout (dcKO) mouse model in which expression of BAF155 and BAF170 was 
lost. As described above, the loss of these two core subunits is sufficient to abolish the complete BAF 
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complex within affected cells. Cre-dependent BAF subunit deletion was driven by the hGFAP 
promoter, enabling us to target late cortical neurogenesis and dorsal and ventral astrogliogenesis. 
Using a combination of immunohistochemistry, EdU incorporation assay, in utero electroporation 
and RNA sequencing, we describe the impact of BAF complex depletion in both neuronal and 
astroglial lineages, finding a profound numerical imbalance between these populations.    
Finally, we sought to identify the molecular pathways that BAF complex could potentially influence 
to exert its effects on the abundance of astroglial cells. To this end, we used RNA sequencing and 
RNA in situ hybridization to single out a molecular factor known to be involved in astroglial 
proliferation which was massively upregulated in our dcKO model. By means of pharmacological 
inhibition, we then provide the first recorded evidence of the interaction of this molecular factor 
with the BAF complex in this cell lineage.  
 
The results described herein provide convincing evidence of the role of BAF complex in regulating 
the proliferation, differentiation and number of cells of the astroglial lineage. Based on this novel 
evidence, we propose an original model of BAF complex function, whereby a cell lineage-dependent 
BAF complex subunit composition acts as a guardian of the balance between neuronal and astroglial 
populations in the developing mouse brain.   
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Chapter 2  
 
Materials and Methods 
 
 
 
2.1 Animals and animal procedures 
 
All animal procedures described in the present doctoral thesis were carried out in accordance with 
Directive 2010/63/EU of the European Parliament and the Council on the protection of animals used 
for scientific purposes and with the German Animal Protection Law.  
All mice were housed with a 12 hours (h) light/dark circadian cycle with freely accessible food and 
water. The highest efforts were made to refine housing conditions and reduce the numbers of 
animals used for the experimental procedures.   
For all studies carried out on embryonic stages the day of detection of vaginal plug (at noon) is 
equivalent to the embryonic day (E) 0.5. For experiments involving postnatal stages the day of birth 
was considered as postnatal day (P) 0.  
 
Investigated animals  
  
 Transgenic colonies 
By means of Cre/loxP system (Sauer, 1998), five different BAF155/BAF170 mutant mouse lines were 
generated and used for the experiments presented in this study; 
• BAF155_BAF170dcKO_hGFAP line (genotype: BAF155fl/fl, BAF170fl/fl, Cre+) carrying hGFAP 
promoter driven, Cre dependent BAF155 and BAF170 dcKO, henceforth referred to as either 
hGFAP-Cre dcKO or dcKO; 
• BAF155_BAF170dcKO_tdTomato_hGFAP reporter line (genotype: BAF155fl/fl, BAF170fl/fl, 
ROSA+/-,  Cre+) exhibiting hGFAP promoter driven, Cre dependent BAF155 and BAF170 dcKO 
coupled with tdTomato (tdTOM) red fluorescent protein expression, also referred to as 
either hGFAP-Cre dcKO tdTomato or dcKO. 
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Because of mutation severity, animals from both of the above described dcKO lines were dying 3-4 
days after birth.  
• BAF155_BAF170Het_tdTomato_hGFAP reporter line (genotype: BAF155fl/+, BAF170fl/+, 
ROSA+/-, Cre+)  with hGFAP promoter driven, Cre dependent heterozygous loss of BAF155 
and BAF170 coupled with tdTOM red fluorescent protein expression, henceforth described 
either as hGFAP-Cre Het tdTomato or as Het; 
• BAF170cKO_hGFAP line (genotype: BAF170fl/fl, Cre+) carrying Cre dependent conditional loss 
of BAF170 driven by hGFAP promoter, henceforth referred to as BAF170KO; 
• BAF155_BAF170dcKO_Olig2 line (genotype: BAF155fl/fl, BAF170fl/fl, Cre+) with oligodendro-
cyte transcription factor 2 (Olig2) promoter driven, Cre dependent BAF155 and BAF170 
dcKO, further described as Olig2-Cre dcKO; because of mutation severity animals from this 
line were dying at birth. 
 
Generation of mouse lines 
Transgenic colonies were obtained by crossing previously described parental colonies: BAF155fl/fl 
(Choi et al., 2012), BAF170fl/fl (Tuoc et al., 2013b), hGFAP-Cre (Zhuo et al., 2001), Olig2-Cre (Zawadzka 
et al., 2010) and ROSA-tdTomato (Ai9 Cre reporter allele) (Madisen et al., 2010). All mice were 
maintained in a C57BL6/J genetic background.  
In brief, BAF155_BAF170dcKO_hGFAP and BAF170cKO_hGFAP animals were obtained by crossing 2 
intermediate lines:  BAF155fl/fl_BAF170fl/fl (line with homozygous flox of BAF155 and BAF170 alleles) 
and BAF155fl/+_ BAF170fl/fl_hGFAP (line with heterozygous flox of BAF155 allele, homozygous flox of 
BAF170 allele and Cre expression under control of hGFAP promoter). The BAF155fl/fl_BAF170fl/fl line 
was initially generated by crossing BAF155fl/fl line with BAF170fl/fl animals. The resulting BAF155fl/+_ 
BAF170fl/+ mice were crossed together and animals with homozygous flox of BAF155 and BAF170 
alleles were chosen for the final steps of BAF155_BAF170dcKO_hGFAP line generation. For the 
creation of the intermediate BAF155fl/+_ BAF170fl/fl_hGFAP line, BAF155fl/fl_BAF170fl/fl animals were 
crossed with hGFAP-Cre line. The resulting mice heterozygous for BAF155 and BAF170 flox 
(BAF155fl/+_ BAF170fl/+) and positive for Cre expression (BAF155fl/+_ BAF170fl/+_hGFAP) were crossed 
to each other for the final generation of BAF155fl/+_BAF170fl/fl_ hGFAP line or BAF170cKO_hGFAP 
line. 
BAF155_BAF170dcKO_tdTomato_hGFAP reporter line was created through the final crossing of 2 
intermediate lines:  BAF155fl/fl_BAF170fl/fl_Rosa+/+ (line with homozygous flox of BAF155 and BAF170 
alleles and homozygous for ROSA) and the previously described BAF155fl/+_ BAF170fl/fl_hGFAP. In 
order to generate BAF155fl/fl_ BAF170fl/fl_Rosa+/+ line, mice from above characterized BAF155fl/fl_ 
BAF170fl/fl line were crossed to ROSA-tdTomato animals. The generated BAF155fl/+_BAF170fl/+_ 
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ROSA+/- mice were crossed to each other and the resulting individuals with homozygous flox of 
BAF155 and BAF170 alleles and homozygous for ROSA were chosen for final crossings in order to 
obtain BAF155_BAF170dcKO_ tdTomato_hGFAP line. 
BAF155_BAF170Het_tdTomato_hGFAP reporter line was generated by crossing above described 
BAF155fl/+_ BAF170fl/+_hGFAP mice to ROSA-tdTomato mice.  
BAF155_BAF170dcKO_Olig2 mutation was achieved by crossing of 2 intermediate lines: the 
previously described BAF155fl/fl_BAF170fl/fl and BAF155fl/+_ BAF170fl/+_Olig2 (line with heterozygous 
flox of BAF155 allele, homozygous flox of BAF170 allele and Cre expression under control of Olig2 
promoter). The animals of BAF155fl/+_ BAF170fl/+_Olig2 intermediate line were generated by crossing 
BAF155fl/fl_ BAF170fl/fl mice to Olig2-Cre animals.   
 
 Experimental and control individuals  
Animals were genotyped by PCR as described in (Madisen et al., 2010; Narayanan, 2017; Tuoc et al., 
2013b). BAF155_BAF170dcKO_hGFAP (genotype: BAF155fl/fl, BAF170fl/fl, Cre+), BAF155_BAF170 
dcKO_tdTomato_hGFAP (genotype: BAF155fl/+, BAF170fl/+, ROSA+/- Cre+), BAF170cKO_hGFAP 
(genotype: BAF170fl/fl, Cre+) and BAF155_BAF170dcKO_Olig2 (genotype: BAF155fl/fl, BAF170fl/fl, Cre+) 
were used as the test specimens whereas the sibling animals of BAF155_BAF170dcKO_hGFAP, which 
did not exhibit the Cre recombinase mutation (regardless of BAF155 and BAF170 alleles being floxed) 
as well as BAF170fl/fl mice served as controls and are henceforth referred to as wild type (WT). 
Because of tdTOM tracing purposes in a few exceptional cases BAF155_BAF170Het_tdTomato_ 
hGFAP mice were used as control probes (whenever stated). Both genders of embryos and pups 
were subjected to the embryonic and early postnatal studies. Only male mice were selected for 
stereotaxic cortical stab experiments.  
 
Ethynyl deoxyuridine (EdU) thymidine analogue injection  
 
EdU thymidine analogue injection was performed for the purpose of labelling proliferative cells, as 
previously described in (Chehrehasa et al., 2009; Flomerfelt and Gress, 2016; Vega and Peterson, 
2005). EdU powder (ThermoFisher Scientific) was dissolved in phosphate buffered saline (PBS) with a 
pH of 7.2 (ThermoFisher Scientific) for a final concentration of 1mg/ml. The solution was pre-
warmed to 37oC prior to animal application. P3 mouse pups were administered a single 
intraperitoneal (IP) EdU injection with a final dosage of 3 mg/kg of mouse body weight.  Animals 
were sacrificed 30 minutes (min) after injection. Collected brain tissues were subsequently analyzed 
for EdU incorporation (see: Chapter 2. Materials and Methods. 2.4).   
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GLI antagonist (GANT61) inhibitor injection 
 
We performed GANT61 injections in order to effectively block glioma associated oncogene 1 (GLI1) 
mediated transcription in treated mice. GANT61 was used as GLI1 antagonist as previously described 
in (Lauth et al., 2007). The protocol of injection was modified from (Huang et al., 2014; Samanta et 
al., 2015). The GANT61 (Enzo Life Sciences) was prepared at the concentration of 0.5mg/ml in sterile 
dimethyl sulfoxide (DMSO) (Merck) with constant mixing for 2h to accomplish an effective 
dissolution. The inhibitor solvent DMSO alone was used as a vehicle in sham injections. Mice crossed 
for the purpose of breeding dcKO and WT were daily injected IP with vehicle (250 µl) or inhibitor 
(250 µl; 8.5mg/kg of mouse body weight). The injections were started at E15.5 stage of gestation 
and the experiment was terminated after 4 consecutive days of drug administration. Late E18.5 
brain tissues were collected, fixed and further analyzed by immunohistochemical methods 
(described in: Chapter 2. Materials and Methods. 2.4).    
 
In utero electroporation  
 
The method of in utero DNA injection and electroporation was adapted from (Saito, 2006; Saito and 
Nakatsuji, 2001). The purpose of the experiment was to trace the postnatal location of cells 
differentiating from late cortical RGCs.  
 
Injected DNA 
 As in (Minocha et al., 2015), the plasmid encoding for the enhanced green fluorescent protein 
(EGFP) expression under the control of cytomegalovirus early enhancer/chicken β actin (CAG) 
promoter - pCAG-IRES-EGFP (kindly provided by Dr. Francois Guillemot) served as an injection DNA. 
For the purpose of amplification the plasmid was transformed to E. coli DH5α strain competent 
bacteria (K 12 strain, Invitrogen). In short, following 10min incubation on ice, 10ng of plasmid were 
mixed with 200µl of competent bacteria. After 30min of incubation on ice, the bacteria were 
subjected to 45 seconds (sec) heat shock performed at 42oC. After that, the mixture was rapidly 
chilled on ice, enriched with 500µm of super optimal catabolite (SOC) medium (ThermoFisher 
Scientific) and incubated with shaking for 1h at 37oC. Subsequently bacteria were plated on lysogeny 
broth (LB) agar screening plates containing ampicillin (50μg/ml of ampicillin (Sigma Aldrich) in LB-
agar medium: 0.5% Yeast extract (Roth), 1% Peptone (Roth), 1% sodium chloride (NaCl) (Roth), 1.5% 
Agar (Roth) in deionized water (dH2O), pH 7.0) and incubated overnight at 37oC. Single colonies of 
bacteria isolated from the plate were afterwards subjected to an overnight culture in ampicillin 
supplemented LB medium (50μg/ml of ampicillin in 0.5% Yeast extract, 1% Peptone, 1% NaCl in 
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dH2O, pH 7.0) with constant shaking at 37oC. Following the mini scale preparation (QIAprep 
Miniprep kit, Qiagen) performed according to the manufacturer instructions, the isolated plasmid 
was assessed by the control restriction digestion (with NotI (New England BioLabs) and SalI (New 
England BioLabs) restriction enzymes, following manufacturers protocol) and the bacterial glycerol 
stock was prepared (600μl of bacteria mixed with 200μl of autoclaved 80% glycerol (Roth)) and 
frozen at -80oC. For the purpose of purification of higher quantity and better quality DNA desired for 
the in utero injection, the plasmid was amplified during an overnight culture inoculated from the 
previously prepared glycerol stock and subsequently maxi scale purified with the purification kit 
(EndoFree Plasmid Purification Kit, Qiagen) according to the manufacturer’s instructions. Plasmid 
DNA was dissolved in TE buffer (EndoFree Plasmid Purification Kit, Qiagen) to the final concentration 
of 2.5µg/µl. For the purpose of visualizing the injection site, right before surgery, the endotoxin free 
plasmid solution (2.5µg/µl) was mixed with 10% Fast Green (FG) (Fast Green FCF, Sigma Aldrich) 
((w/v) in PBS) in the proportion of 2:1.  
 
Injected animals 
Late E16.5-timed pregnant mice crossed for the BAF155_BAF170dcKO_hGFAP mutation (BAF155fl/fl_ 
BAF170fl/fl crossed to BAF155fl/+_BAF170fl/fl_hGFAP (cre+)) were used for this surgical procedure.  
Perioperative analgesia was achieved by subcutaneous injection of Carprofen (5mg/kg mouse body 
weight, Rimadyl, Pfizer). After approximately 30min the mouse was transferred to a sealed container 
where anesthesia was initiated by inhalation of 5% isoflurane (Forene, Abbvie) in pure oxygen. Once 
sedated, the animal was quickly placed in a supine position on a 37oC warm thermostatic heating 
pad (ATC 1000, World Precision Instruments) where anesthesia was maintained with 1.5-2.5% 
isoflurane in pure oxygen (flow speed: 0.8L/min) inhaled through a snout mask (Kopf Instruments). 
The depth of anesthesia and analgesia was assessed through the whole time of surgical procedure 
by monitoring of the rate of breathing and checking paw-pinch reflexes (Adams and Pacharinsak, 
2015). Ointment (Bepanthen, Bayer) was applied to protect the eyes from desiccation. The 
abdominal skin was disinfected with an antiseptic (Kodan, Shülke) and subsequently incised along 
the midline for a length of about 2.5cm (Figure 2). The abdomen was covered with sterile gauze 
(Nobatop 8, Nobamed) with a small opening hole manually excised to access the site of the surgery. 
A cut of about 2cm through the linea alba and peritoneum allowed access to the abdominal cavity. 
The embryos were gently pulled out on gauze. The gauze, exposed internal organs and the uterine 
horns containing the embryos were continuously moisturized with sterile and pre-warmed 0.9% 
sodium chloride (NaCl) (NaCl 0.9%, B. Braun). Tapered capillaries pre-pulled from borosilicate glass 
(GB150F-8P, Science Products) served as injection pipettes. The capillaries were heated and pulled 
actively by a micropipette puller (P-97, Sutter Instruments) with the conditions depending on 
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specific batch of used borosilicate glass. Before used, the capillaries were cut under the microscope 
(Axioscope 2 mot+, Zeiss) to a tip diameter of around 20µm. One µl of plasmid/FG solution (2:1) was 
pressure injected into the lateral ventricle of the right hemisphere of each embryo (Figure 2), using a 
pedal-controlled microinjector (PDES-02DX picospritzer, Npi). The head of each embryo was 
subsequently clasped with tweezer-like 5mm circular electrodes (CUY650P5, Nepa Gene) and the 
cathode was placed to the side of the developing somatosensory cortical area (Figure 2). Five 50ms 
long pulses of 35mV separated by 900ms intervals were delivered to each embryo. The electric field 
was generated by the pedal controlled electroporator (NEPA21, Nepa Gene). Afterwards the 
embryos were moisturized with sterile and pre-warmed 0.9% NaCl and subsequently returned into 
the peritoneal cavity. The abdominal muscles were sutured with the polyester surgical thread 
(Ethibond excel 6951H, Ethicon) and the skin wound was closed by clipping (AutoClip staple system, 
FST) (Figure 2). The animal was placed in the pre-warmed cage allowing for recovery. For analgesic 
and anti-inflammatory post-surgical care Carprofen was subcutaneously injected every 24h for 2 
consecutive days and Metamizol (1.5g/ml, Novaminisulfon, Zentiva) was given in drinking water. 
   
 
 
 
 
Figure 2 | Scheme depicting the procedure of in utero plasmid injection and electroporation. The 
abdomen of E16.5–time pregnant mouse was incised. The pCIG2/FG solution was injected to the lateral 
ventricle of each embryo. The specific orientation of electrodes allowed for the electroporation of the 
ventricle surface of the somatosensory area. After returning the embryos into abdominal cavity the 
mouse was sutured and allowed to recover. Adapted and modified from (Manfredsson, 2016). FG, Fast 
Green; pCIG2, pCAG-IRES-EGFP.   
  
    
Embryos were left in utero till delivery. Electroporated brain tissue was collected from P3 pups and 
the EGFP expression was assessed prior-fixation by epifluorescent stereomicroscope (SM21500, 
Nicon). Only EGFP positive brains were chosen for fixation, sectioning and further immunostaining 
analysis (protocols described in: Chapter 2. Materials and Methods. 2.2 and 2.4).    
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Stereotaxic cortical stab injury 
 
A blade stab lesion procedure was performed in order to induce reactive astrocytes (Figure 3) in 
adult animals (Allahyari and Garcia, 2015).  
 
 
 
 
 
Figure 3 | Scheme depicting the procedure and experimental paradigm of stereotaxic cortical stab 
injury. (A) Surgical scalpel blade (indicated by empty arrows) attached to the operator arm of stereotaxic 
frame. (B) Small craniotomy over the area of somatosensory cortex. Full arrow indicates Bregma, empty 
arrows indicate lowered scalpel blade. The anterior and posterior directions are indicated by a two 
headed arrow. (C) Experimental paradigm illustrating the generation of GFAP positive reactive astrocytes 
after 2-7 days from stab injury operation. b, Bregma; DPI, day post-injury; s, surgical scalpel blade.   
 
 
Stabbed animals 
P60 male mice (BAF170fl/fl with C57BL6/J background) were used for this surgical procedure. 
Perioperative analgesia was achieved by subcutaneous injection of Carprofen (5mg/kg mouse body 
weight, Rimadyl, Pfizer). After approximately 30min from analgesic administration the mouse was 
transferred to the secure lid container and exposed to the inhalant mixture of 5% isoflurane (Forene, 
Abbvie) in pure oxygen for the purpose of the initiation of anesthesia. The sedated animal was 
rapidly placed on a 37oC warm thermostatic heating plate (ATC 1000, World Precision Instruments) 
and the head was fixed in the small animal stereotaxic frame (Kopf Instruments). The anesthesia was 
continued by the administration of 1.5-2.5% isoflurane in pure oxygen (flow speed: 0.8L/min) via 
snout mask (Kopf Instruments). The depth of anesthesia was assessed by the monitoring of the rate 
of breathing and checking paw-pinch reflexes (Adams and Pacharinsak, 2015). The eyes were 
prevented from dehydration by the direct ointment application (Bepanthen, Bayer). The head was 
shaved, disinfected with an antiseptic (Kodan, Shülke) and subsequently administered to the local 
analgesia by subcutaneous lidocaine injection (2% Xylocaine, AstraZeneca). The scalp was opened by 
a small incision carried in parallel to anterior posterior axis. The periosteum tissue was removed and 
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the somatosensory area was delineated following the coordinates of -1.5 to -2mm  caudal and 3.5 to 
4mm medial from Bregma (Paxinos and Franklin, 2001). A small craniotomy was performed over the 
barrel cortex and a surgical scalpel blade (No. 11, Martor) was slowly lowered into the brain to a 
depth of 3mm using the arm of stereotaxic frame (Figure 3A and B). After retraction of the blade the 
surface of the brain was moisturized with a few drops of a pre-warmed and sterile 0.9% NaCl. 
Occasionally occurring bleedings were stopped by hemostatic gel sponge (Gelasypt, Sanofi).  
Afterwards the scalp was surgically stitched by polyamide surgical suture (6.0/697H, Ethilon) and the 
animal was placed in the pre-warmed cage allowing for recovery.  
For analgesic and anti-inflammatory post-surgical care Carprofen was subcutaneously injected every 
24h and Metamizol was administered in drinking water (1.5g/ml, Novaminisulfon, Zentiva). Stabbed 
animals were perfused at 2, 4 and 7 days post injury (DPI). The isolated brain slices were used for 
immunohistochemical stainings. Protocols for perfusion and immunohistochemical analysis are 
described below (see: Chapter 2. Materials and Methods. 2.2 and 2.4).   
 
2.2 Tissue fixation and processing 
 
Embryonic and early postnatal tissue 
 
E13.5–P3 brain tissues were used for the purpose of the embryonic and early postnatal studies.  
Following the opening of the skull, E15.5-P3 brains were extracted in chilled diethyl pyrocarbonate 
(DEPC) treated PBS (0.1% (v/v) DEPC/PBS) (PBS/DEPC). Because of small size and fragility the skull 
dissection step was omitted for E13.5 stages and the whole embryo head was used for further steps 
of this protocol. Residual blood was removed by rinsing with chilled PBS/DEPC. Collected tissues 
were transferred to ice-cold 4% paraformaldehyde (PFA) (w/v) in 0.1M phosphate buffer (PB) pH 7.4 
(4% PFA/PB) for: 4h (for E13.5 stage), 2h (for E15.5 stage), 2.5h (for E17.5 stage), 3h (for E18.5 and 
P0 stages) or 3.5h (for P3 stage) allowing for immersion fixation. Fixed tissues were rinsed with 
chilled PBS/DEPC and dehydrated by an overnight incubation in 25% sucrose (w/v) in PBS/DEPC at 
4oC. The following day, the tissues were placed in embedding medium for cryopreservation (O.C.T. 
Compound, Sakura) and stored at -20oC until sectioning.  
For brain coronal sections preparation, cryopreserved tissues were cut to a thickness of 14µm (for 
embryonic brains) or 18µm (for postnatal brains) with a cryostat (CM 3050S, Leica). Brain slices were 
collected on adhesion microscope slides (Superfrost Plus, ThermoFisher Scientific) and used for 
stainings (see: Chapter 2. Materials and Methods. 2.4). 
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Adult brains 
 
Adult brains were used for the reactive astrogliogenesis investigation or BAF complex subunits 
expression pattern studies. P60 non-injured and stab injured mice were perfused before the brain 
tissue dissection. At the day of experiment termination, mice were subjected to an overdose of 
Ketamine (10%, Medistar) injected IP. Once immobility and sedation were achieved, animals were 
transcardially perfused with 10% sucrose solution ((w/v) in dH2O) for 10min and subsequently with 
4% PFA/PB for 30min. Pre-fixed brains were isolated from the skull and subjected to an overnight 
fixation in 4%PFA/PB at 4oC. Afterwards fixative was removed, the brains were placed in sodium 
azide-containing PB (0.05% sodium azide (v/v) PB) and stored at 4oC until sliced.  
Containing somatosensory cortex medial regions of perfused brains were isolated and sliced through 
the lesions area (and corresponding areas for non-injured mice) into 30µm thick consecutive coronal 
sections using a vibratome (VT1200S, Leica). Prepared slices were collected in sodium azide treated 
PB and stored at 4oC until free floating immunohistochemical analysis (described in: Chapter 2. 
Materials and Methods. 2.4).  
 
2.3 Tissue preservation 
 
E17.5 and P3 embryonic and early postnatal cortical tissue as well as P3 tissue of basal ganglia area 
were isolated and cryopreserved for the purpose of further transcriptome and protein 
investigations. Cortex and basal ganglia were separated according to the protocols described in 
(Beaudoin et al., 2012; Schildge et al., 2013).  
Briefly, following decapitation E17.5 and P3 brains were dissected in chilled PBS/DEPC. The 
meninges, olfactory bulbs, thalamus and cerebellum were removed and the hemispheres were 
separated from each other. Subsequently following anatomical differences the cortical structure was 
removed from the basal ganglia. Isolated tissues were frozen in liquid nitrogen and stored at -80oC 
until used. E17.5 cortex was isolated chiefly by Linh Pham.  
 
2.4 Staining methods 
 
Fluorescent immunohistochemistry (on slide) 
 
The following protocol was used for immunohistochemical analyses performed on cryosectionned 
embryonic and early postnatal brain slices collected on microscope slides and preserved at -20oC. 
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Primary antibodies 
The following monoclonal (mAb) and polyclonal (pAb) primary antibodies were used in this protocol 
(corresponding dilutions and commercial sources shown in brackets): anti-ACSBG1 rabbit pAb 
(1:500, ab65154, Abcam), anti-BAF60a mouse mAb IgG2a (1:200, 611728, BD Biosciences), anti-
BAF155 mouse mAb IgG1 (1:100, sc-48350, Santa Cruz Biotechnology), anti-BAF170 mouse mAb IgG1 
(1:100, sc-17838, Santa Cruz Biotechnology), anti-BAF250a mouse mAb IgG1 (1:100, sc-32761, Santa 
Cruz Biotechnology), anti-BLBP rabbit pAb (1:200, ABN14, Merck Millipore), anti-BRG1 mouse mAb 
IgG1 (1:100, sc-17796, Santa Cruz Biotechnology), anti-CLEAVED CASPASE-3 rabbit pAb (1:200, 
#9661, Cell Signaling), anti-GFAP mouse mAb IgG1 (1:500, G3893, Sigma Aldrich), anti-GFAP rabbit 
pAb (1:400, Z0334, DakoCytomation), anti-GLAST guinea pig pAb (1:500, Af-1000-1, Frontier 
Institute), anti-GS mouse mAb IgG2a (1:200, MAB302, Merck Millipore), anti-Ki67 mouse mAb IgG1 
(1:20, NCL-L-Ki67-MM1, Leica Biosystems), anti-NFiA rabbit pAb (1:200, HPA006111-100UL, Sigma 
Aldrich), anti-SATB2 mouse mAb IgG1 (1:200, ab51502, Abcam), anti-SOX9 rabbit pAb (1:1000, 
AB5535, Merck Millipore).  
 
Secondary antibodies 
All secondary antibodies used in this protocol were diluted to 1:400. The list of applied secondary 
antibodies is as follows (corresponding commercial sources shown in brackets): goat anti-mouse 
IgG1 Alexa Fluor 488 (A-21121, Invitrogen), goat anti-mouse IgG2a Alexa Fluor 488 (A-21131, 
Invitrogen), goat anti-mouse IgG1 Alexa Fluor 568 (A-21124, Invitrogen), goat anti-mouse IgG1 Alexa 
Fluor 647 (A-21240, Invitrogen), goat anti-mouse IgG2a Alexa Fluor 633 (A-21136, Invitrogen), goat 
anti-rabbit Alexa Fluor 488 (A-21042, Invitrogen), goat anti-rabbit Alexa Fluor 568 (A-11011, 
Invitrogen), goat anti-rabbit Alexa Fluor 647 (A-21244, Invitrogen), goat anti-guinea pig Alexa Fluor 
488 (A-11073, Invitrogen), goat anti-guinea pig Alexa Fluor 568 (A-11075, Invitrogen), goat anti-
guinea pig Alexa Fluor 633 (A-21105, Invitrogen).  
 
Staining procedure 
Fourteen and 18µm thick cryopreserved sections (see: Chapter 2. Materials and Methods. 2.2) were 
thawed and washed with 0.01M PBS. Potential non-specific antibodies binding sites were blocked 
and the cell membranes were permeabilised by an 1h incubation with 5% normal goat serum 
(Biozol) and Triton X 100 (Roth) in PBS (0.1% (v/v) Triton X 100/PBS) (blocking solution). Next, 
primary antibodies diluted in blocking solution were applied and incubated overnight at 4oC. The 
following day the sections were thoroughly washed with 0.01M PBS and subsequently incubated at 
the room temperature (RT) for 2h with fluorophore-conjugated secondary antibodies diluted in 
blocking solution. After that, slides were rinsed with 0.01M PBS and the nuclei of cells were 
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counterstained by 5min incubation with 0.1% 4’ 6-diaminodino-2-phenylindole (DAPI) (Molecular 
Probes) (v/v) in blocking solution. Ultimately, the slides were washed with 0.01M PBS, drained and 
closed by mounting the coverslips (Menzel, ThermoFisher Scientific) with an aqueous mounting 
medium (Aqua-Poly/Mount, Polysciences). Immunostained slides were stored at 4oC until described 
further in this section fluorescence signal acquisition. 
 
Fluorescent immunohistochemistry (free floating) 
 
Free floating fluorescent immunohistochemistry was used for the detection of GFAP expression in 
30µm thick coronal sections of perfusion fixed (see: Chapter 2. Materials and methods. 2.2) adult 
brains so as to examine reactive astrogliogenesis. Additionally we used this procedure to investigate 
the expression of BAF complex subunits in protoplasmic astrocytes of adult (P60) WT animals.   
 
Primary antibodies 
The following monoclonal (mAb) and polyclonal (pAb) primary antibodies were used in this protocol 
(corresponding dilutions and commercial sources shown in brackets): anti-ACSBG1 rabbit pAb 
(1:500, ab65154, Abcam), anti-BAF60a mouse mAb IgG2a (1:200, 611728, BD Biosciences), anti-
BAF170 mouse mAb IgG1 (1:100, sc-17838, Santa Cruz Biotechnology), anti-BAF250a mouse mAb 
IgG1 (1:100, sc-32761, Santa Cruz Biotechnology), anti-BRG1 mouse mAb IgG1 (1:100, sc-17796, 
Santa Cruz Biotechnology), anti-GFAP mouse mAb IgG1 (1:500, G3893, Sigma Aldrich) and anti-GFAP 
rabbit pAb (1:400, Z0334, DakoCytomation). 
 
Secondary antibodies 
All secondary antibodies used in this protocol were diluted to 1:500. The list of applied secondary 
antibodies is as follows (corresponding commercial sources shown in brackets): goat anti-mouse 
IgG1 Alexa Fluor 488 (A-21121, Invitrogen), goat anti-mouse IgG1 Alexa Fluor 568 (A-21124, 
Invitrogen), goat anti-mouse IgG1 Alexa Fluor 647 (A-21240, Invitrogen), goat anti-mouse IgG2a Alexa 
Fluor 633 (A-21136, Invitrogen), goat anti-rabbit Alexa Fluor 488 (A-21042, Invitrogen).  
 
Staining procedure 
The 4oC stored slices were successively washed with 0.01M PB (pH 7.4), 0.0005M Tris buffer (Sigma 
Aldrich) (TB) (pH 7.6), 0.05M TB containing 0.9%NaCl (TBS) (pH 7.6) and Triton X 100 treated TBS 
(0.5% (v/v) Triton X 100/TBS, pH 7.6) (TBST) 2 times 15min each at RT. After that, the slices were 
subjected to the 1.5h blocking of non-specific antigens with 10% normal goat serum in bovine serum 
albumin (BSA, Sigma Aldrich) treated TBST (0.25% (v/v) BSA/PBS) (blocking solution) on a shaking 
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plate. Subsequently, the tissues were incubated overnight at 4oC with constant shaking with primary 
antibodies diluted in blocking solution. The following day the slices were washed 5 times with TBST 
buffer and subsequently incubated with the fluorophore-conjugated secondary antibodies diluted 
1:500 in TBST at RT for 2h. For the purpose of nuclei visualization stained slices were treated with 
DAPI (Molecular Probes) diluted 1:1000 in TBS buffer for 5min at RT. Following the successive steps 
of rinsing with TBS buffer (1 time) and TB buffer (3 times), the immunostained slices were mounted 
and coverslipped with mounting medium (Aqua-Poly/Mount, Polysciences). The slides were stored 
at 4oC until microscopy. 
 
EdU detection 
 
The experiment of EdU detection was performed on cryopreserved embryonic and early postnatal 
slices isolated from animals subjected to the analogue injection. EdU was stained by means of EdU 
detection kit (Click-IT plus EdU Alexa Fluor 647 Imaging Kit, ThermoFisher Scientific). The 
experimental procedure was carried out according to manufacturer’s protocol. Once stained for 
EdU, the sections were subjected to immunohistochemical analysis so as to perform colocalization 
studies.  
 
Chromogenic in situ hybridization  
 
The chromogenic in situ hybridization experiment was carried out in order to stain Gli1 transcripts by 
means of their detection with digoxigenin (DIG)-labelled Gli1 specific complementary (c) RNA probes 
(riboprobes). The experiment was performed on embryonic and early postnatal brain slices collected 
on microscope slides following cryosectioning and cryopreservation. The protocol was adapted from 
(Wagener et al., 2010).  
In order to minimize the risk of RNA degradation all possible steps were taken to remove RNA-
digesting RNAses from the experimental environment. All solutions used for this procedure were 
treated with DEPC (to the final concentration of 0.1% of DEPC) and subsequently autoclaved. All 
glassware and slide holders were baked for 4h in 180oC heated laboratory oven (Memmert, 400) one 
day before use. The experiment was carried out in RNAse free conditions from the moment of in 
vitro transcription reaction on.  
 
DIG-labelled probe generation 
Gli1 specific single strand antisense and sense DIG-labelled riboprobes were generated from the 
pBluescript vector containing the insert of 1266bp long fragment of mouse Gli1 cDNA (pm-Gli1) 
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kindly provided by Prof. Heidi Hahn and Dr. Anja Uhmann (Pelczar et al., 2013). As for the previously 
described pCAG-IRES-EGFP (see: Chapter 2. Materials and Methods. 2.1), the plasmid was amplified 
in E. coli DH5α strain competent bacteria and subsequently maxi scale purified by means of a 
purification kit (Plasmid Maxi Kit, Qiagen). Isolated circular pm-Gli1 plasmid DNA was subsequently 
subjected to linearization carried out by an enzymatic digestion with the adequate restriction 
enzymes (NotI and HindIII (ThermoFisher Scientific); NotI digested plasmids were used for the 
antisense probe generation whereas plasmid linearized with HindIII served further for the sense 
probe preparation). Restriction digestion reactions were run following the instructions provided by 
the enzyme producer. After the completion of enzymatic reaction the digestion mix was loaded onto 
a 1.5% agarose gel (1.5% agarose (Roth) in Tris /Borate/ Ethylenediaminetetraacetic acid (EDTA, MP 
Biomedicals LLC) (TBE) buffer). Following a short electrophoresis (performed at 90V), linearized 
forms of plasmid were extracted by purification kit (NucleoSpin Gel and PCR Clean-up, Maherey-
Nagel). For the purpose of DIG-labeled sense and antisense probe preparation, purified linearized 
pm-Gli1 plasmid forms were subjected to an in vitro transcription procedure in RNAse free 
conditions. For the antisense Gli1 probe generation the in vitro transcription reaction was performed 
with the T3 polymerase (Roche). For the purpose of the sense Gli1 probe preparation the linearized 
plasmid was transcribed with the T7 polymerase (Roche). The in vitro transcription reactions were 
carried out according to manufacturer’s instruction and labeling was achieved using DIG-labelled 
nucleotides (DIG RNA Labeling Mix, Roche). Once transcribed, the DIG-labelled sense and antisense 
probes were isolated by precipitation. The precipitation reaction was carried out with a pre-cooled (-
20oC) solution containing 4M Lithium Chloride (LiCl) and 100% ethanol (EtOH) in 0.2M EDTA and 
allowed to run for 2h at -80oC. Obtained pellets were washed with 70% EtOH and subsequently dried 
by the incubation at 37oC. The precipitated DIG-labelled riboprobes were dissolved in autoclaved 
and DEPC treated dH2O (0.1% (v/v) DEPC/ dH2O) and the quantity and quality was assessed by a 
fluorometer (Qubit 2.0, ThermoFisher Scientific). Prepared probes were stored at -80oC until used 
for in situ hybridization experiment. Shh riboprobes were kindly provided by Dr. Joanna Pyczek.     
 
 Chromogenic in situ hybridization (on slide) 
Cryopreserved sections (see: Chapter 2. Materials and Methods. 2.2) were thawed and subsequently 
subjected to 20min of post-fixation with 4%PFA/PB on ice. Once post-fixed the sections were rinsed 
2 times with 0.01M PBS 10min each. To block the endogenous peroxidase activity and therefore 
minimize the background staining, the tissues were incubated for 15min with 1% hydrogen peroxide 
(Roth) (v/v) in methanol (Roth). After that, slides were washed 2 times for 2min with 0.01M PBS and 
then subjected to 0.2M hydrochloric acid (HCl, Merck) for 8min for the purpose of tissue 
permeabilization and protein extraction. Following 2min wash with 0.01M PBS, the permeabilization 
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step was continued by 3min of incubation with proteinase K-containing solution (Sigma Aldrich, 
20µg/ml in 1M TB buffer, pH7.5, 0.0005M EDTA, pH 8.0).  Subsequently, the slides were rinsed for 
5min with 0.01M PBS. Tissue integrity was preserved by means of subsequent 20min incubation on 
ice with 4%PFA/PB. To further minimize background, slices were incubated in a solution containing 
0.1M triethanolamine hydrochloride with 0.2% acetic anhydride and then washed once with 0.01M 
PBS and once with 2x saline sodium citrate (SSC) buffer, pH 7.0 ((diluted with DEPC/ dH2O from 20x 
SSC: 0.3M NaCl, 0.03M sodium citrate (Sigma Aldrich)) for 5min each. Following successive steps of 
dehydration with 30% EtOH, 50% EtOH (20sec each), 70% EtOH (1min), 80% EtOH, 95% EtOH, twice 
100% EtOH (20sec each), the tissues were incubated with the hybridization buffer (HB) ((50% 
formamide (Roth) (v/v), 4×SSC (diluted with DEPC/ dH2O from 20x SSC), 250 µg/ml DNA, MB-grade 
from the fish sperm (Roche), 100 µg/ml tRNA (Roche), 5% dextran sulfate (D8906-109, Sigma 
Aldrich) (v/v), 1% Denhardt’s solution (D9905, Sigma Aldrich) (v/v)) for 1h at 55oC and finally 
hybridized with DIG-labeled Gli1 or Shh sense and antisense probes diluted in HB to the final 
concentration of 200 ng/ml overnight at 55oC. The following day the tissues were subjected to high-
stringency consecutive washings with 5xSSC (diluted with DEPC/ dH2O from 20x SSC) for 1min at 
65OC, 50% formamide (v/v) in 2xSSC (diluted with DEPC/ dH2O from 20x SSC) for 30min at 65oC, 50% 
formamide (v/v) in 1xSSC (diluted with DEPC/ dH2O from 20x SSC) for 30min at 65oC and 0.1xSSC 
(diluted from 20x SSC) for 30min at 65oC. After that, the slices were washed 3 times with TBS pH 7.5 
at 30oC, 2min each and subsequently treated with 1% blocking reagent (Roche) (v/v) in TBS pH 7.5 
for 30min at RT. Following blocking step the tissues were incubated overnight at 4oC with anti-DIG 
alkaline phosphatase (AP) conjugated antibody (Anti-Digoxigenin-AP, Roche) diluted in blocking 
buffer in the proportion of 1:500. After that, the sections were successively rinsed with TBS pH7.5 (2 
times, 10min each) and with the reaction buffer ((0.1M Tris-HCl, 0.1M NaCl pH 9.5, 0.05M 
magnesium chloride (MgCl2) (Roth)) 1 time for 10min. The AP signal was developed by incubation 
with a developing solution composed of a mixture of 4-Nitro blue tetrazolium chloride (NBT, Roche) 
and 4-toluidine salt (BCITP, Roche) in the reaction buffer. The developing solution was prepared 
following producer’s instructions. The intensity of developing signal was assessed by a microscopic 
control (Axioscope 2 mot+, Zeiss). After obtaining a satisfying signal quality, the reaction was 
interrupted by washing with TBS buffer. The slides were then coverslipped (Menzel, ThermoFisher 
Scientific) following mounting with Kaiser's glycerol gelatine medium (Merck). The sections 
hybridized with sense probes were considered as a negative control (no signal observed after the 
development step) whereas sections hybridized with antisense probe were considered as stained for 
Gli1/Shh transcripts. The developed slides were stored at 4oC until microscopic signal acquisition 
(described in: Chapter 2. Materials and Methods. 2.5).  
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2.5 Image acquisition and processing  
 
Bright field microscopy 
 
The bright field micrographs of the coronal sections stained for Gli1 mRNA expression were captured 
by means of 25x objective (LCI Plan-Apochromat, Zeiss) of an Axio Imager 2 light microscope (Zeiss). 
The microscope was controlled by the Neurolucida software (MBF Bioscience) and the images were 
digitized with a CCD camera (Retiga 2000R, Qimaging). The final bright field images of the brain 
sections, as they appear in figures, are minimum intensity projections of the image stacks acquired 
with 1µm z-step size.  
The overview bright field images of the P3 WT and dcKO brains were acquired with a light 
stereomicroscope (M205FA, Leica) operated by a Leica application suite X software platform (LAS X, 
Leica).  
 
Fluorescence microscopy   
 
The fluorescence images were acquired with the following confocal scanning laser microscopes: 
• TCS SP2 (Leica) with a 20x objective (HC PL APO 20x/0.70 IMM, Leica), the microscope was 
controlled by Leica confocal software (LCS, Leica) and the table motor was controlled by the 
arivis software (arivis Vision4D, arivis AG);  
• TCS SP5 (Leica) with the use of a 40x objective (HCX PL APO CS 40.0x1.25 OIL UV, Leica) and 
63x objective (HCX PL APO CS 63×/1.40-0.60 OIL, Leica), the microscope was operated by 
Leica application suite advanced fluorescence software (Las AF, Leica); 
• TCS SP8 (Leica) with the use of a 20x objective (HC PL APO CS2 63x/1.40 OIL, Leica) and 63x 
objective (HC PL APO CS2 63x/1.40 OIL, Leica), the microscope was controlled by LASX 
software (LAS X, Leica). 
 
The fluorescent images presented in the figures 4-11 and 15-17 are single plane acquisitions. The 
other micrographs are maximum intensity projections of the acquired image stacks (stacks with 1µm 
z-step size acquired with 40x as well as 63x objectives; stacks with 3.5µm z-step size acquired with 
20x objectives). 
 
The confocal microscopy with TCS SP5 and TCS SP8 was carried out at the Facility for Innovative Light 
Microscopy (FILM) at the Max Planck Institute for Biophysical Chemistry, Göttingen.   
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Image processing 
 
The images were processed according to their signal, background and noise magnitude. Adequate 
corrections of colour levels, colour range and noise as well as pseudo colour applications were done 
by means of Photoshop software (Photoshop CS6, Adobe) and LAS X software (LAS X, Leica). Image 
stack acquisitions of fluorescent micrographs were projected for maximal intensity with LAS X 
software. Minimal intensity projections of bright field image stacks were achieved by means of 
Neurolucida software (Neurolucida, MBF Bioscience). Multiple frame acquisitions obtained with TCS 
SP2 or TCS SP5 confocal microscopes were manually stitched by use of arivis software (arivis 
Vision4D, arivis AG) or Adobe Photoshop. Multiple frame micrographs acquired by TCS SP8 confocal 
microscope were automatically merged by LAS X software. 
CorelDraw X6 (CorelDRAW Graphics Suite X6, Corel) served as a software for manual drawing of 
schematics or final figure arrangements.  
 
2.6 Cell quantifications and statistical analysis 
 
Quantifications and measurements 
 
All cell quantifications presented in this thesis were performed manually by means of Neurolucida 
software (MBF Bioscience). 
 
 Cells with fluorescence signal 
Cells expressing analyzed marker detected by immunofluorescence and positive for nuclear DAPI 
staining were manually registered along the z axis of the acquired confocal image stacks. Cells were 
quantified from the region of interest chosen before immunostaining (Paxinos et al., 2006) and 
imaged accordingly. The quantifications were made from the total area of the acquired micrographs. 
Images of cortex were stitched before quantification in order to analyze the entire cortical thickness. 
Additionally the absolute number of cells in the quantified area was measured by manual 
quantifications of DAPI counterstain positives. In the majority of cases, the final numbers of marker-
expressing cells were normalized to the absolute numbers of DAPI positives in the quantified area.  
 
 Cells with chromogenic signal 
Gli1 positive cells detected by chromogenic in situ hybridization were manually counted directly 
under the microscope (Axioscope 2 mot+, Zeiss). The areas of interest (cortex and VP) were 
delineated manually based on the comparisons to the reference brain coronal sections taken from 
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(Paxinos et al., 2006). The surface area of regions of interest was calculated by Neurolucida 
software. The final numbers presented in the figures are densities of Gli1 positive cells in defined 
regions of interest.  
 
Immunofluorescence intensity (FI) measurements 
Semi-automated FI measurements were performed on the 40x confocal image stacks of 
immunofluorescent stainings of BAF complex subunits. The purpose of this analysis was to assess the 
BAF complex subunits expression levels in astrocytic RGCs as well as in AGPs and CP cells, and to 
compare it to the BAF complex subunit expression levels found in other cell types in the section 
under scrutiny.  
Briefly, first all of BAF subunit positive cells were manually marked using the Neurolucida software. 
The software marker was placed directly over the most brightly fluorescent spot of the cell. Another 
Neurolucida marker was used to register NFiA positive/GLAST positive AGPs and placed in the same 
manner. In cortical areas, NFIA positive/GLAST positive cells of the CP were registered separately 
from those located in the VZ. The delineation of CP and VZ was estimated visually from the DAPI 
staining and with help from (Paxinos et al., 2006). NFIA positive/GLAST positive cells in the CP were 
considered to be AGPs, whereas those in the VZ were considered as astrocytic RGCs.  
After that the coordinates of manually placed markers were exported and used together with 
corresponding stack images for the automated FI measurements in ImageJ (Fiji, NIH). There, a 
custom written script automatically measured the average FI within a radius of 5µm from each 
marker. FI measurements were taken only from the channel containing the BAF immunostaining. 
The ImageJ script was written by Pavel Truschow.  
This procedure resulted in large datasets, where one FI value was assigned to every manually placed 
marker. These values were subsequently normalized to the highest FI value in the dataset.   
Normalized data were represented as Beeswarm plots (plot spread points) generated by the 
plotSpread function, downloaded from www.mathworks.com and modified accordingly in Matlab 
(r2010b, Mathworks). Additionally FIs of individual BAF subunits stainings revealed for each 
investigated cortical cellular population of WT P0 mice (astrocytic RGCs, AGPs and CP cells) were 
averaged in Excel spreadsheet (Excel 2013, Microsoft) and subsequently represented by scatterplot 
generated in Sigma Plot 12 (Systat) and arranged in CorelDraw X6 (CorelDRAW Graphics Suite X6, 
Corel).  
 
Density plots 
Distribution density plots of cells expressing any given marker (GLAST, BLBP or Gli1) were generated 
for 2 analyzed cortical areas (M2 and S1BF) in E17.5 and P3 WT and dcKO animals.  
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Briefly, the marker of interest was registered manually along the z axis of the analyzed stack (as 
described above) and within manually delineated columns. Columns were covering the full cortical 
thickness (from the VZ (E17.5)/deep cerebral white (DW) (P3) up to the PS). Because of anatomical 
differences the thickness of the columns differed between WT and dcKO. The size of columns was 
assessed with the quick measure line function of the Neurolucida software. The relative distance of 
each registered individual cell to the PS was calculated based on Neurolucida markers’ coordinates 
with NeurolucidaExplorer (MBP Bioscience). Columns were divided into 16 equally sized bins (from 
the PS to the VZ/DW) and the density of cells in each bin was calculated per mm3. The calculations 
were made in Excel spreadsheet (Excel 2013, Microsoft) and the final density plots were generated 
in Sigma Plot 12 (Systat) and arranged in CorelDraw X6 (CorelDRAW Graphics Suite X6, Corel).  
 
 Anatomical size assessment 
The medio-lateral (M-L) and rostro-caudal (R-C) extent as well as the cortical thickness of P3 WT and 
dcKO brains were measured by the quick measure line function of the Neurolucida software. 
 
Statistical analysis 
 
Datasets were processed in Excel for calculation of final means and standard deviations.  
Statistical analysis was done by means of Sigma Plot 12 (Systat). The statistical difference between 
the analyzed groups was assessed on the basis of student’s t-test and Mann-Whitney Rank-Sum test. 
The Mann-Whitney Rank-Sum test was used whenever data were not normally distributed, and 
normality of distribution was tested using Shapiro-Wilk or equal variance tests. The difference 
between the input groups was not considered significant if the resulting p-value exceeded 0.05. The 
scale of significance levels in figures is as follows: *p≤0.05, **p ≤0.01, *** p≤0.001, **** p≤0.0001. 
All graphs shown in this thesis were generated by Sigma Plot and subsequently arranged in 
CorelDraw X6 (CorelDRAW Graphics Suite X6, Corel). 
 
2.7 Protein isolation and Western blot (WB) 
 
WB was used to compare the levels of BAF155 and BAF170 protein expression in cortex of dcKO and 
WT E17.5 mice.  
 
Extraction of proteins 
E17.5 cortical tissues cryopreserved at -80°C (see: Chapter 2. Materials and Methods. 2.3) were 
thawed on ice and subsequently mixed with 2x non-reducing sample buffer (Pierce Lane Marker, 
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ThermoFisher Scientific). Following 2 cycles of tissue sonication using an ultrasonic homogenizer 
(Sonoplus, Bandelin Electronics) the proteins were subjected to reduction with 5% β-
mercaptoethanol (2-Mercaptoethanol, Sigma Aldrich) and subsequently denaturated at 95oC for 
5min. The concentration of isolated proteins was assessed by spectrophotometric measurements of 
the absorbance at 280nm performed with NanoDrop (NanoDrop2000, ThermoFisher Scientific). 
Extracted protein samples were stored at -80oC until use.  
 
Western blot 
Cryopreserved protein samples were thawed on ice and subsequently subjected to molecular 
weight-dependent protein separation facilitated by sodium dodecyl sulfate (SDS)-polyacrylamide gel 
(PAGE) electrophoresis. Briefly, 150µg of proteins of each isolated sample (3 WT and 3 dcKO) were 
loaded on previously prepared SDS-polyacrylamide gel (10% resolving gel: Acrylamide (Roth), 1.5M 
Tris pH 8.8, 10% SDS (w/v) in H2O (Sigma Aldrich), 10% ammonium persulfate (APS) (Sigma Aldrich), 
tetramethylethylenediamine (TEMED) (Sigma Aldrich) in dH2O; 4% stacking gel: Acrylamide, 0.5M 
Tris pH 6.8, 10% SDS (w/v) in H2O, 10% APS, TEMED in dH2O; poured immediately after mixing 
between 2 glass plates (Mini-protean , Bio-Rad), the 10 well comb (Mini-protean, Bio-Rad) was 
placed accordingly after pouring). After that the proteins were separated in an electric field of 100V 
for 1.5h.  
Following SDS-PAGE electrophoresis proteins were subjected to polyvinylidene difluoride (PDVF) 
membrane (Immobilon-P, Merck) transfer by wet-blotting at 150A for 1.5h. The PDVF membrane 
was pre-treated with 100% methanol (for 15sec) and the blotting chamber was filled with transfer 
buffer (2.9% (w/v) Glycine, 6% (w/v) Tris, 20% (v/v) Methanol and 0.04% (v/v) SDS in H2O). 
Afterwards the membrane was into 3 parts (1 containing proteins of the size of ≥170kDa, second 
containing proteins of the size between 160 and 50kDa and third containing proteins with the 
molecular weight ≤50kDa), washed with 0.01M PBS for 10min and subsequently blocked for 1h with 
5% milk powder (w/v) in 0.01M PBS (blocking solution) on a rocking plate. Once blocked, the 
membranes were incubated overnight on a rocking plate at 4oC, with the adequate primary 
antibodies: anti-BAF170 rabbit pAb (1:500, ab64853, Abcam); anti-BAF155 mouse mAb IgG1 (1:200, 
sc-48350, Santa Cruz Biotechnology) and anti-GAPDH mouse mAb IgG1 (1:2000, TA802519, OriGene) 
diluted in blocking solution in corresponding proportions. The following day the membranes were 
rinsed 2 times with 0.2% (v/v) Tween 20 (Roth) in 0.01M PBS (PBST) and then incubated for 2h at RT 
with the corresponding horseradish peroxidase (HPR) conjugated secondary antibodies (goat anti-
mouse (115-035-003, Dianova) and goat anti-rabbit (111-035-003, Dianova)) diluted in blocking 
solution in the proportion of 1:2000. After that the immunoblots were rinsed with PBST 3 times 
15min each. The HRP derived signal was then developed by means of a Western Blotting Detection 
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Kit (ECL, Amersham) following the manufacturers instruction. The chemoluminescent signal was 
detected with the Fluorchem Q (FluorChem Q system, Protein simple) and the signal intensity was 
measured by ImageJ (Fiji, NIH).  
 
2.8 RNA isolation and RNA sequencing (RNA-seq) 
 
RNA isolation and subsequent RNA-seq experiment was performed in order to reveal and compare 
the dorsal pallium (DP) and/or ventral pallium (VP) transcriptome of E17.5 and P3 WT and dcKO 
mice. In total 4 control and 4 mutant E17.5 or P3 DP as well as 4 control and 4 mutant P3 VP 
transcriptomes were sequenced.   
 
RNA isolation 
The cryopreserved E17.5 and P3 tissues (see: Chapter 2. Materials and Methods. 2.3) were subjected 
to the total RNA extraction by use of the RNA purification kit (RNeasy Plus Mini, Qiagen) following 
manufacturer’s protocol. All of the steps of the purification were performed in RNAse free 
conditions. Isolated RNA was stored at -80oC until sequencing.  
 
RNA sequencing 
RNA-seq (cDNA library preparation, quality control assessment, sequence reads and transcriptome 
assembly) were carried out in collaboration with Prof. André Fischer’s laboratory (with help of Dr. 
Cemil Kerimoglu and Susanne Burkhardt, University Medical Center (UMG), German Center for 
Neurodegenerative Diseases (DZNE)). In brief, cDNA libraries were generated by means of Library 
Prep Kit (TruSeq RNA Library Prep Kit v2, Illumina) following manufacturer’s instructions.  
Subsequently the quality of prepared DNA was assessed by Agilent 2100 Bioanalyzer. FASTQ 
conversions and base calling were performed by use of Illumina scripts as described in (Halder et al., 
2016). The transcriptome was assembled by mapping of the reads to the mm10 mouse reference 
genome by means of STAR aligner v2.3.0 as previously described in (Djebali et al., 2012) and 
subsequent differential expression studies were performed by DESeq2, Bioconductor as previously 
described in (Love et al., 2014). Gene ontology (GO) Enrichment Analysis (ToppGene; 
http://geneontology.org/) (Chen et al., 2009) allowed for revealing the mutant enriched 
transcriptome pathways. Minor transcriptome analysis e.g. enriched glioma transcripts or 
downregulated late born neuron transcripts were performed on the basis of literature screening. 
The graphs were prepared in Sigma Plot 12 (Systat), RStudio (CRAN.R-project) as well as Matlab 
(r2010b, Mathworks) and subsequently arranged in CorelDraw X6 (CorelDRAW Graphics Suite X6, 
Corel).    
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Chapter 3  
 
Results 
 
 
 
3.1 Dynamic expression pattern of BAF complex subunits during astrocytogenesis  
 
The aim of this study was to elucidate the impact of BAF complex on astrocytes development. We 
started our investigation from the analysis of BAF complex expression pattern within the astroglial 
lineage during the initial steps of forebrain astrogliogenesis. As astrocytes specification sets on 
within RGCs at later stages of mouse brain development (Rowitch and Kriegstein, 2010), a first step 
towards our goal was to assess BAF subunits expression within this particular cell lineage.    
 
BAF subunits expression in astrocytic RGCs 
Primarily forebrain astrocytes arise from astrocytic RGCs that reside in VZ of the perinatal cortex, 
LGE and MGE (Bayraktar et al., 2014; Minocha et al., 2015; Tsai et al., 2012). This developmental 
feature guided our choice of areas for investigation. Furthermore it is known that cortical 
astrogliogenesis starts during the late phase of embryonic development, around gestational stage 
E17.5 (Minocha et al., 2015; Mission et al., 1991; Rowitch and Kriegstein, 2010). However the exact 
time point of the initiation of astrogliogenesis within ventral (residing in MGE and LGE) RGCs remains 
unclear (Minocha et al., 2017). Because the astrogliogenic potential of perinatal ventral germinal 
zones has been described (Bayraktar et al., 2014; Gallo and Deneen, 2014; Minocha et al., 2015; Tsai 
et al., 2012) we therefore focused our investigation of astrocytic RGCs of MGE and LGE on the E17.5 
developmental time point. Additionally, regardless of embryonic stage of development, RGCs exhibit 
the set of hallmarks typical for astroglial lineage, expressing inter alia astrocyte specific markers like 
GLAST (Chaboub and Deneen, 2012; Malatesta et al., 2000; Shibata et al., 1997). Hence the exact 
identification of the astroglial switch within RGCs is highly hindered by their durable expression of 
astroglial characteristics. This aspect impedes the choice of a proper cellular marker of astrocytic 
RGCs. Several lines of evidence indicate de novo induction of NFiA within the RGCs residing in the VZ 
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during the initiation of the gliogenic period (Chaboub and Deneen, 2013; Deneen et al., 2006; Gallo 
and Deneen, 2014; Rowitch and Kriegstein, 2010). However, due to the broad range of cells 
expressing NFiA through the full thickness of the perinatal cortex (Bunt et al., 2017), this marker 
could not be used as an exclusive indicator of astrocytic RGCs. Thus we chose to identify RGCs 
committed to astrocyte lineage by their simultaneous expression of NFiA and GLAST (Deneen et al., 
2006; Kang et al., 2012).  
Considering these points, expression of BAF complex subunits was immunohistochemically assessed 
in NFiA/GLAST positive astrocytic RGCs from the areas of MGE, LGE and cortical VZ of WT E17.5 
murine brains. BAF complexes consist of different assemblies of numerous subunits (Kadoch and 
Crabtree, 2015; Sokpor et al., 2017; Son and Crabtree, 2014). We investigated expression of 5 BAF 
subunits, including a catalytic ATPase subunit - BRG1, two invariable scaffolding subunits: BAF155 
and BAF170 (Narayanan and Tuoc, 2014b; Phelan et al., 1999; Ronan et al., 2013; Yoo and Crabtree, 
2009), and two randomly chosen variant subunits; the actin dependent regulator of chromatin -
BAF60a (Chen et al., 2012; Meng et al., 2018; Oh et al., 2008) and the AT-rich interaction domain 
containing - BAF250a (Lei et al., 2015; Li et al., 2010).  
Overall the BAF subunits analyzed exhibited ubiquitous expression in many regions of stained brain 
tissues (data not shown). The gradual staining throughout the full cortical thickness allowed for the 
discrimination of the group of cells residing in VZ with only few BAF subunit positive cells found in 
the adjacent SVZ (Figure 4 and 11). Unlike in cortex, the ventral telencephalon staining for most of 
the BAF subunits investigated did not highlight a clear distinction of VZ residing cells (in LGE and 
MGE) (Figure 5 and 6).  
All of the analyzed BAF complex subunits were detected in astrocytic RGCs of E17.5 WT murine 
cortex (Figure 4A-E), LGE (Figure 5A-E) and MGE (Figure 6A-E) VZs. Quantitatively, more than 80% of 
NFiA/GLAST positive astrocytic RGCs analyzed in all 3 astrocytic germinal zones exhibited expression 
of each investigated BAF complex subunit (Figure 4-6, F). The immunoreactivities towards BRG1, 
BAF155, BAF60a and BAF250a were close to 100% (97.8±0.97%, 99.8±0.15%, 98.6±0.79% and 
98.0±0.92% of cortical astrocytic RGCs; 98.3±0.56%, 99.7±0.3%, 98.8±0.56% and 98.2± 0.45% of LGE 
astrocytic RGCs and 98.3±0.75%, 99.9±0.12%, 99.0±0.57% and 98.1±0.46% of MGE RGCs positive for 
BRG1, BAF155, BAF60a and BAF250a respectively). Given that the high level of colocalization 
between BAF subunits and NFiA/GLAST positive astrocytic RGCs did not show sizeable variations 
between single investigated animals (for BRG1 in cortex VZ: n=6, in LGE VZ: n=5 and in MGE VZ: n=5, 
for the rest of subunits in all investigated regions: n=4), the expression of BRG1, BAF155, BAF60a and 
BAF250a emerges as the perpetual ubiquitous feature of astrocytic RGCs. Strikingly the expression of 
BAF170 subunit seemed to deviate from this trend (Figure 4-6C and F). In all examined areas at least 
10% of astrocytic RGCs did not exhibit immunohistochemically detectable levels of BAF170 subunit
36 
 
 
 
Figure 4 | Expression of BAF complex subunits in murine astrocytic cortical RGCs. (A-E) Staining of E17.5 
cortical WT sections for astroglial progenitor markers; GLAST (green), NFiA (red) as well as BAF subunits 
(pseudo coloured in blue): BRG1 (A), BAF155 (B), BAF170 (C), BAF60a (D) and BAF250a (E). DAPI staining 
is gray (pseudo coloured). Cells expressing GLAST and NFiA located in VZ are astrocytic RGCs. Directions 
to VZ and CP pointed by two headed arrow, the border between VZ and IZ marked by dashed line. Right 
boards of (A-E) are magnifications of delineated VZ areas. Full arrowheads indicate astrocytic RGCs 
expressing BAF subunit, empty ones point to lack of expression. (F) Percentages of BAF subunit positive 
cells per total GLAST/NFiA positive VZ RGCs. Data are averages ± σ of n=4-6 replicates (BRG1: n=6, 
BAF155, BAF170, BAF60a and BAF250a: n=4). Cx, cortex; CP, cortical plate; VZ, ventricular zone; WT, wild 
type. 
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(89.2±3.7%, 87.1±1.6% and 84.4±1.8% of astrocytic RGCs positive for BAF170 staining in the area of 
cortical, LGE and MGE VZ respectively). This finding may indicate a potential gradual decline of 
BAF170 scaffolding subunit within a small population of astrocytic RGCs. Interestingly the astrocytic 
RGCs from the area of MGE shown the lowest rate of the colocalization with stained BAF170 subunit 
(84.4%, Figure 6F). MGE VZ has been reported as an area where astrogliogenesis may start earlier 
than typical for cortex day E17.5 (Minocha et al., 2017; Minocha et al., 2015). Thus the decrease of 
the amount of cells exhibiting immunohistochemically detectable BAF170 expression within 
astrocytic RGCs seems to be correlated with the level of the advancement of the astroglial 
development within the germinal zones analyzed.  
Furthermore, considering that cell specific BAF complexes function as multimeric assemblies of at 
least 15 different subunits (Lessard et al., 2007; Narayanan et al., 2015; Sokpor et al., 2017; Wu et 
al., 2007), the immunostaining approach seems insufficient for the evaluation of the entire BAF 
complex presence within astrocytic RGCs. However the final assembly and functionality of the cell 
type specific BAF complex depends on the presence of the common core and scaffolding subunits 
(Phelan et al., 1999; Sokpor et al., 2017). Thus taking into account the fact that BAF155 and BAF170 
belong to the group of the BAF complex core and scaffolding proteins (Phelan et al., 1999; Sokpor et 
al., 2017), we could extrapolate the existence of the entire astrocytic RGCs complex. Additionally the 
analysis of the expression of the BRG1 ATPase protein, a main core catalytic subunit for the majority 
of known nervous system BAF complexes (Kadoch and Crabtree, 2015; Trotter and Archer, 2008; Yoo 
and Crabtree, 2009), confirms the soundness of the chosen approach. Accordingly, the distinct 
variant subunits integrate to the core and scaffolding proteins assembling the final complexes 
(Narayanan and Tuoc, 2014b; Ronan et al., 2013). Therefore the expression of the BAF60a and 
BAF250a within astrocytic RGCs that possess ATPase and scaffolding proteins may be taken as 
indication that the entire BAF complex assembles properly and includes the subunits we analyzed 
here.  
 
Overall, based on our immunostaining and quantifications, we conclude that the perinatal astrocytic 
RGCs residing in the VZ of cortex, LGE and MGE (all known astroglial germinal zones) express protein 
subunits: BRG1, BAF155, BAF170, BAF60a and BAF250a, which together indicates proper assembly of 
the BAF chromatin remodeling complex.   
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Figure 5 | Expression of BAF complex subunits in RGCs of murine LGE. Immunostaining of mouse E17.5 
LGE WT sections for astroglial progenitors markers; GLAST (green), NFiA (red) as well as BAF complex 
subunits (in blue, pseudo coloured): BRG1 (A), BAF155 (B), BAF170 (C), BAF60a (D) and BAF250a (E). The 
nuclear DAPI staining is grey (pseudo coloured). Cells expressing GLAST and NFiA located in VZ of LGE are 
astrocytic RGCs. Right boards of each (A-E) are magnified insets of delineated VZ areas. Full arrowheads 
indicate astrocytic RGCs expressing investigated BAF complex subunit, empty arrowheads indicate lack of 
expression. Quantitative analysis of the percentages of BAF subunit positive cells per total GLAST/NFiA 
positive VZ RGCs (F). Data are averages ± σ of n=4-5 animals (BRG1: n=5, BAF155: n=4, BAF170: n=4, 
BAF60a: n=4, BAF250a: n=4). LGE, lateral ganglionic eminence; VZ, ventricular zone; WT, wild type.   
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Figure 6 | Expression of BAF complex subunits in RGCs of murine MGE. (A-E) Immunostaining of mouse 
E17.5 MGE WT sections for astroglial progenitors markers; GLAST (in green) and NFiA (in red) as well as 
BAF complex subunits (in blue, pseudo coloured): BRG1 (A), BAF155 (B), BAF170 (C), BAF60a (D) and 
BAF250a (E). The nuclear DAPI staining is gray (pseudo coloured). Cells expressing GLAST and NFiA 
located in VZ of MGE are astrocytic RGCs. Right boards of each (A-E) are magnified insets of delineated VZ 
areas. Full arrowheads indicate astrocytic RGCs expressing BAF complex subunit, empty arrowheads 
indicate lack of expression. (F) Percentages of BAF subunit positive cells per total GLAST/NFiA positive VZ 
RGCs. Data are averages ± σ of n=4-5 animals (BRG1: n=5, BAF155: n=4, BAF170: n=4, BAF60a: n=4, 
BAF250a: n=4). MGE, medial ganglionic eminence; VZ, ventricular zone; WT, wild type.   
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Differential expression of BAF subunits in astrocytic precursor cells 
The findings described above suggest the presence of BAF complex in the astrocytic RGCs, an initial 
progenitor cell lineage that further sequentially differentiates towards astrocytes (Gray and Sanes, 
1992; Molofsky and Deneen, 2015; Rowitch and Kriegstein, 2010). At the onset of astroglial 
differentiation, some of the astrocytic RGCs detach from the surface of the VZs and translocate their 
cellular bodies outside of germinal zones (Cameron and Rakic, 1991; Guillemot, 2007; Marshall and 
Goldman, 2002; Minocha et al., 2015; Mission et al., 1991; Molofsky and Deneen, 2015; Rowitch and 
Kriegstein, 2010). These cells, AGPs, undergoing transient amplification (Ge and Jia, 2016; Ge et al., 
2012) transform into astrocytes after reaching their final destinations (Ge et al., 2012; Kriegstein and 
Alvarez-Buylla, 2009; Molofsky and Deneen, 2015). Given that many studies indicate that reshuffling 
of the subunit composition of the BAF complex has a profound impact on the process of cellular 
differentiation (Bachmann et al., 2016; Kadoch and Crabtree, 2015; Lessard et al., 2007; Tuoc et al., 
2013b; Vogel-Ciernia and Wood, 2014; Wu et al., 2007), we next evaluated the expression of 
previously investigated subunits within AGPs. Accordingly, we immunohistochemically assessed the 
expression of BRG1, BAF155, BAF170, BAF60a and BAF250a within NFiA/GLAST expressing AGPs that 
migrated towards the pia mater (as the derivatives of cortical VZ astrocytic RGCs (Bayraktar et al., 
2014; Tsai et al., 2012), Figure 7A-E) or deeper into the striatum (caudate putamen (CPu) or central 
amygdala nucleus (CANu) areas as the derivatives of LGE and MGE VZ astrocytic RGCs (Bayraktar et 
al., 2014; Tsai et al., 2012), Figure 8A-E). We identified AGPs by their combined expression of NFiA 
and GLAST. We chose double immunostaining approach over single marker investigation because 
cells exhibiting solely GLAST or NFiA immunoreactivity could be mistaken for non-astrocytic cells, as 
GLAST is widely expressed by non-astrocytic outer radial glial progenitors (oRGPs) (Heng et al., 2017) 
and a broad range of cells express NFiA (Bunt et al., 2017)). In order to track the dynamics of the 
subunit changes we opted for analysis in the cortical and striatal regions of brain tissues isolated 
form WT mice at the gestational stages of E17.5 and P0 (Figure 7 and 8). 
The percentages of E17.5 cortical and striatal AGPs expressing BRG1, BAF170, BAF60a and BAF250a 
visibly differ from that of astrocytic RGCs (Figure 4-8F). The E17.5 NFiA/GLAST positive AGPs 
exhibited lowered staining affinity towards these BAF complex subunits (Figure 7 and 8). As depicted 
in colour coded matrixes, the expression pattern of BAF170 in AGPs showed the most dramatic 
changes (Figure 7C, F and 8C, F). A quantitative analysis indicated that in E17.5 brains only 19.3±1.3% 
of cortical and 12.8±1.2% striatal AGPs exhibited immunohistochemically detectable levels of 
BAF170 protein (Figure 7F and 8F). Interestingly, the reduction in the amount of NFiA/GLAST positive 
AGPs exhibiting BRG1, BAF60a or BAF250a staining progressed in time. The number of 88.2±1.8% of 
cortical AGPs expressing BRG1 at E17.5 significantly declined to 77.9±6.7% at P0 (Figure 7A and F). 
The difference in BRG1 expression within striatal AGPs emerges as more striking (Figure 8A and F). In 
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Figure 7 | BAF complex subunits exhibit time dependent differential expression pattern within cortical 
AGPs. (A-E) Immunofluorescence staining of E17.5 (left panels of each) and P0 (right panels of each) WT 
coronal cortical sections (AuCx area) detecting the expression of GP/ AGP markers; GLAST (in green) and 
NFiA (in red) as well as BAF complex subunits (in blue and gray): BRG1 (A), BAF155 (B), BAF170 (C), 
BAF60a (D) and BAF250a (E). Cells co-expressing GLAST and NFiA found outside of VZ are AGPs. For each, 
the lower boards are single channel gray scale images of analyzed BAF subunit. Full arrowheads indicate 
AGPs positive, whereas empty arrowheads point to AGPs negative for immunohistochemical detection of 
corresponding BAF complex subunit. In each E17.5 section the border between IZ and CP is outlined with 
dashed line. Overview pictures of P0 brains stained for BAF155 or BAF170 are shown in Appendix, Figure 
42 (provided here pictures were taken in regions delineated by dashed line (1)) (F) Quantitative analysis 
of the amount of BAF subunit positive GLAST/NFiA positive cortical AGPs. Colour coded matrix shows the 
percentage share of cortical AGPs expressing analyzed BAF complex subunit in 6 investigated WT animals 
harvested at 2 different time points: E17.5 (WT1, WT2 and WT3) and P0 (WT1, WT2 and WT3). Dark blue 
indicates high whereas light blue colour indicates low percentage of AGPs with immunohistochemically 
detectable expression of BAF complex subunit. Numbers stated under each matrix column are average 
percentage data ± σ for n=3-7 experimental replicates (BRG1/E17.5: n=7, BRG1/P0: n=5, BAF155/E17.5: 
n=4, BAF155/P0: n=4, BAF170/E17.5: n=4, BAF170/P0: n=4, BAF60a/E17.5: n=4, BAF60a/P0: n=6, 
BAF250a/E17.5: n=4, BAF250a/P0: n=3). Statistically significant reduction in AGPs exhibiting staining for 
corresponding BAF complex subunit marked by stars; **p≤0.01, ***p≤0.001, NS not significant (for 
BAF170) in t student test, for BAF155: NS not significant in Mann Whitney Rank Sum test (P<0.05 in 
Normality Shapiro-Wilk test). Quantifications performed in full cortical column (excluding VZ/DW) of S1BF 
and AuCx areas. CP, cortical plate; IZ, intermediate zone; NS, not significant; WT, wild type. 
 
 
E17.5 striatum 90.3±2.2% AGPs stained for BRG1, however in P0 murine striatal regions only 
70.9±3.8% NFiA/GLAST positive AGPs expressed detectable levels of BRG1 (Figure 8F). Similarly the 
fraction of 87.2±2.4% of cortical or 86.0 ±1.7% striatal AGPs exhibiting staining for BAF60a 
significantly decreased to 75.6±4.4% or 58.1±4.1% respectively (Figure 7D, F and 8D, F). Likewise, in 
case of BRG1 and BAF60a the number of BAF250a positive cortical and striatal AGPs significantly 
declined from 93.0±1.4% and 92.7±3.3% in E17.5 to 77.4±4.1% and 71.9±4.1% in P0 cortical and 
striatal areas respectively (Figure 7E, F and 8E, F). Previously described BAF170 expression pattern 
within E17.5 cortical and striatal AGPs did not significantly vary by comparison to the neonatal stage 
of development (Figure 7C, F and 8C, F). Intriguingly, among all analyzed BAF complex subunits, only 
BAF155 exhibited a high degree of colocalization with NFiA/GLAST positive AGPs (for E17.5 cortical 
AGPs: 99.6±0.8%, for E17.5 striatal AGPs: 98.3±0.2%), which did not significantly change over the 
time (for P0 cortical AGPs: 99.4±0.7%, for P0 striatal AGPs: 97.9±0.7%, Figure 7B, F and 8B, F). 
Overall we could observe a significant downregulation of the percentages of the cortical and striatal 
AGPs positive for BRG1, BAF170, BAF60a and BAF250a staining during the course of murine brain 
development. This however does not apply to BAF155, which was present in predominant fraction of 
NFiA/GLAST positive cortical and striatal AGPs (close to 100%). 
 
Even though some of AGPs did not stain for the investigated BAF complex subunits, a variable 
fractions of these cells were labelled, indicating expression of the targeted subunits (Figure 7-8A-E).
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Figure 8 | BAF complex subunits exhibit time dependent differential expression pattern within ventral 
AGPs. (A-E) Immunofluorescence staining of E17.5 (left panels of each) and P0 (right panels of each) WT 
coronal VP sections (CANu area) detecting the expression of GP/ AGP markers; GLAST (in green) and NFiA 
(in red) as well as BAF complex subunits (in blue and gray): BRG1 (A), BAF155 (B), BAF170 (C), BAF60a (D) 
and BAF250a (E). Cells expressing GLAST and NFiA are AGPs.  For each, down boards are single channel 
gray scale images of analyzed BAF complex subunit. Full arrowheads indicate AGPs positive, whereas 
empty arrowheads point AGPs negative for immunohistochemical detection of corresponding BAF 
complex subunit. Overview pictures of P0 brains stained for BAF155 or BAF170 are shown in Appendix, 
Figure 42 (provided here pictures were taken in regions marked by 2). (F) Quantitative analysis of the 
amount of BAF subunit positive ventral AGPs expressing GLAST/NFiA. Colour matrix shows the 
percentage share of ventral AGPs expressing analyzed BAF complex subunit in 6 investigated WT animals 
harvested at 2 different time points: E17.5 (WT1, WT2 and WT3) and P0 (WT1, WT2 and WT3). Dark blue 
colour relates to high whereas light blue colour relates to low percentage share of AGPs with 
immunohistochemically detectable expression of BAF complex subunit. Numbers stated under each 
column of matrix are average percentage data ± σ for n=3-4 WT animals (BRG1/E17.5: n=4, BRG1/P0: 
n=4, BAF155/E17.5: n=4, BAF155/P0: n=4, BAF170/E17.5: n=3, BAF170/P0: n=4, BAF60a/E17.5: n=3, 
BAF60a/P0: n=4, BAF250a/E17.5: n=4, BAF250a/P0: n=3). Statistically significant reduction between 
investigated developmental stages in AGPs exhibiting staining for corresponding BAF complex subunit 
marked by stars; ***p≤0.001, NS not significant in t student test. Quantifications performed in the areas 
of CANu and CPu. CANu, central amygdala nucleus; NS, not significant; WT, wild type.   
 
 
Thus as a next step we decided to investigate the exact levels of BAF complex subunits expressed by 
AGPs and evaluate them with reference to their global expression pattern. Accordingly, we 
measured the average FI of examined BAF complex subunits for each cell exhibiting subunit positive 
staining within P0 murine cortex (Figure 9) and striatum (Figure 10). The FI of corresponding BAF 
subunit was subsequently evaluated within AGPs found in the same cortical or striatal region. All of 
the FIs acquired for a single evaluated section were then normalized to the highest value registered 
within the entire group of analyzed cells (the highest FI=1, see Chapter 2. Materials and Methods. 
2.6).  
As represented in beeswarm plots (Figure 9 and 10 A’-E’), the cells expressing given BAF subunit 
showed a broad range of staining intensities (blue colour data points, considered as ‘BAF subunit 
expression levels’). Strikingly the FIs measured for BRG1, BAF170 and BAF60a within cortical and 
striatal AGPs were among the lowest acquired and usually amounted to 20-30% of the highest 
registered value (Figure 9 and 10 A’-E’). The FI of BAF250a expressed by cortical AGPs tended to be 
minimally elevated by comparison to that of above described subunits (many of cells exhibited 
fluorescence as high as 60% of the highest value). However striatal AGPs showed equally low 
BAF250a FIs (comparing to striatal AGPs FI measured for BRG1, BAF170 and BAF60a). As previously 
described and unlike other investigated subunits, the vast majority of AGPs stained for BAF155. 
Strikingly, as shown in Figure 9B, B’ and 10B, B’, these AGPs did not exhibit FIs that could be easily 
classified as ‘high’ or ‘low’. To the contrary, some of AGPs exhibited the highest BAF155 FIs found 
among all investigated cells, whereas other shown rather low levels of staining (well presented in 
Figure 10B, cells pointed by white arrows). The diverse and widely fluctuating FIs of BAF155 subunit 
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Figure 9 | Diminished expression levels of BAF complex subunits in AGPs of murine cortex. (A-E) 
Coronal tissue sections through WT murine P0 cortex (AuCx area) stained with antibodies to AGP 
markers; GLAST (in green) and NFiA (in red) together with antibodies detecting BAF complex subunits (in 
blue, pseudo coloured): BRG1 (A), BAF155 (B), BAF170 (C), BAF60a (D) and BAF250a (E). The nuclei of 
cells stained with DAPI (in pseudo colour gray). Cells simultaneously expressing GLAST and NFiA are AGPs. 
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Second, third and fourth panel of each shows magnified insets of delineated areas. The rightmost boards 
are single channel images of immunofluorescence signal for adequate BAF complex subunit. Full 
arrowheads point to AGPs and their expression of corresponding BAF complex subunit, empty 
arrowheads point to non-astrocytic cells and their expression of adequate BAF complex subunit. Cell 
bodies of indicated AGPs outlined with dashed line. Overview pictures of P0 brains stained for BAF155 or 
BAF170 are shown in Appendix, Figure 42 (provided here pictures were taken in regions marked by 1). 
(A’-E’) FI analysis of P0 cortical sections (S1BF and AuCx for each) stained with antibodies to BAF complex 
subunits: BRG1 (A’), BAF155 (B’), BAF170 (C’), BAF60a (D’) and BAF250a (E’). Beeswarm plots represent 
readouts of FIs for given BAF subunit staining normalized to the highest value of readout among all 
analyzed cells (=1) for all BAF subunit positive (blue data points) and AGPs (red data points). Data points 
are single readouts of BAF FIs from cortical areas of n=3 animals (results for WT1 plotted as data points in 
shape of star, results for WT2 plotted as dots, results for WT3 plotted as data points in shape of cross). 
AGPs, astroglial progenitors; Cx, cortex; NFI, normalized fluorescence intensity; WT, wild type. 
 
 
expressed by AGPs may indicate highly dynamic changes in BAF155 abundance within this cell type. 
It was described that changes in expression levels of certain BAF proteins exert an influence on the 
expression of other complex subunits (Chen and Archer, 2005; Panamarova et al., 2016; Tuoc et al., 
2013b). In particular, it has been shown that the abundance of BAF155 depends on the amount of 
BAF170. Indeed, the knockout (KO) of BAF170 increases BAF155 expression (Tuoc et al., 2013b). 
Thus the elevated expression levels of BAF155 reflected in high FIs could be initially caused by a 
reshuffle of the BAF complex composition within AGPs, where we found a substantially reduced 
abundance of BAF170 (Figure 7C-10C). On the other hand the observed decreased FIs of BAF155 
within some of the investigated AGPs (Figure 9B’ and 10B’) may suggest that initially elevated (as 
described above, by the diminished abundance of BAF170) expression levels of BAF155 start to be 
downregulated, as in case of other investigated subunits. Thus overall we assume that AGPs can be 
described as cells exhibiting declining levels of BAF subunits expression.   
 
In the course of brain development, RGCs differentiate to various neural cell types (Chojnacki and 
Weiss, 2008; Gotz and Barde, 2005). It is well established that cortical RGCs differentiate towards 
neurons initially (E10.5-E16.5/E17.5) and astrocytes later (approximately from E17.5) (Gotz and 
Barde, 2005; Kriegstein and Alvarez-Buylla, 2009; Rowitch and Kriegstein, 2010). To globally compare 
the differences in BAF complex subunits expression during RGCs differentiation towards astrocytic 
and non-astrocytic cells (neurons) we evaluated the FIs of BAF complex subunits within three 
populations of perinatal murine neural cells: RGCs, AGPs and CP residing cells. We chose to 
investigate the FIs of all cells found in CP assuming that the majority of these were neurons (thus 
considering the averaged readouts for CP as neuronal). As in the FI measurements described above, 
we averaged FIs of each examined BAF complex subunit for every cell exhibiting a positive staining 
within the full cortical thickness of developing S1BF area of P0 mouse brains. The FIs for the 
corresponding BAF subunit were subsequently evaluated within AGPs, RGCs and cells residing in CP
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Figure 10 | Diminished expression levels of BAF complex subunits in AGPs of murine VP. (A-E) Coronal 
tissue sections through WT murine P0 VP (CANu/CPu area) stained with antibodies to AGP markers; 
GLAST (in green) and NFiA (in red) together with antibodies detecting BAF complex subunits (in blue, 
pseudo coloured): BRG1 (A), BAF155 (B), BAF170 (C), BAF60a (D) and BAF250a (E). The nuclei of cells 
stained with DAPI (in pseudo colour gray). Cells simultaneously expressing GLAST and NFiA are AGPs. 
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Second, third and fourth panel of each shows magnified insets of delineated areas. The right most boards 
are single channel images of immunofluorescence signal for adequate BAF complex subunit. Full 
arrowheads point to AGPs and their expression of corresponding BAF complex subunit, empty 
arrowheads point to non-astrocytic cells and their expression of corresponding BAF complex subunit. Cell 
bodies of indicated AGPs outlined with dashed line. Overview pictures of P0 brains stained for BAF155 or 
BAF170 are shown in Appendix, Figure 42 (provided here pictures were taken in the regions marked by 
2). (A’-E’) FI analysis of P0 VP sections (CANu/CPu area) stained with antibodies to BAF complex subunits: 
BRG1 (A’), BAF155 (B’), BAF170 (C’), BAF60a (D’) and BAF250a (E’). Beeswarm plots represent readouts of 
FI for adequate BAF subunit staining normalized to the highest value of readout among all analyzed cells 
(=1) for all BAF subunit positive (blue data points) and AGPs (red data points). Data points are single 
readouts of BAF FI from VP of n=3 animals (results for WT1 plotted as data points in shape of star, results 
for WT2 plotted as dots, results for WT3 plotted as data points in shape of cross). AGPs, astroglial 
progenitors, NFI, normalized fluorescence intensity; WT, wild type.   
 
 
(found in the same cortical region). Like previously, all of the FIs acquired for a single evaluated 
section were then normalized to the highest value registered within the entire group of the analyzed 
cells (see Chapter 2. Materials and Methods. 2.6).  
The results of measurements are presented in Figure 11A-E. As depicted by violin plots and visible in 
corresponding micrographs the majority of investigated CP cells exhibited relatively high expression 
levels of BRG1, BAF170, BAF60a and BAF250a. As previously stated, RGCs also stained for these BAF 
subunits but with lower average FIs than CP cells (Figure 11A, C-E). Strikingly the FIs of BRG1, 
BAF170, BAF60a and BAF250a measured in AGPs (light blue colour violin plots) were even lower 
than in RGCs. As predicted and in agreement with the results described above, the FIs acquired for 
BAF155 stained cells revealed diverse expression levels within AGPs and RGCs (Figure 11B).  
We then asked what the changes in subunits expression that occur as RGCs differentiate towards 
neurons or AGPs are. In order to address this question we normalized average BAF FIs of CP cells and 
AGPs to the average RGCs FIs of the corresponding analyzed subunit (RGCs FI=1, Figure 11F, marked 
by gray dashed line). As shown in Figure 11F, cells residing in the CP (considered as neurons) 
exhibited elevated average FI of BRG1, BAF170, BAF60a and BAF250a (dark blue data points) staining 
compared to RGCs. To the contrary, AGPs featured a downregulation of average FIs (light blue data 
points) relative to RGCs. Importantly the FI measurements for each set of the compared RGCs, AGPs 
and CP cells were performed on the same acquired micrographs. Like previously, BAF155 stood as an 
exceptional case with CP cells exhibiting downregulated FIs of the staining with respect to the 
enriched with BAF155 FIs RGCs (Figure 11B, F). Additionally, we did not notice major differences in 
averaged FIs of BAF155 staining between AGPs and RGCs. 
 
In summary, we observed a significant downregulation of the percentages of the cortical and striatal 
AGPs positive for BRG1, BAF170, BAF60a and BAF250a immunostaining during the course of murine 
brain development. Moreover the remaining AGPs expressing detectable levels of the tested BAF
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Figure 11 | Distinct neural cortical populations exhibit different expression levels of BAF complex 
subunits. (A-E) Coronal sections through WT S1BF cortical area of P0 mice stained with antibodies to AGP 
markers; GLAST (in green) and NFiA (in red) together with antibodies detecting BAF complex subunits (in 
pseudo colour blue): BRG1 (A), BAF155 (B), BAF170 (C), BAF60a (D) and BAF250a (E). Cells simultaneously 
expressing GLAST and NFiA are AGPs. Overview pictures of P0 brains stained for BAF155 or BAF170 are 
shown in Appendix, Figure 42 (provided here pictures were taken in regions marked by 3). The left most 
boards of each are single channel images of immunofluorescence signal for adequate BAF complex 
subunit. Full arrowheads point to example AGPs and their expression of given BAF subunit. The extreme 
right panels are violin plots representing quantitative FIs analysis for the adequate BAF subunit staining. 
Each single readout was normalized to the highest FI value among all analyzed cells (=1). Violin plots 
represent normalized FI surveys for n=3 animals for all BAF subunit positive cells located in CP (dark blue 
plots), BAF subunit positive RGCs (blue plots) and AGPs (light blue plots). (F) Average FI in CP cells and 
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AGPs relative to average FI of RGCs measured in P0 WT S1BF cortical area. Full data points represent 
average for n=3 animals. Average FI for given population of single animal showed by empty data points. 
Dark blue colour corresponds to the results acquired for CP whereas light blue to the readouts for AGPs. 
AGPs, astroglial progenitors; CP, cortical plate; NFI, normalized fluorescence intensity; RGCs, radial glial 
cells; VZ, ventricular zone; WT, wild type.    
 
 
subunits exhibited a clear downregulation of these subunits staining affinity, resulting in declined FIs 
(refered to as ‘expression levels’), also with respect to CP residing cells (‘neurons’) and cortical VZ 
RGCs. Importantly, P0 CP cells among which neurons constitute a vast majority (Tiberi et al., 2012) 
showed elevated FIs of BRG1, BAF170, BAF60a and BAF250a staining. It indicates a difference in 
expression of these BAF subunits between astrocytic and non-astrocytic (presumably neuronal) cell 
lineages. This phenomenon nonetheless did not apply to BAF155, which was broadly expressed by 
AGPs. However, assuming that the high ratio of BAF155 expressed by AGPs relates to its BAF170-
dependent stoichiometry (as described above) and decreases with time (other interpretations are 
discussed in: Chapter 4. Discussion. 4.1), it seems that the expression levels of BAF complex 
elements decrease as astrocytic RGCs detach from the VZ and transform to AGPs.    
 
3.2 Enforced BAF complex loss in astrocytic RGCs - dcKO approach 
 
Having established that the expression of BAF subunits ubiquitous in neurons and astrocytic RGCs 
tends to cease within AGPs, we investigated the impact of BAF complex depletion on astrocytic 
RGCs. We took this step to determine whether the loss of the BAF complex would cause that 
astrocytic RGCs detach from the VZ and translocate as proliferative AGPs.    
We addressed this question in vivo by means of BAF complex deletion targeted to late RGCs. To this 
end, we generated a transgenic mutant mouse model with human glial fibrillary acidic protein 
(hGFAP) promoter-driven dcKO of BAF155 and BAF170 (hGFAP-Cre dcKO) (Narayanan et al., 2015; 
Nguyen et al., 2018; Zhuo et al., 2001). 
 
hGFAP promoter driven recombination 
First, by means of ROSA-tdTomato system (Madisen et al., 2010) used in heterozygous (Het) mice 
(see Chapter 2. Materials and Methods. 2.1) we traced the activity of hGFAP promoter within 
astrocytic RGCs. As presented in Figure 12 the choice of hGFAP promoter as a driver of 
recombination allowed us to affect all known dorsal and ventral forebrain astrocytic germinal zones 
(Bayraktar et al., 2014; Minocha et al., 2015; Tsai et al., 2012). In agreement with the literature 
(Anthony and Heintz, 2008), we found that hGFAP-Cre driven recombination starts in hippocampal 
and medial cortical VZ (Figure 12 A), later propagating to all areas of DP as development proceeds
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Figure 12 | hGFAP promoter drives recombination in all astrocytic germinal zones of murine forebrain. 
(A-C) Coronal sections of brains of hGFAP-Cre Het tdTomato mice at: E13.5 (A), E15.5 (B) and E17.5 (C). 
tdTomato (tdTOM) signal in red, DAPI in blue. A-C, middle: single channel tdTOM images. Arrowheads 
indicate astrocytic germinal zones with recombination detected at given stage in: Cx VZ (A), MGE VZ (B) 
and LGE VZ (C). A-C, right: are magnified pictures of tdTOM positive cells in given areas. (D-F) Schematics 
showing adult forebrain astrocytes born in embryonic astrocytic germinal zones affected by 
recombination: (D) CC and Cx astrocytes descend from Cx RGCs (E) these of VPI and Str from MGE RGCs 
and (F) Str and PCx astrocytes from LGE RGCs. Graphics prepared based on (Bayraktar et al., 2014; Tsai et 
al., 2012). CC, corpus callosum; Cx, cortex; MGE, medial ganglionic eminence; MCx, medial cortex; LGE, 
lateral ganglionic eminence; RGCs, radial glial cells; PCx, piriform cortex; Str, striatum; VPl, ventral 
pallidum.   
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(Figure 12A, B). Interestingly the activity of hGFAP promoter within ventral astrocytic germinal zone 
of MGE started to emerge later than that of DP and was observed around E15.5 (Figure 12B). The 
astrocytic RGCs affected latest were these of LGE where the recombination occurred around E17.5 
(Figure 12C).  
Based on previously published tracing studies (Tsai et al., 2012), we could indicate forebrain 
astrocyte populations, progenitors (astrocytic RGCs) of which exhibited hGFAP-Cre driven 
recombination (thus will be affected by introduced BAF complex dcKO). Accordingly, it is known that 
astrocytes of cortex and corpus callosum originate from cortical astrocytic RGCs (recombination 
within cortical VZ starts as early as E13.5, Figure 12D). At the same time astrocytes populating 
striatum and ventral pallidum as well as striatum and piriform cortex were shown to be derivatives 
of astrocytic RGCs of MGE (affected at E15.5, Figure 12E) and LGE respectively (affected at E17.5, 
Figure 12F).  
 
Overall performed tracing studies confirmed that hGFAP promoter allows for targeting of all known 
dorsal and ventral astrocytic RGCs populations, thereby allowing us to affect different forebrain 
astrocyte populations.   
 
Expression of BAF complex subunits in hGFAP-Cre dcKO forebrain 
It has been previously established that dcKO of BAF155 and BAF170 results in a complete deletion of 
the entire BAF complex from the affected cells (Narayanan et al., 2015).  
To assess the efficacy of this process within our hGFAP-Cre dcKO system (further referred to as dcKO 
for simplicity), we first compared the protein expression levels of BAF155 and BAF170 in WT and 
mutant E17.5 DP. The choice of this area allowed a proper evaluation of protein levels, as the 
cortical recombination in dcKO starts relatively early (around E13.5, Figure 12A), thus only a small 
fraction of tissue should contain KO unaffected cells.  
Western blot (WB) analysis of E17.5 DP lysate proteomes (Figure 13) revealed a massive reduction in 
BAF155 and BAF170 protein abundance within dcKO cortex compared to WT (Figure 13A). 
Quantitatively, the average levels of BAF155 and BAF170 expression in dcKO cortex amounted to 35-
40% and 32-35% of these of WT (=100%), respectively (Figure 13F).  
The observation of residual BAF155/BAF170 levels in dcKO prompted us to investigate the possible 
cellular sources of these proteins. Using immunochemistry, we evaluated BAF155 and BAF170 
expression in E17.5 coronal sections of Het (used as control) and hGFAP-Cre dcKO tdTomato mice 
(Figure 13B). As expected, both BAF complex subunits were depleted in dcKO astrocytic germinal 
zones (Figure 13B and C) exhibiting hGFAP promoter activity (tdTOM tracing). A faint signal was 
observed in the LGE of dcKO (indicated by arrow head in Figure 13B). We conjectured that this was
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Figure 13 | Loss of BAF complex subunits in astrocytic cortical RGCs affected by hGFAP-Cre dcKO. (A) 
BAF155 and BAF170 protein expression analysis in WT and dcKO murine E17.5 DP tissues. Left panel 
shows a schematic explanation of experimental principle. E17.5 WT/dcKO embryos were subjected to DP 
dissection, subsequent protein isolation and WB analysis. Right board shows representative blots 
indicating expression of BAF170 (MW~170kDa, upper blot), BAF155 (MW~155kDa, middle blot) and 
GAPDH (housekeeping gene, MW~36kDa, lower blot) in 3 independent WT (right panel) and 3 
independent dcKO (left panel) E17.5 DPs after WB experiment. The molecular weight of proteins (in kDa) 
marked on the right side of each blot. Quantitative representation of WB analysis shown in F. (B-C) E17.5 
Het and dcKO coronal sections stained with antibodies to BAF155/BAF170 (in green and grey). 
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Endogenous tdTOM signal is red. (B) Overview pictures of Het (used as control) and dcKO medial area 
brain slices. For each down panels are single channel grey scale images. Regions exhibiting 
BAF155/BAF170 expression indicated with arrowheads. (C) Magnified insets of DP VZ (from the region of 
future M2 area, indicated in overview pictures by dashed line) showing downregulated expression of 
BAF155/BAF170 in the region of VZ in dcKO animals by comparison to WT. The surface of the VZ marked 
with dashed line. (D-E) Immunofluorescence analysis of mouse E17.5 WT and dcKO DP VZ coronal 
sections stained with antibody to astroglial progenitor marker – GLAST (in red) together with antibodies 
detecting BAF complex subunits (in grey): BRG1 (D) and BAF60a (E). Nuclear DAPI staining in blue. 
Immunohistochemical analysis shown depletion of BRG1 and BAF60a in GLAST positive astrocytic RGCs of 
dcKO animals. For C, D and E full arrowheads indicate cells positive for given BAF complex subunit, empty 
arrowheads indicate cells lacking BAF subunit expression. (F) Box plot representing dcKO BAF170 and 
BAF155 PI shown as ratio of WT results measured from the blot for 3 independent animals. WB analysis 
indicated significantly reduced amount of BAF155 and BAF170 in E17.5 dcKO DP by comparison to WT. 
(G) Percentages of given BAF subunit positive per total GLAST positive astrocytic RBCs in the DP of E17.5 
WT and dcKO mice. Data are averages ± σ of n=3 animals. For F and G ***p≤0.001, *p≤0.05, in t student 
test. dcKO, double knockout; DP, dorsal pallium; Het, heterozygous; MW, molecular weight; PI, pixel 
intensity; VP, ventral pallium; VZ, ventricular zone; WB, Western blot WT, wild type.   
 
 
due to the relatively late initiation of hGFAP promoter activity within this region, as described above. 
In addition and importantly protoplasmic astrocytes found within ventral regions of postnatal dcKO 
brains were deprived of BAF complex subunits, indicating for the efficient dcKO within ventral 
astrocytic germinal zones (Appendix, Figure 43).    
Our previous study indicated that dcKO of BAF155 and BAF170 in ESCs, cultured neurons and early 
cortical development results in a complete deletion of the entire BAF complex from the affected 
cells (Narayanan et al., 2015). We therefore determined whether astrocytic RGCs of dcKO mice 
express BAF subunits (Figure 13C-E). Accordingly, we immunohistochemically assessed GLAST 
positive astrocytic RGCs of cortex VZ of E17.5 dcKO (that presumably did not stain for 
BAF155/BAF170, Figure 13C) and Het cortical for the expression of 2 BAF complex subunits: BRG1 
(Figure 13D) and BAF60a (Figure 13E). Strikingly, cortical VZ of dcKO (shown to be deprived of 
BAF155 and BAF170) exhibited staining for both, BRG1 and BAF60a. However, as indicated in Figure 
13D, E and G numbers of GLAST positive E17.5 dcKO cortical astrocytic RGCs expressing BRG1 or 
BAF60a were highly reduced comparing to control animals (Figure 13G), indicating BAF complex 
degradation within these cells.  
 
Thus we confirm the full elimination of BAF complex from astrocytic RGCs achieved by means of 
hGFAP-Cre driven dcKO of BAF155 and BAF170. 
 
 BAF complex depleted mice - initial severity assessment 
The post-partum mortality of generated dcKO animals was sorely high, limiting their average lifespan 
to P3-4. The external appearance of P3-4 mutant mouse body did not differ from WT or Het 
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littermates, apart from their slightly smaller size. However a striking anatomical difference was 
observed between the brains of WT and dcKO mice (Figure 14A-D).  
 
 
 
 
 
Figure 14 | Reduced cortical size of BAF complex depleted postnatal mouse brains. (A) Bright field 
images of WT and dcKO brains of P3 mice. (B) Box plot representing differences between R-C and M-L 
extent in WT and dcKO brains. The cartoon below indicates the dimensions measured. (C) DAPI staining 
of WT and dcKO coronal P3 murine brain slices showing visible anatomical differences. (D) Cortical 
thickness differences between M1 and S1BF areas of P3 WT and dcKO mouse brains. Horizontal lines 
within each bar indicate average value for (A) n=10-12 experimental replicates (WT RC/ML extent: n=10, 
dcKO RC/ML extent: n=12), (D) n=11-13 experimental replicates (WT M1 area: n=11, WT S1BF area: n=12, 
dcKO M1 area: n=13, dcKO S1BF area: n=12); for (B) R-C extent ***p≤0.001 in t-student test, for (B) M-L 
extent ***p≤0.001 in Mann-Whitney Rank Sum test, for (D) M1 area ***p≤0.001 in Mann-Whitney Rank 
Sum test and for (D) S1BF area *p≤0.05 in t-student test. dcKO, double knockout; M1, primary motor 
cortex; M-L, medio-lateral; R-C, rostro-caudal; S1BF, primary somatosensory barrel cortex; WT, wild type.  
 
 
The undeveloped P3 dcKO brain displayed an atrophied cortex and cerebellum (Figure 14A). 
Noticeable changes to the cortex were in its rostro-caudal and medio-lateral extents, which were 
measurably smaller (Figure 14B). Notably, as shown in Figure 14C, dcKO brains did not develop a 
hippocampal structure and featured a significantly reduced cortical thickness, particularly in medial 
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areas. Quantitatively, measurements of primary motor cortex (M1) thickness indicated an almost 2.5 
fold reduction compared to WT (Figure 14D). Strikingly, in more lateral areas, the thickness of cortex 
tended to normalize, with only minimal discrepancies between genotypes in S1BF area (Figure 14D).  
 
 Foreword to astroglial phenotype assessment 
The purpose of this study was to elucidate the role of BAF complex in astrocytes development. As 
explained above, having generated transgenic mutant mouse model with specific hGFAP-Cre driven 
dcKO of BAF155 and BAF170, we were capable of targeting all 3 astrocytic germinal zones and 
eliminating BAF complex from astrocytic RGCs. Because our model featured high juvenile mortality, 
we could not assess astrogliogenesis beyond P3. As a result, the analysis presented henceforth will 
mostly focus on this developmental postnatal stage. We also evaluated the initial steps of cortical 
astroglia formation on E17.5 dcKO and WT tissues.  
 
3.3 Cortical phenotype  
 
It has been established that in rodents forebrain, astrocytes arise from dorsal and ventral germinal 
zones, however the most exhaustive surveys of astrocyte development concern cortical astrogenesis 
(Bayraktar et al., 2014; Miller and Gauthier, 2007; Minocha et al., 2017; Minocha et al., 2015). Thus 
despite the limited general knowledge about astrocyte developmental processes, the timing of the 
generation of cortical astroglia has been soundly examined and estimated to be around E17.5 
(Cameron and Rakic, 1991; Minocha et al., 2015; Mission et al., 1991). Interestingly our hGFAP-Cre 
dcKO mouse model showed a loss of BAF complex subunits inter alia within cortical astrocytic RGCs 
allowing for a peculiar mimicking of the reduction in BAF expression observed for WT AGPs (as 
described in Chapter 3. Results. 3.1). It was evident from visual inspection that the cortex of 
postnatal dcKO mice was markedly reduced in size, both in its extents and thickness, indicating wide-
ranging consequences of hGFAP-Cre induced mutation. Taken together, these observations 
prompted us to investigate the potential cortical astroglial phenotype of dcKO mice. 
 
From RGCs to AGPs – initial steps of cortical embryonic astrogenesis in dcKO mice 
Asking whether the generation of cortical astrocytes would be altered by loss of BAF complex, we 
first evaluated the general pool of astroglial precursors (astrocytic RGCs and AGPs) in dcKO and 
control cortex. Thus by means of immunostaining we assessed the expression of BLBP (Brunne et al., 
2010; Gotz et al., 2015), GLAST (Brunne et al., 2010; Shibata et al., 1997) and SOX9 (Kang et al., 2012; 
Nagao et al., 2016) in coronal sections of Het/WT (control) and dcKO brain tissues harvested at E17.5 
(Figure 15A-E).  
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Figure 15 | Embryonic murine DP affected by BAF complex KO exhibits elevated numbers of cells 
expressing astrocytic RGCs and AGP markers. (A-E) Immunofluorescence staining of Het, WT and dcKO 
E17.5 mouse medial coronal brain sections showing expression of astrocytic RGCs/AGP markers: (A-C) 
BLBP (in blue), (A,D-E) GLAST (in green) and (E) SOX9 (in gray). The endogenous tdTOM signal is red (only 
for A). (A) Overview pictures of Het (used as control) and dcKO medial area brain slices. Cortical regions 
of CP/IZ and VZ control and dcKO brains exhibiting differences in evaluated markers expression indicated 
with arrowheads. (B-E) Magnified insets of MCx (developing M2 area, for B and C) and LCx (developing S1 
areas, for D and E) regions of IZ/CP and VZ showing elevated expression of astrocytic RGCs/AGP markers 
in dcKO by comparison to WT. For each IZ/CP image the directions towards PS and VZ are indicated by 
two-headed arrow. For B, D and E full arrowheads indicate AGP/astrocytic RGCs positive for given 
marker. For C full arrowheads indicate AGP/astrocytic RGCs positive for GLAST and BLBP, empty 
arrowheads indicate cells positive only for BLBP. (E) Percentages of AGP marker positive cells per DAPI 
positive cells in the DP of E17.5 WT and dcKO mice. Data are averages ± σ of n=3-4 animals (BLBP/WT: 
n=4, BLBP/dcKO: n=3, GLAST/WT: n=3, GLAST/dcKO: n=3, SOX9/WT: n=3, SOX/dcKO: n=3); ***p≤0.001, 
**p≤0.01, in t student test, for SOX9: NS, not significant in Mann Whitney Rank Sum test. Manual 
quantifications of DAPI positive cells expressing given AGP marker and all DAPI positive cells performed in 
full cortical columns of 3 different regions of DP (developing M1, M2 and S1 areas) and summed up for 
each individual n. AGPs, astroglial progenitors; CP, cortical plate; dcKO, double knockout; DP, dorsal 
pallium; GPs, glial progenitors; Het, heterozygous; PS, pial surface; VZ, ventricular zone; WT, wild type.   
 
 
As indicated in Figure 15A, BLBP and GLAST positive astroglial precursors were highly altered in the 
dcKO DP affected by hGFAP-Cre driven recombination (tdTOM positive cortical regions) compared to 
the Het control. Furthermore, the micrographs of VZ and CP/intermediate zone (IZ) areas and 
corresponding quantitative analysis indicated that the total amount of BLBP positive cells (manually 
quantified and then compared to that of all DAPI positive cells registered in the same area) in dcKO 
DP significantly (***p≤0.001) outnumbered that of WT (where 24.9±1.6% and 13.8±2.3% of DAPI 
positive cells were BLBP expressing progenitors in dcKO and WT respectively; Figure 15A-C and E). 
Similarly, dcKO DP showed elevated numbers of GLAST (significantly, **p≤0.01; Figure 15A, C-F) and 
SOX9 (not significantly, p>0.05; Figure 15E and F) expressing precursors. Quantitatively, in dcKO 
20.9±1.9% and 21.8±0.8% of all DP DAPI positive cells expressed GLAST and SOX9 respectively 
(Figure 15E). In WT, GLAST positive progenitors constituted 15.2±1.1% whereas SOX9 expressing 
cells accounted for 14.3±0.8% (analyzing per all DAPI stained cells). Interestingly, the percentages of 
upregulated precursor cells positive for BLBP, GLAST and SOX9 in investigated dcKO DP differed 
between each other (Figure 15F). This distinguished astrocytic precursors of dcKO from that of WT, 
in which all markers were mostly co-expressed by the same group of cells (Figure 15C and E). Thus, 
as shown in Figure 15C, WT astrocyte precursors stained simultaneously for both astroglial proteins: 
BLBP and GLAST, however dcKO precursor cells positive for BLBP to a large degree did not exhibit 
GLAST expression (which was pronounced in lower dcKO GLAST positive cellular count compared to 
that of dcKO BLBP, Figure 15F). This very interesting feature did not apply to GLAST positive dcKO 
astrocytic precursors which commonly expressed BLBP (Figure 15C, indicated by full arrowheads). 
Notably, this feature appeared to be dependent on the area of investigation. As shown in Figure 
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15A, the number of GLAST cells was increasing the more lateral the area (detailed analysis presented 
further in this subsection). Strikingly GLAST and SOX9 were present in the same cell populations of 
WT as well as dcKO DP. These observations show the predominance of BLBP expression among E17.5 
dcKO precursor cells.  
 
Heretofore we have found that the loss of BAF complex in astrocytic RGCs causes massive increase in 
the abundance of cells expressing astrocyte precursor (astrocytic RGCs or AGPs) related proteins. 
However, in view of our finding that the expression levels of BAF subunits in WT mice decrease as 
astrocytic RGCs transform to AGPs, another crucial question had emerged: are these numerous cells 
observed in dcKO cortex astrocytic RGCs or AGPs?  
As previously stated, astrocytic RGCs express a set of astrocyte specific markers (Hartfuss et al., 
2001). The expression of these markers (e.g. BLBP, GLAST and SOX9) persists in AGPs (Chaboub and 
Deneen, 2013; Molofsky et al., 2012), hampering discrimination between these two populations 
(Chaboub and Deneen, 2013). However, it has been well established that the onset of astroglial 
differentiation corresponds to the VZ surface detachment of the differentiating astrocytic RGCs and 
their subsequent migration as AGPs outside of germinal zones (Cameron and Rakic, 1991; Ge et al., 
2012; Guillemot, 2007; Marshall and Goldman, 2002; Minocha et al., 2015; Mission et al., 1991; 
Molofsky and Deneen, 2015; Rowitch and Kriegstein, 2010). Thus, we next investigated the spatial 
distribution of GLAST or BLBP positive cells through the cortical thickness of dcKO and WT E17.5 
cortex. It has been already visible in Figure 15 that unlike in control conditions, many BLBP, GLAST 
and SOX9 positive cells could be found in dcKO IZ/CP. However, as indicated in Figure 15A, the 
distribution and abundance of investigated cells appeared to be dependent on cortical region of 
dcKO murine brains. Noticing that GLAST and BLBP positive cells quantity and cortical location differs 
in medial and lateral cortical areas, we focused our next analysis on 2 cortical regions: developing 
M1 (refered to as medial region (MCx)) and S1 (refered to as lateral region (LCx)) areas (overview in 
Figure 15). Additionally, in order to illustrate the localization of GLAST and BLBP positive cells 
localization, we generated distribution density plots (Figure 16A and D, see Chapter 2. Materials and 
Methods. 2.6). As indicated in Figure 16 A and D, most GLAST and BLBP positive cells in the medial 
and lateral areas of WT E17.5 cortex populated the cortical VZ, with only single positive found 
outside, in other cortical areas. Notably, the distribution of GLAST and BLBP positive cells greatly 
differed in dcKO MCx and LCx. Overall, GLAST and BLBP expressing cells of developing dcKO M1 area 
tended to detach from the VZ, not allowing for preservation of the AS (Figure 16A and D, indicated 
by arrowheads in dcKO images). As depicted in the corresponding density line graphs (solid line), 
both GLAST and BLBP expressing cells were present in VZ of dcKO cortex. However, their densities 
within this area were visibly lower than these of WT. In addition, great numbers of GLAST and BLBP
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Figure 16 | Loss of RG features and delamination of cells expressing AGP markers in BAF complex 
deficient embryonic DP suggests their AGPs cell fate commitment. (A, D) Immunofluorescence analysis 
of coronal brain sections through WT and dcKO E17.5 murine MCx (future M1 area) and LCx (future S1 
area) stained with antibodies to astroglial progenitor markers (in green); GLAST (A) and BLBP (D). The 
nuclei of cells visualized by DAPI intercalation (in blue). Overview pictures provided in Figure 15. Cells 
expressing GLAST and BLBP densely packed in the region of VZ with the preserved AS are astrocytic RGCs, 
delamination of cells expressing GLAST and BLBP from the VZ suggests the AGPs cell fate commitment of 
astrocytic RGCs. Full arrowheads indicate astrocytic RGCs (when attached to the AS and located in VZ)/ 
AGPs (when delaminated from VZ) expressing GLAST and BLBP. The surface of the VZ (for WT brains 
corresponds with AS) marked with dashed line. Line graphs represented in the extreme right boards of 
each (MCx and LCx for A and D) are distribution density plots generated for given marker in whole cortical 
column (divided in 16 equally sized bins) of given cortical area for WT (dashed line) and dcKO (solid line) 
animals (average plots for n=3 animals shown as thick green colour lines, plots for individual animals 
shown as thin gray colour lines). Each graph represents bin no. (0-16) juxtaposed with corresponding cell 
density in cubic millimeters. PS area corresponds to bin no. 1, VZ area corresponds to bin no. 15 (both 
marked with dashed lines). Distribution of GLAST/BLBP expressing cells in the WT MCx and LCx shows a 
clear peak in VZ area, whereas GLAST/BLBP positive cells in dcKO exhibited distribution scattered across 
the cortical column particularly visible in MCx. (B, E) Percentages of AGP marker positive cells: GLAST (B) 
and BLBP (D) per DAPI positive cells in the regions of MCx (future M1 area) and LCx (future S1 area) of 
E17.5 WT and dcKO mice. Data are averages ± σ of n=3-4 animals (for WT: GLAST/MCx: n=4, GLAST/LCx: 
n=4, BLBP/MCx: n=3, BLBP/ LCx: n=3; for dcKO: GLAST/MCx: n=3, GLAST/LCx: n=3, BLBP/MCx: n=3, BLBP/ 
LCx: n=3); ***p≤0.001, NS, not significant in t student test. (C, F) Pie charts showing the degree of VZ AS 
delamination of GLAST (C) and BLBP (F) positive cells in WT (upper panel) and dcKO (lower panel) E17.5 
DP. Light green colour indicates percentages of marker positive cells residing in VZ attached to the AS, 
dark green colour indicates percentages of marker positive cells detached from VZ AS. Data are averages 
of n=3 animals (for WT: GLAST+/detached=20.3, GLAST+/AS=79.7±5.1%; BLBP+/detached=15.7, 
BLBP+/AS=84.3±6.5%; for dcKO: GLAST+/detached=90.6, GLAST+/AS=9.4±6.3%; BLBP+/detached=90.5, 
BLBP+/AS=9.5±4.6%). AGPs, astroglial progenitors; AS, apical surface; dcKO, double knockout; den. , 
density; DP, dorsal pallium; MCx, medial cortex (refers to the future M1 area); NS, not significant; LCx, 
lateral cortex (refers to the future S1 area); PS, pial surface; VZ, ventricular zone; WT, wild type.   
  
 
positive cells were found outside of the germinal zone, in the intermediate regions of dcKO MCx. The 
loss of AS in S1 area of dcKO brain was not as remarkable as in MCx (Figure 16A-D, LCx). However, 
we still could observe a substantial amount of GLAST and BLBP positive cells in cortical areas other 
than dcKO VZ.  
Interestingly, the percentages of DAPI positive cells expressing GLAST and BLBP (Figure 16B and E) 
revealed striking region dependent differences. In M1 area of dcKO, BLBP expressing cells 
significantly (***p≤0.001) outnumbered those of WT (with 30.5±4.3% and 15.4±1.1% of DAPI 
positive cells were BLBP expressing progenitors in dcKO and WT respectively). The same analysis for 
GLAST positive cells did not indicate significant differences between genotypes (p>0.05; 18.9±2.6% 
of dcKO and 15.8±1.6% of WT DAPI positive cells exhibited GLAST staining). This difference in cell 
abundance was obvious from the density plots generated for dcKO M1 area, with a reduced density 
of GLAST positive cells compared to BLBP (Figure 16A and D). However, regardless of their amount, 
the dcKO GLAST expressing cells still exhibited a scattered distribution, omitting the VZ (Figure 16 A 
and D; density plots). Surprisingly, these differences between genotypes did not appear in LCx 
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regions. In S1 area the percentages of DAPI positive cells expressing GLAST or BLBP found in dcKO 
brains were significantly higher than these of WT, with similar marker to DAPI ratios (***p≤0.001 for 
both analyzed markers; in WT 15.7±1.8% and 15.1±2.0%; in dcKO 23.6±1.5% and 23.4±3.2% of DAPI 
positive cells expressed GLAST and BLBP respectively). Thus, in dcKO DP, GLAST and BLBP positive 
cells differ in their abundance relative to WT (more BLBP and GLAST positive cells in dcKO cortex) as 
well as in their distribution (GLAST and BLBP positive cells were present in comparable amounts in 
the MCx and LCx of WT, while in dcKO, BLBP positive cells were more numerous in MCx than in LCx, 
with the opposite being true for GLAST positive cells). 
In order to show the total degree of astrocytic RGCs delamination we further quantified the amount 
of all GLAST or BLBP positive cells found in VZ (tightly packed and directly creating the AS, as well as 
connected to the cells building the AS) and compared them to the numbers of cells that were 
delaminated. As indicated in Figure 16C and F, 80% of GLAST and 84% of BLBP positive cells in M1 
and S1 (results were pooled) were residing in WT VZ attached to the AS. Thus, only 20% of GLAST 
and 16% of BLBP expressing cells were found to be detached and scattered throughout other cortical 
regions of WT brain. To the contrary, dcKO GLAST and BLBP positive cells showed a strong 
delamination with only 9% of GLAST and 10% of BLBP exhibiting cells facing the VZ surface. 
Accordingly, 91% of GLAST and 90% of BLBP expressing cells detached from VZ AS and migrated 
outside the germinal zone (Figure 16C and F; dcKO), indicating a tremendous delamination of BAF 
complex depleted astrocytic RGCs.   
   
Altogether, our immunohistochemical analyses and quantifications show that the hGFAP-Cre driven 
loss of BAF complex within E17.5 cortical astrocytic RGCs causes their massive detachment from the 
surface of the VZ. This observation indicates a premature onset of astrocytic RGCs differentiation to 
AGPs in the brains of dcKO mice. Additionally, astrocyte precursors were more numerous in dcKO 
cortex than in WT, however their abundance and distribution varied depending on cortical area, with 
pronounced difference between medial and lateral regions. Finally, these results seem to confirm 
our previous assumption that a reduction in the abundance of BAF complex subunits causes the 
transformation of astrocytic RGCs to AGPs (see Chapter 3. Results. 3.1).   
 
 AGPs in postnatal cortex – dcKO versus WT phenotype 
It is well know that the majority of astrocytic RGCs finish to differentiate into AGPs shortly after birth 
(Ge et al., 2012). This implies that in the early postnatal DP of WT mice the abundance of AGPs will 
increase compared to that of E17.5 cortex. Accordingly, this process may blur the difference 
between WT and dcKO astroglial phenotypes described above. In order to address this issue we 
decided to examine the abundance of AGPs and their distribution in P3 WT and dcKO cortex. Bearing 
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in mind the above described divergent AGPs phenotype of dcKO DP, we decided to again investigate 
GLAST and BLBP expressing cells within medial (developing M1 area) and lateral (developing S1 area) 
regions of postnatal cortex. For this purpose immunostaining analysis of GLAST and BLBP expression 
was conducted in WT and dcKO brain coronal sections isolated from P3 murine pups (Figure 17A and 
D). Additionally, we generated spatial distribution density plots (Figure 17A and D) as previously 
described (Chapter 2. Materials and Methods. 2.6) and the GLAST or BLBP positive cell numbers 
were manually registered and related to total cellular numbers (DAPI positive) within selected areas 
of cortex (Figure 17B and E). The percentages of markers positive cells found in the DW or scattered 
through the cortical thickness are shown in Figure 17C and F. 
Overall, GLAST and BLBP positive cells were found through the full thickness of WT as well as dcKO 
cortex (Figure 17A and D, indicated by arrowheads). In WT M1 and S1 areas (MCx and LCx), as 
indicated in micrographs and density plots, a substantial amount of GLAST and BLBP expressing AGPs 
resided in DW (former VZ). However, the abundance of AGPs found scattered across these cortical 
areas was visibly higher than that of E17.5 (Figure 16A and D, Figure 17A and D). Even though the 
absolute numbers of GLAST and BLBP expressing cells appeared to not to deviate from these 
assessed for E17.5 M1 and S1 area (Figure17B and E, Figure 17 B and E), 60% of GLAST and 56% of 
BLBP positive cells were found outside of DW (Figure 17C and F), indicating an increase in AGPs 
abundance. As previously, expression pattern of GLAST and BLBP positive cells assessed in dcKO MCx 
and LCx greatly differed from that of WT. First of all, the abundance of GLAST and BLBP positive cells 
found in MCx of P3 dcKO DP was significantly greater comparing to WT (***p≤0.001 for both 
analyzed markers). Interestingly, the amount of GLAST expressing cells in MCx area of P3 mutant 
brain was elevated compared to E17.5 (for P3: 26.0±3.9%, for E17.5: 18.9±2.6% of DAPI positive cells 
expressing GLAST). However, the abundance of BLBP positive cells found in M1 area appeared not to 
differ between E17.5 and P3 (for P3: 32.3±5.4%, for E17.5: 30.5±4.3% of DAPI positive cells 
expressing BLBP). Therefore, the most parsimonious and straightforward explanation of this finding 
is that we observe the reconstitution of GLAST expression among MCx residing AGPs. Similarly to M1 
area, the GLAST and BLBP positive cells of S1 LCx area of dcKO significantly outnumbered WT cells 
(***p≤0.001 where 23.4±2.1% and 9.5±1.3% of DAPI positive expressed GLAST and **p≤0.01 where 
27.9±5.2% and 12.7±1.3% of DAPI positive expressed BLBP in dcKO and WT LCx respectively). 
Additionally, in agreement with E17.5 data, only 10% of all GLAST and 12% of all BLBP positive cells 
could be found at the surface of VZ (dcKO animals did not develop DW structure) of the M1 and S1 
areas (Figure 17C and F; pie chart, dcKO). Accordingly, 90% of total GLAST expressing population and 
88% of total BLBP expressing population were found to be scattered across the cortical thickness 
omitting the VZ surface. This phenomenon is visible in spatial distribution plots where high densities 
of GLAST and BLBP positive cells were obvious outside of dcKO DW (Figure 17A and D). Strikingly, the 
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Figure 17 | Numerous AGPs markers expressing cells scattered through the cortical column of BAF 
complex KO postnatal DP. (A, D) Immunofluorescence analysis of coronal brain sections through WT and 
dcKO P3 murine MCx (M2 area) and LCx (S1BF area) stained with antibodies to astroglial 
progenitor/astrocyte markers (in green); GLAST (A; overview in Figure 20) and BLBP (D, overview in 
Appendix, Figure 45A). The nuclei of cells stained by DAPI (in blue). Line graphs represented in the 
extreme right (MCx and LCx for A and D) are distribution density plots generated for a given marker in the 
whole cortical column (for each divided for 16 the same size bins) of a given cortical area for WT (dashed 
line) and dcKO (solid line) animals (average plots for n=3 animals shown as thick green colour lines, plots 
for individual animals shown as thin gray colour lines). Each graph represents bin no. (0-16) juxtaposed 
with corresponding cell density found in cubic millimeters. PS area corresponds with bin no. 1, DW area 
corresponds with bin no. 15 (both marked with dashed lines). Distribution of GLAST/BLBP expressing cells 
in the WT MCx and LCx shows clear peak in DW area with several cells found in CP and IZ, whereas 
GLAST/BLBP positive cells in dcKO were scattered across the cortical column without a single peak 
corresponding to the area of DW. (B, E) Percentages of AGP/astrocyte marker positive cells: GLAST (B) 
and BLBP (D) per DAPI positive cells in the regions of MCx (M2 area) and LCx (S1BF area) of P3 WT and 
dcKO mice. Data are averages ± σ of n=3 animals; ***p≤0.001, **p≤0.01 in t student test. (C, F) Pie charts 
showing the degree of DW detachment of GLAST (C) and BLBP (F) positive cells in WT (upper panel) and 
dcKO (lower panel) P3 DP. Light green colour indicates percentages of marker positive cells residing in 
DW (in WT)/attached to the VZS (in dcKO), dark green colour indicates percentages of marker positive 
cells outside DW. Data are averages of n=3 animals (for WT: GLAST+/detached=60.9, GLAST+/DW=39.1± 
7.6%; BLBP+/detached=56.0, BLBP+/DW=56.0±5.4%; for dcKO: GLAST+/detached= 89.8, GLAST+/VZS= 
10.2±4.2%; BLBP+/detached=88.8, BLBP+/VZS=11.2 ±5.27%). AGPs, astrocytic progenitors; dcKO, double 
knockout; den., density; DP, dorsal pallium; DW, deep cerebral white; MCx, medial cortex (refers to the 
M1 area); LCx, lateral cortex (refers to the S1 area); PS, pial surface; VZS, ventricular zone surface; WT, 
wild type.   
 
 
spatial distribution of the cells evaluated in dcKO M1 and S1 areas seemed to differ from that of 
E17.5 (Figure 16A and D, Figure 17A and D). The comparison of dcKO density plots generated for 
E17.5 and P3 GLAST and BLBP expressing cells found in MCx and LCx indicated a tendency for P3 
dcKO GLAST and BLBP positive AGPs to reside closer to the PS. 
 
In summary, we conclude that despite the visibly advanced differentiation of astrocytic RGCs 
towards AGPs in early postnatal WT DP, higher AGPs abundance suggests that the astrogliogenic 
processes are much more advanced in cortex affected by BAF complex depletion. 
 
 Astroglial identity of upregulated progenitors  
Previous studies from our group showed that the loss of BAF155 subunit evokes delamination of 
RGCs from the cortical VZ and subsequent generation of oRGPs (Narayanan et al., 2018). These 
progenitors exhibit several characteristics of AGPs. They are lacking apical junctions and thus reside 
outside the VZ, and express some common astrocyte markers such as GLAST or BLBP (Heng et al., 
2017; Narayanan et al., 2018; Pollen et al., 2015). Regardless of their AGPs – like features, oRGPs do 
not produce astrocytes, and in primates they are believed to generate the majority of cortical 
neurons, to the point that they were suggested to be responsible for cortical expansion and folding 
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(Dehay and Kennedy, 2007; Hansen et al., 2010; Lui et al., 2011; Pollen et al., 2015). 
In order to confirm the astroglial identity of the upregulated progenitors found in dcKO cortex we 
decided to immunohistochemically investigate the NFiA expression within upregulated GLAST 
positive cells (Figure 18; see Chapter 3. Results. 3.3). We chose NFiA to identify astroglia because of 
its well-known role in astrocyte differentiation, reprogramming and maintenance (Caiazzo et al., 
2015; Deneen et al., 2006; Kang et al., 2012; Molofsky et al., 2012). Additionally NFiA RNA was not 
found to be present in the group of astroglial transcripts enriched within oRGPs (in contrast to e.g. 
Ptprz1, Blbp or Tnc) (Pollen et al., 2015). However, due to the broad range of cells exhibiting NFiA 
staining through the cortex (Bunt et al., 2017), this marker could not be used as an exclusive marker 
of astroglial fate. Thus we chose to confirm the astroglial nature of the elevated progenitors by their 
simultaneous expression of NFiA and GLAST (Deneen et al., 2006; Kang et al., 2012). 
We therefore assessed co-expression of GLAST and NFiA by immunostaining performed on P3 brain 
coronal sections isolated from WT and dcKO mouse pups. Due to the distinct GLAST phenotype of 
medial or lateral cortical regions of dcKO brain (previously described), the expression of the markers 
selected was further analyzed in developing M1 (MCx) and S1 areas (Figure 18).  
The NFiA staining showed strong enrichment in WT MCx and LCx, prominently marking DW and layer 
V located cells with single positives scattered across the cortical thickness (Figure 18 A-C; WT). To 
the contrary, numerous NFiA expressing cells found in dcKO MCx and LCx areas exhibited rather 
dispersed location eschewing grouping in LV (Figure 18 A-C; dcKO). Interestingly, the percentages of 
all DAPI positive cells exhibiting NFiA staining were significantly upregulated in medial (M1) as well 
as lateral (S1) areas of dcKO cortex (**p≤0.01; 25.7±4.9% and 47.9±3.9% of DAPI positive cells found 
in MCx as well as 31.7±4.8% and 46.1±2.5% of DAPI positive cells found in LCx of WT and dcKO 
respectively, Figure 18D). Increased numbers of NFiA positives may indicate a massive promotion of 
glial fate cells that do not necessarily express other astroglial markers (e.g. GLAST or BLBP). This 
interpretation appears legitimate when considering the critical role of NFiA in gliogenesis initiation 
(Kang et al., 2012) as well as the loss of GLAST and BLBP within early RGCs affected by BAF complex 
depletion (Nguyen et al., 2018). However, a massive upregulation of NFiA within dcKO cortex 
revealed by quantitative study could be due to the reduced cortical thickness and misinterpreted 
glial/neuronal fate of counted NFiA positive cells (Bunt et al., 2017).  
Importantly, double immunohistochemical analysis revealed that the majority of WT as well as dcKO 
GLAST positive cells co-expressed NFiA (indicated by full arrowheads). As typical AGPs, GLAST/NFiA 
positive cells could be localized across the cortical thickness of M1 and S1, near PS, in CP and in DW 
of both WT and dcKO brains (Figure 18B and C). Additionally, several GLAST positive cells found in CP 
(empty arrowheads) of WT and dcKO mice did not express NFiA, suggesting that their fate is not to 
become AGPs. These cells could be oRGPs however, more experiments need to be done in order to
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Figure 18 | Astroglial identity of GLAST positive cortical progenitors in BAF complex deficient DP. (A-C) 
Coronal sections through P3 brains of WT and dcKO mice stained with antibodies to astroglial progenitor 
markers; GLAST (in green) and NFiA (in red). The nuclear DAPI staining is blue. Cells expressing GLAST and 
NFiA are AGPs. GLAST positive cells lacking expression of NFiA are (possibly) oRGPs. (A) Overview pictures 
of WT and dcKO DP areas. (B-C) Magnified insets of (B) MCx (developing M1 area) and (C) LCx (developing 
S1 area) delineated in (A). Full arrowheads indicate AGP expressing GLAST and NFiA, empty arrowheads 
indicate progenitors expressing only GLAST. For (C) lower panels of magnified LCx view are enlarged 
insets of delineated areas of PS, CP and DW. For (B) nuclei of arrow indicated cells outlined with dashed 
line. (D) Percentages of NFiA positive GP per total number of DAPI positive cells in the regions of MCx 
(M1 area) and LCx (S1BF area) of P3 WT and dcKO DP. Data are averages ± σ of n=3 animals; **p≤0.01, in 
student’s t-test. (E) Pie charts showing the degree of colocalization between GLAST and NFiA in WT 
(upper graph) and dcKO (lower graph) P3 DP. Red colour indicates percentages of GLAST positive cells 
expressing NFiA, green colour indicates percentages of GLAST positive cells negative for NFiA. Data are 
averages of n=5-6 experimental replicates (for WT: n=5, GLAST+/NFiA+=77.09%, GLAST+/NFiA-
=22.9±8.1%; for dcKO: n=6, GLAST+/NFiA+=82.6%, GLAST+/NFiA-=17.4%±4.7%). CP, cortical plate; dcKO, 
double knockout; DP, dorsal pallium; DW, deep cerebral white; MCx, medial cortex (refers to M1 area); 
LCx, lateral cortex (refers to S1BF area); PS, pial surface; WT, wild type.  
 
 
prove this assumption (Fietz et al., 2010; Narayanan et al., 2018; Wang et al., 2016a). The 
quantitative study of GLAST/NFiA co-expression revealed that 83% of GLAST positive cells found in 
DP of dcKO brains exhibited NFiA expression (Figure 18E). Similarly, 77% of GLAST positive 
progenitors registered in WT DP expressed NFiA. Only 17% of dcKO and 23% of WT GLAST staining 
cells could potentially be considered as oRGPs, as they did not exhibit NFiA staining. Thus the 
majority of GLAST positive cells found in cortex of P3 WT and dcKO mice were AGPs.  
In summary, we could confirm that the increased abundance of GLAST expressing cells in DP of dcKO 
mouse brains was related to active astroglial processes presumably evoked by hGFAP-Cre driven BAF 
complex depletion within astrocytic RGCs. 
 
 Aberrant gene expression profile of dcKO affected DP 
Beyond a mere immunohistochemical investigation of protein expression, the analysis of the 
transcriptome may help us reveal and understand the changes evoked by hGFAP-Cre driven BAF 
complex depletion. Thus, as a next step we decided to examine and compare the gene expression 
profiles of WT and dcKO murine DP isolated from E17.5 embryos and P3 pups. We focused our 
analysis on these two distinct developmental stages because of two particular reasons. First of all, 
we wanted to inquire whether dcKO evoked DP transcriptome changes increase over the time. 
Secondarily, we wished to capture these transcriptome aberrations that persist in developing dcKO 
DP. We chose the E17.5 stage as murine cortical astrogliogenesis starts approximately at this 
gestational day (Cameron and Rakic, 1991; Minocha et al., 2015). The selection of P3 as another time 
point was dictated by necessity, as the lifespan of dcKO mice did not exceed 3-4 days post-partum. In 
order to assess the expression profiles of the selected genes, RNA was isolated from E17.5 and P3 
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WT and dcKO DP tissue lysates and subsequently subjected to sequencing analysis (see Chapter 2. 
Materials and Methods. 2.8). RNA-seq experiment was conducted in collaboration with Prof. André 
Fischer.  
The analysis of the transcriptome revealed massive gene expression aberrations found within DP of 
E17.5 and P3 dcKO mice (Figure 19). As indicated by volcano plots, 623 and 3199 transcripts were 
significantly downregulated in E17.5 and P3 dcKO DP, respectively (p≤0.01, -Log p≥2, Figure 19A and 
B, blue colour). Accordingly, in E17.5 dcKO DP 533 transcripts were significantly upregulated (Figure 
19A, in red colour). The number of aberrantly upregulated genes increased to 2804 transcripts found 
in DP of P3 dcKO mice (Figure 19B, in red).  
Thus the loss of BAF complex in cells of DP targeted by hGFAP-Cre evoked massive aberrations in 
gene expression profiles that amplified over developmental time.  
Next, in order to inquire whether transcriptome aberrations persist in developing dcKO DP, we 
compared the transcripts significantly up and downregulated found in DP of E17.5 and P3 mice 
(Figure 19C and D). As shown by means of Venn diagrams, 440 transcripts (blue colour diagrams) 
were found to be significantly downregulated in DP of both analyzed developmental stages. 
Similarly, in DP of E17.5 and P3 dcKO 284 transcript were upregulated at both developmental stages 
(red colour diagrams). This analysis indicated the existence of a subset of genes whose normal 
expression was permanently disrupted following BAF complex depletion.  
After finding that substantial transcriptome changes persist in developing dcKO DP, we decided to 
classify the aberrant down and upregulated transcripts according to their biological functionality 
using GO enrichment analysis (http://geneontology.org/). As shown in Figure 19E, transcripts found 
to be highly downregulated in DP at both developmental stages (E17.5 and P3) were known 
regulators of neurogenesis, responsible inter alia for neuronal maturation and differentiation, 
axonogenesis or dendrite development. Importantly, the transcriptome changes were enhanced in 
DP of P3 dcKO mice, suggesting that deficits in neuronal development were possibly already present 
at E17.5 (at least at the transcriptome level) and could not be rescued at later developmental stages 
(indicating that abundant GLAST/BLBP progenitors observed in dcKO did not differentiate to 
neurons). A similar enrichment analysis performed for the transcripts significantly upregulated in 
E17.5 and P3 dcKO DP indicated a durably increased expression of genes positively regulating cell 
proliferation (Figure 19F). Additionally, it was found that stem cell proliferation transcripts, 
prominent at E17.5, tended to decline in postnatal dcKO DP in favour of transcripts related to 
proliferation of other cell types. Unfortunately GO analysis did not reveal a common pool of 
transcripts related to gliogenic processes and modulated at both developmental stages, however as 
indicated by white-red heat map, some of transcripts upregulated in DP of E17.5 dcKO could be 
related to glial cell fate commitment. Similarly, a group of upregulated transcripts found in DP of P3
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Figure 19 | Aberrant gene expression profile in BAF complex depleted embryonic and postnatal DP. (A-
B) Transcriptome of (A) E17.5 and (B) P3 hGFAP-Cre dcKO versus WT DP. Volcano plots represent Log2 
fold change of transcript abundance together with –Log of corresponding p value for all significantly 
upregulated (in red) and downregulated (in blue) transcripts. Gray colour indicates transcripts with 
insignificant changes (p>0.01). The exact number of down and upregulated transcripts is noted in blue 
and red respectively. (C-D) Venn diagrams illustrating overlap between (C) downregulated and (D) 
upregulated transcripts of E17.5 and P3 hGFAP-Cre dcKO DP. Numbers in gray indicate exact amount of 
transcripts down- (C) and upregulated (D). (E-F) Examples of biological processes significantly down- (E) 
and upregulated or unchanged (F) in E17.5 and P3 hGFAP-Cre dcKO DP. Heat maps show Log of p value 
for corresponding analyzed GO pathway. Dendrograms depict existing relation between downregulated 
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(neurogenesis related) and upregulated (gliogenesis and proliferation related) pathways. Data are 
averages of n=3-4 animals (E17.5 DP; hGFAP-Cre dcKO: n=3, WT: n=4; P3 DP; hGFAP-Cre dcKO: n=4, WT: 
n=4). For all investigated transcripts p≤0.01. In GO pathway enrichment analysis Bonferroni-corrected for 
p<0.05. Transcriptome results stating about neurogenesis and proliferation at E17.5 have been already 
published in (Nguyen et al., 2018). dcKO, double conditional knockout. 
 
 
dcKO was described as positive regulators of glial cell differentiation (Figure 19F). Thus, this analysis 
indicated advanced gliogenic processes visible in the revealed transcriptome aberrations of dcKO DP.      
 
In summary, the data presented here constitute elegant evidence for massive changes in DP gene 
expression profiles evoked by hGFAP-Cre driven BAF complex loss. Some of these changes could be 
classified as neurogenesis related, in case of transcripts significantly downregulated in BAF depleted 
tissues, as well as gliogenesis and proliferation related, for transcripts of which BAF complex loss 
caused significant upregulation. Overall, our transcriptome analysis revealed two important features 
of the BAF-depleted cortex: impaired neurogenesis and enhanced gliogenesis and proliferation.    
 
 Production of neurons or AGPs? Neuronal deficits in dcKO postnatal cortex  
Given that the initial analysis of dcKO evoked transcriptional changes indicated a massive 
impairment of neurogenesis, as a next step we decided to gain further insight into neuronal deficits 
in BAF complex depleted P3 DP (Figure 20). In view of our previous observations that BAF subunits 
are upregulated in neurons (see Chapter 3. Results. 3.1), the neuronal development of BAF depleted 
progenitors appeared especially intriguing. Importantly, we decided to investigate dcKO impact on 
late born neurons (upper layers neurons), as these are the last to be developed before neurogenesis 
ceases and astrogenesis takes over (Miller and Gauthier, 2007).  
In order to evaluate the abundance of upper layer neurons we first decided to assess the expression 
of the late born neuron marker - special AT-rich sequence-binding protein 2 (SATB2) in DP coronal 
sections of WT and dcKO P3 pups by immunostaining (Britanova et al., 2008; Georgala et al., 2011). 
Additionally, for the purpose of comparing neuronal and astroglial phenotypes, we also assessed 
these sections for the expression of the AGPs enriched marker – GLAST (Zhao et al., 2014). Like 
previously, due to the distinct astroglial phenotype in medial and lateral cortical regions, as well as 
because of the reduced cortical thickness of dcKO brain (described in Chapter 3. Results. 3.2), the 
expression of the markers chosen was evaluated in developing M1 (MCx) and S1 (LCx) areas (Figure 
20A-E).  
In agreement with transcriptome data, double SATB2/GLAST immunostaining analysis of P3 DP 
revealed a massive reduction in SATB2 expressing neuronal pool in favour of GLAST positive AGPs 
(Figure 20A). Importantly, similarly to the astroglial phenotype described earlier, the abundance and 
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cortical position of SATB2 positive late born neurons exhibited regional differences with distinct 
phenotypes found in medial and lateral cortical areas of dcKO mice (Figure 20A-C). As presented in 
Figure 20B and C (pointed by empty arrowheads), SATB2 staining was visibly enriched in upper layers 
of developing WT M1 (MCx) and S1 (LCx) cortical areas. Interestingly, as shown in bar graphs 
presented in Figure 20D and C, SATB2 positive cells constituted around 50% of all DAPI cells found in 
the regions of MCx and LCx of P3 WT pups. Thus, SATB2 staining data indicated that advanced and 
proper neurogenesis processes take place in WT DP. Strikingly, the expression of SATB2 within P3 
dcKO MCx was significantly (***p≤0.001) reduced compared to that of WT, with few SATB2 positive 
cells scattered across the cortical thickness (Figure 20B and D, empty arrowheads).  
The same antibody staining of dcKO LCx area appeared to be more prominent (Figure 20C), however, 
still significantly reduced (**p≤0.01) compared to WT S1 (Figure 20 E). In addition, in contrast to the 
MCx region, stained dcKO SATB2 positive neurons preferentially populated upper cortical areas of 
LCx exhibiting specific medio-rostral gradient of enrichment (Figure 20A). 
As described previously, dcKO DP exhibited highly elevated levels of GLAST expressing cells that 
were found to be spread throughout the full cortical thickness (Figure 20A-C, examples indicated by 
full arrowheads). Interestingly, in dcKO MCx the percentages of DAPI positive cells expressing GLAST 
appeared to be higher than these of DAPI cells expressing SATB2 (Figure 20D). This was not the case 
in dcKO LCx (Figure 20E). Importantly, the depletion of late born neurons in P3 dcKO DP could be 
confirmed by our RNA-seq data. Screening the literature allowed us to identify 15 late born neurons 
specific genes characteristic for mouse neocortex (Molyneaux et al., 2007). We searched our 
transcriptome sequencing data for the expression of these genes. As indicated in the bar graph in 
Figure 20H, these late born neurons related transcripts (Molyneaux et al., 2007) were significantly 
downregulated in P3 DP of dcKO. Importantly, the reduction of SATB2 (Figure 20A-E) described 
above was found to be significant as well at the RNA level (Figure 20H). Additionally, it is known that 
BRN2 is one of the crucial regulators of late neurogenesis (Dominguez et al., 2013) and it is largely 
due to its suppression by NFiA and SOX9 that the molecular processes within RGCs switch from 
neurogenic to astroglial (Nagao et al., 2016). Importantly Brn2 was one of the late born neuron 
related transcripts found to be downregulated in dcKO DP, suggesting the promotion of astrogenesis 
and suppression of late born neurons development in dcKO DP.   
Bearing in mind that the hGFAP-Cre driven recombination starts earlier than the late neurogenesis 
processes (see Chapter 3. Results. 3.2) we then decided to inquire about the scale of total neuronal 
depletion investigating how many of significantly downregulated transcripts (found in dcKO P3 DP by 
RNA-seq; described above) would be related to neuronal development, morphology and physiology. 
For this purpose, by means of GO analysis we sorted all of significantly downregulated transcripts
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Figure 20 | Postnatal murine DP affected by BAF complex KO exhibits severe neuronal deficits 
favouring AGPs production. (A-C) Immunofluorescence analysis of P3 WT and dcKO murine cortical 
coronal sections stained with antibody to upper layer neurons marker – SATB2 (in magenta) together 
with antibody to AGPs marker – GLAST (in green). The nuclei of cells visualized by DAPI intercalation (in 
blue). (A) Overview pictures of WT and dcKO cortical areas. (B-C) Magnified insets of (B) MCx (M1 area) 
and (C) LCx (S1 area) delineated in (A). For (B) lower panels of each are enlarged views of outlined areas. 
Full arrowheads indicate AGPs expressing GLAST, empty arrowheads indicate neurons expressing SATB2. 
(D-E) Bar graphs showing percentage share of SATB2 positive cells and GLAST positive cells in all DAPI 
positive cells of P3 WT and dcKO mouse (D) MCx and (E) LCx. Data are averages ± σ of n=3 animals; 
***p≤0.001, **p≤0.01 in t student test. (F) Expression profile of significantly downregulated neuronal cell 
related transcripts (in black) juxtaposed with all significantly downregulated transcripts (in blue) in DP of 
P3 hGFAP-Cre dcKO versus WT mice. Scatter plot represents Log2 fold change of transcript abundance 
together with –Log of corresponding p value for all significantly downregulated transcripts. The exact 
transcripts numbers noted in brackets. (G) GO cellular component enrichment analysis indicating groups 
of genes related to neuronal cellular elements significantly downregulated in P3 DP hGFAP-Cre dcKO. 
Exact GO ID numbers shown in brackets. Bar graph represents –Log of corresponding p value for each 
indicated cellular component category. (H) Bar graph representing Log2 fold change of late born neuron 
related transcripts abundance in DP of P3 dcKO animals. Transcriptome data are averages of n=4 animals. 
For all investigated transcripts p≤0.01. In GO pathway enrichment analysis Bonferroni corrected for 
p<0.05. dcKO, double knockout; MCx, medial cortex (refers to M1 area); LCx, lateral cortex (refers to S1 
area); WT, wild type. 
 
 
(3199 blue colour data points, Figure 20F) into two groups: neuronal cell related and unrelated. 
Strikingly, 425 transcripts out of all 3199 could be classified as neuronal cell related. Importantly, as 
shown by scatterplot (Figure 20F), many of neuron-related transcripts were strongly downregulated 
with high significance (black data points). Additionally, GO cellular component enrichment analysis 
revealed groups of transcripts related to neuronal cellular elements significantly downregulated in 
P3 DP (Figure 20G). Among them the 5 most aberrant were these related to neuronal projection, 
synapse, dendrite, cell body and axon. All of the transcripts assigned to these 5 groups were highly 
and significantly downregulated in P3 dcKO DP comparing to that of WT (e.g. the amount of 
transcripts related to neuronal projections was over 35 times lower in dcKO DP than in WT; Figure 
20G).   
 
Taken together, these results indicate that hGFAP-Cre driven BAF complex loss manifests itself as 
severe neuronal deficits in postnatal DP. Additionally, the data suggests that BAF complex plays a 
decisive role in balancing cortical neurogenesis and astrogenesis, as its depletion leads to the 
promotion of astroglia (AGPs) production and suppresses late born neurogenesis.  
 
 Proliferation of BAF complex depleted cortical AGPs  
During the first postnatal weeks, the abundance of rodent astroglia increases up to 8-fold (Bandeira 
et al., 2009). Exciting reports of 2 - photon imaging and bromodeoxyuridine (BrdU) pulsing 
experiments indicated locally proliferative AGPs as a major source for astroglia expansion (Chaboub 
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and Deneen, 2013; Ge et al., 2012; Tien et al., 2012). However, little is known about the molecular 
underpinnings controlling this process. Considering that the gliogenesis and proliferation related 
transcripts were significantly upregulated in embryonic as well as postnatal DP of dcKO murine 
brain, a further goal of our project was to determine whether highly numerous BAF complex 
depleted AGPs found in P3 cortex exhibit elevated proliferation capacities.  
For this purpose two types of experiments addressing cellular proliferation were performed. The 
first involves immunohistochemistry of the proliferation marker – Ki67 (Scholzen and Gerdes, 2000) 
within BLBP positive AGPs (Figure 21). The second consists of the labelling and identification of the 
fraction of the proliferative cells by IP injected thymidine analogue - EdU (Chehrehasa et al., 2009; 
Flomerfelt and Gress, 2016; Vega and Peterson, 2005) and subsequent recognition of proliferative 
cells by immunostaining analysis (Figure 22A).  
Accordingly, by means of immunofluorescence analysis, we assessed the expression of AGPs 
enriched marker – BLBP together with proliferation marker – Ki67 (Figure 21C). We performed this 
immunostaining on coronal sections of developing M1 (MCx) and S1 (LCx) cortical areas of WT and 
dcKO P3 brains (Figure 21A and B).  
As indicated in Figure 21A and B, some of WT BLBP expressing cells found in MCx and LCx areas did 
exhibit Ki67 staining (full arrowheads) indicating active local proliferation of AGPs in postnatal DP. 
Quantitatively these WT proliferative AGPs accounted for 15.2±2.5% of all BLBP positive (the results 
of manual quantifications performed in both stained areas of cortex were pulled together; bar graph 
presented in Figure 21D). Strikingly, the BLBP enriched cells found in MCx and LCx of dcKO DP 
frequently exhibited Ki67 expression. Quantitatively 26.7±5.4% of dcKO BLBP positive cells stained 
for Ki67, significantly outnumbering Ki67 expressing BLBP positive cells found in WT (*p≤0.05; 
Figure22 A, B and D).  
Further, as explained above, we decided to investigate the proliferation of BLBP positive cells by 
another method - EdU labeling. For this purpose EdU was injected into WT/dcKO P3 pups 30 minutes 
before brain isolation (Figure 22A). As EdU incorporates to DNA during the S phase of cell cycle, this 
method allowed us to label the fraction of cells that were proliferative at the time of tissue 
collection. Next, we detected BLBP and EdU by immunostaining (Figure 22B). Overall, BLBP stained 
cells that incorporated EdU were found in cortex of WT and dcKO (Figure 22B, full arrowheads). 
However, the fraction of BLBP expressing cells exhibiting EdU labelling was significantly higher in 
dcKO compared to that of WT (**p≤0.01; in WT 12.9±1.8% whereas in dcKO 19.1±1.3% of all BLBP 
stained for EdU). Additionally, a substantial amount of WT BLBP/EdU positive cells was found in DW 
area of cortex (Figure 22B DW; full arrowheads) indicating their astrocytic RGCs fate rather than 
AGPs (Tramontin et al., 2003). To the contrary, dcKO BLBP/EdU stained cells were scattered through 
the full cortical thickness, which suggests that these were proliferative AGPs. Considering this
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Figure 21 | High proliferation capacities of BAF complex depleted dorsal AGPs (I). (A) Coronal tissue 
sections through WT and dcKO P3 mouse MCx (developing M1 area) and LCx (developing S1 area) stained 
with antibody detecting AGPs enriched marker - BLBP (in green) together with proliferation marker Ki67 
(in magenta). The nuclear DAPI staining is blue. Cells expressing BLBP together with Ki67 are proliferative 
AGPs. For (B) lower boards of each are magnified insets of delineated areas. Full arrowheads indicate 
proliferative AGPs, empty arrowheads indicate non-proliferative AGPs. (C) Scheme explaining the 
principle of proliferation analysis by Ki67 staining. Ki67 (magenta) is expressed during all active phases of 
the cell cycle. (D) Percentages of proliferative AGPs found among all BLBP expressing cells, registered in 
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the total cortex (MCx and LCx) of P3 WT and dcKO mice. Data are averages ± σ of (A) n=3 experimental 
replicates; *p≤0.05 in t- student test. (E) Expression profile of significantly upregulated glioma/astrocyte 
proliferation related transcripts (in black) juxtaposed with all cell proliferation related transcripts (in red) 
upregulated in DP of P3 hGFAP-Cre dcKO versus WT mice. Scatter plot represents Log2 fold change of 
transcript abundance together with –Log of corresponding p value for all significantly upregulated 
proliferation related transcripts. The Log2 fold change level of upregulation as well as names of 
glioma/astrocyte proliferation related transcripts represented as black dots in scatter plot are shown in 
G. (F) Pie chart showing the percentage of glioma/astrocyte proliferation related transcripts among all 
significantly upregulated proliferation associated transcripts. The exact transcript number shown in 
brackets. For E and F black colour refers to the glioma/astrocyte proliferation related transcripts, red 
colour refers to other upregulated proliferation related transcripts. Transcriptome data are averages of 
n=4 animals. For all investigated transcripts p≤0.01. In GO pathway enrichment analysis, used for 
proliferation related transcripts detection, Bonferroni-corrected for p<0.05. Cx, cortex; dcKO, double 
knockout; MCx, medial cortex (refers to the developing M1 area); LCx, lateral cortex (refers to the 
developing S1area); WT, wild type.  
 
 
observation we then asked how many of BLBP expressing cells labelled by EdU could be found 
scattered through the cortical thickness in WT and dcKO and which fraction of these resided in DW. 
Since mutant animals did not develop DW structure we decided to count the number of BLBP/EdU 
positives found at the surface of dcKO VZ. As presented in pie charts (Figure 22D) only 15% of WT 
BLBP expressing cells that incorporated EdU could be found in the areas of cortex different than DW. 
In contrast to WT, 98% of dcKO EdU labelled BLBP positive cells were detached from the VZ surface 
and scattered across the full cortical thickness. This implies that the majority (98%) of dcKO 
BLBP/EdU stained proliferative cells may classify as AGPs. The same classification applies to the 
smaller fraction of WT EdU labelled BLBP expressing cells, which accounted only for 15%.  
Thus, our Ki67 immunostaining/EdU incorporation experiments confirmed the elevated proliferation 
capacities of BAF complex depleted BLBP positive AGPs.  
 
Another line of evidence supporting this conclusion could be drawn from transcriptome sequencing 
data. Given that the initial GO analysis of dcKO revealed transcriptional changes indicative of a 
massive upregulation of proliferation related transcripts, we next investigated the involvement of 
these transcripts in astrocyte or glioma proliferation regulation (Figure 21E-G, Table 1). Screening 
the literature for information on the 151 proliferation related transcripts that were upregulated in 
dcKO DP, we found that 27 of these (18%, Figure 21F) were related to the proliferation of astrocyte 
and/or glioma. The relation between these two groups is shown by scatterplot in Figure 21E. The 
level of upregulation (Log2 fold change of given transcript abundance) of all proliferation related (red 
data points) as well as astrocyte and/or glioma related (black data points) is plotted together with 
the significance (with –Log of corresponding p value). Additionally, the Log2 fold changes of 15 genes 
related to astrocyte and/or glioma proliferation, whose expression was most upregulated, are 
shown in bar graph of Figure 21G (detailed description of these provided in Table 1). As described in
78 
 
 
 
Figure 22 | High proliferation capacities of BAF complex depleted dorsal AGPs (II). (A) Scheme 
explaining the principle of proliferation analysis by thymidine analogue (EdU) injection. IP injected EdU 
(red colour) incorporates to DNA during the S phase of cell cycle allowing for the labelling of the fraction 
of proliferative cells. (B) Immunofluorescence analysis of mouse P3 cortex (M1 area) WT and dcKO 
sections detecting BLBP positive AGPs (in green) and EdU (in red) that incorporated into DNA of cells after 
30 minutes from IP injection. Cells expressing BLBP positively stained for EdU are proliferative AGPs 
(scattered through cortex) or astrocytic RGCs (residing in DW). Lower boards of each are magnified insets 
of delineated areas of PS, CP and DW. Full arrowheads indicate EdU positive cells expressing BLBP, empty 
arrowheads indicate examples of EdU negative/BLBP positive cells. Cell bodies of some of BLBP 
expressing cells negative for EdU outlined with dashed line. (C) Percentages of proliferative BLBP positive 
cells registered in P3 WT and dcKO murine cortex. Bar graph indicates the percentage of BLBP expressing 
cells positive for EdU 30 minutes after injection. Data are averages ± σ of n=4 experimental replicates; 
**p≤0.01 in t- student test. (D) Pie charts showing the degree of DW detachment of BLBP/EdU positive 
cells in WT (upper panel) and dcKO (lower panel) P3 DP. Light green colour indicates percentages of 
BLBP/EdU positive cells residing in DW, dark green colour indicates percentages of these cells found 
outside DW. Data are averages of n=3 animals (for WT: BLBP+/EdU+ detached=15.2, BLBP+/EdU+ 
DW=84.8±2.4%; for dcKO: BLBP+/EdU+ detached= 97.7, BLBP+/EdU+ DW=2.3±0.8%). CP, cortical plate; 
Cx, cortex; dcKO, double knockout; DW, deep cerebral white; IP, intraperitoneal injection; PS, pial 
surface; WT, wild type.   
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NAME LOG2 FOLD CHANGE P VALUE 
ASTROCYTES/GLIOMA 
PROLIF. RELATED REFERENCES 
Twist1 1.88 2.75E-09 astrocytes and glioma (Elias et al., 2005; Wasilewski et 
al., 2017) 
Lin28a 1.54 1.10E-05 glioma (Mao et al., 2013) 
Pax3 1.44 3.06E-05 glioma (Su et al., 2016; Xia et al., 2013) 
Gli1 1.30 3.19E-16 astrocytes and glioma (Clement et al., 2007; Garcia et al., 
2010; Pitter et al., 2014) 
Pax6 1.20 1.79E-15 glioma (Liu et al., 2012) 
S100a6 1.07 2.58E-07 astrocytes and glioma (Yamada and Jinno, 2012, 2014) 
Hmgn5 1.04 8.97E-17 glioma (Cao et al., 2017) 
Egr1 1.02 4.22E-07 astrocytes (Mayer et al., 2009) 
Ntn1 0.97 1.09E-06 glioma (Sanvoranart et al., 2016) 
Emp3 0.95 8.62E-05 glioma (Jun et al., 2017) 
Rac2 0.92 2.00E-08 glioma (Lai et al., 2017) 
Aqp1 0.90 0.008705 glioma (Hayashi et al., 2007) 
Epor 0.86 0.000601 glioma (Peres et al., 2011) 
Btk 0.85 0.001167 glioma (Yue et al., 2017) 
Klf4 0.79 0.000114 glioma (Tang et al., 2016) 
Jag1 0.76 6.77E-09 astrocytes (LeComte et al., 2015) 
Id4 0.73 4.78E-08 astrocytes (Lee et al., 2011) 
Hmox1 0.71 7.82E-09 glioma (Ghosh et al., 2016) 
Sox2 0.68 6.58E-14 glioma (Annovazzi et al., 2011) 
Tspo 0.67 0.009165 glioma (Werry et al., 2015) 
Ccnd1 0.67 4.64E-10 glioma (Cao et al., 2017) 
Hpse 0.66 0.002486 glioma (Kundu et al., 2016) 
Ptch1 0.66 1.02E-07 glioma (Clement et al., 2007) 
Cdc7 0.63 3.97E-07 glioma (Erbayraktar et al., 2016; Li et al., 
2018a) 
Hdac1 0.63 0.000456 glioma (Li et al., 2018b) 
Tgfβ3 0.60 4.39E-06 glioma (De Falco et al., 2007) 
Wwtr1 0.58 1.22E-09 glioma (Qiu et al., 2016) 
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Table 1 | Astrocyte/glioma proliferation related transcripts upregulated in DP of P3 dcKO mice. The 
table describes 27 transcripts related to astrocyte/glioma proliferation significantly upregulated in DP of 
P3 dcKO stating the level of upregulation (log2 fold change), significance (p value), involvement in 
astrocyte and/or glioma proliferation (astrocytes/glioma prolif. related) and corresponding literature 
source (references). Prolif. , proliferation.  
 
 
Table 1 the majority of the genes selected was related to glioma proliferation, where out of 27 only 
5 are proven to regulate astrocyte proliferation. According to recent literature, these were Twist1 
(Wasilewski et al., 2017), Gli1 (Garcia et al., 2010; Pitter et al., 2014) , S100a6 (Yamada and Jinno, 
2012, 2014), Jag1 (LeComte et al., 2015) and Id4 (Lee et al., 2011). In addition, all of these regulators 
are known to be involved in reactive astrocyte proliferation induction rather than in postnatal 
multiplication of AGPs (except for Gli1 and S100a6). This creates the impression of a lack of 
upregulation of ‘real’ astrocyte proliferation regulators. However, the process of astrocyte 
proliferation has not been widely investigated and key informations about its molecular regulation 
are missing. Thus, the possibility of a deep analysis of our transcriptome data was frustrated by the 
lack of literature describing the molecular control of astrocyte proliferation.    
 
In summary, BAF complex depleted AGPs of postnatal DP are highly proliferative. Additionally, the 
proliferation processes evoked by hGFAP-Cre driven BAF loss were accompanied by upregulation of 
several glioma related proliferation regulators. 
 
 The more AGPs – the less astrocytes? Maturating protoplasmic astrocytes in dcKO DP 
Having established that the loss of BAF complex in astrocytic RGCs causes a massive increase in the 
abundance of AGPs we then asked whether this aberrant amount of progenitors affects the numbers 
of maturating astrocytes, which we expected to increase. Because the AGPs of dcKO were found to 
be scattered throughout the cortical thickness we turned our attention to maturating gray matter 
(protoplasmic) astrocytes, which normally exhibit a similar distribution pattern (Cahoy et al., 2008; Li 
et al., 2012; Oberheim et al., 2012). Using immunohistochemistry, we assessed the expression of the 
mature protoplasmic astrocyte marker - ACSBG1 (Cahoy et al., 2008; Chaboub and Deneen, 2013; Li 
et al., 2012) in coronal sections of WT and dcKO P3 brain tissue. The selection of this time point was 
dictated by our observation of the elevated abundance of AGPs in P3 mutant mice, as well as by the 
necessity of proper WT control experiment (E17.5 WT brain tissue did not exhibit ACSBG1 staining, 
Appendix, Figure 46). Additionally, due to the distinct AGPs cortical phenotype in medial and lateral 
regions of dcKO cortex (previously described), the expression of ACSBG1 was also assessed in 
developing M1 (MCx) and S1 areas (Figure 23A-C, E). The immunostaining showed ACSBG1 positive 
cells scattered through the full thickness of WT gray matter in MCx and LCx areas (Figure 23A-C,
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Figure 23 | Area dependent astrocyte differentiation in BAF complex depleted cortex of postnatal mice. 
(A-C) Immunofluorescence staining of coronal sections through P3 WT and dcKO murine DP regions 
detecting the expression of astroglial marker – ACSBG1 (in green and gray). The nuclei of cells visualized 
by DAPI intercalation (in blue). (A) Overview pictures of WT and dcKO cortical areas. (B-C) Magnified 
insets of (B) MCx (developing M1 area) and (C) LCx (developing S1 area) delineated in (A). For (B) lower 
panels of each are enlarged views of outlined areas (RGB and gray scale images). Full arrowheads indicate 
ACSBG1 positive astrocytes. (D) ACSBG1 immunostaining for MCx area of E17.5, P0 and P3 dcKO DP. 
Nuclear DAPI staining shown in blue. (E and F) Bar graphs representing percentage share of ACSBG1 
positive cells in all DAPI positive cells in indicated areas of P3 WT and dcKO mouse DP (E) or in MCx area 
of E17.5, P0 and P3 dcKO mice (F). Data are averages ± σ of n=2-3 (E) or n=3-4 (F) experimental replicates; 
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***p≤0.001 in t student test, NA not applicable (n=2). CP, cortical plate; Cx, cortex; dcKO, double 
knockout; DW, deep cerebral white; MCx, medial cortex (refers to M1 area), LCx, lateral cortex (refers to 
developing S1 area); NA, not applicable; PS, pial surface; VP, ventral pallium; WT, wild type.  
 
 
pointed by arrowheads), exhibiting a distribution pattern typical for protoplasmic astrocytes (Cahoy 
et al., 2008). Surprisingly MCx area of dcKO DP did not stain for ACSBG1 (Figure 23A and B). This was 
apparent in our quantifications, where among all DAPI cells found in M1 area of analyzed brain dcKO 
sections, less than 1% expressed ACSBG1. Thus, the dcKO MCx exhibited a strong reduction in the 
abundance of protoplasmic astrocyte compared to WT (***p≤0.001, Figure 23E). Interestingly, the 
same antibody staining of dcKO LCx area appeared to be more prominent (Figure 23C). Moreover, 
quantitatively, comparing to the developing WT S1 area, more dcKO DAPI positive cells expressed 
ACSBG1 (Figure 23A, C and E; percentage value of DAPI cells expressing ACSBG1). In addition, dcKO 
affected protoplasmic LCx astrocytes showed characteristic, hypertrophic morphologies with highly 
enriched cellular ACSBG1 staining comparing to that of WT (Figure 23C, magnified insets).   
 
Overall, ACSBG1 positive astrocytes exhibited specific medio-rostral gradient of cortical distribution 
with diminished expression in medial and elevated expression in lateral areas (Figure 23A-C).  
 
This striking phenomenon of lack of development of protoplasmic astrocytes in the medial areas of 
dcKO affected cortex prompted us to inquire about the reasons for this deficiency. As the premature 
embryonic differentiation of MCx AGPs to ACSBG1 positive protoplasmic astrocytes followed by e.g. 
apoptosis or migration could offer an elegant explanation to the above described gradient, we 
therefore decided to evaluate the expression of ACSBG1 in E17.5 and P0 M1 cortical sections of 
dcKO mice. As presented in Figure 23D, MCx areas of any developmental stage (E17.5, P0 and P3) of 
dcKO brain did not exhibit ACSBG1 positive cells (except for isolated cells that accounted for no more 
than 1% of DAPI positive cells, Figure 23F). Thus it is not due to the premature differentiation that 
MCx of dcKO is deprived of ACSBG1 positive astrocytes.  
Possible apoptosis (programmed cell death) of AGPs affected by BAF complex depletion could serve 
as another explanation of lack of their differentiation to protoplasmic astrocytes in MCx of dcKO 
cortex. Thus, as a next step we sought to investigate the process of apoptosis in AGPs (Figure 24). 
For this purpose we immunohistochemically evaluated the expression of one of the final executor 
proteins  of programmed cell death – CASPASE 3 (CASP3) (Porter and Janicke, 1999) in AGPs. We 
performed this study on coronal brain slices isolated from WT and dcKO mice at two developmental 
stages: E17.5 and P0. We chose to investigate tissues isolated at E17.5, as we wanted to test 
apoptosis at the beginning of the cortical astrogliogenesis. Additionally, we sought to check whether 
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the possible wave of apoptosis precedes the previously investigated P3 stage, therefore we also 
decided to assess CASP3 expression in P0 brain tissues. As shown in Figure 24A and B, cells found in 
MCx and LCx of E17.5 and P0 dcKO mice more frequently stained for CASP3 comparing to that of WT 
(indicated by empty and full arrowheads). Some of those found in dcKO as well as WT tissues, 
however not all, were apoptotic GLAST positive AGPs (pointed by full arrowheads). Quantitatively, in 
MCx of E17.5 dcKO mice 1.9±0.9% of GLAST stained cells as well as 1.0±0.4% of DAPI positive cells 
expressed CASP3 (pointed by full and empty arrowheads respectively) (Figure 24C and D). A similar 
analysis performed in LCx of E17.5 dcKO indicated that 2.0±0.8% of GLAST stained cells expressed 
CASP3 whereas globally 0.9±0.3% of DAPI stained cells exhibited positive staining for CASP3. As 
shown in bar graphs of Figure 25C and D, these percentage values of cells expressing CASP3 found in 
MCx and LCx of E17.5 dcKO significantly outnumbered the percentages quantified for the 
corresponding areas of E17.5 WT cortex (**p≤0.01; in WT MCx 0.1±0.03% of DAPI and 0.3±0.2% of 
GLAST positive cells stained for CASP3 whereas in WT LCx 0.1±0.02% of DAPI and 0.3±0.2% of GLAST 
stained cells expressed CASP3; Figure 24C and D). Thus, we could observe elevated apoptosis in 
dcKO cortex harvested at the developmental stage corresponding to the time of early cortical 
astrogliogenesis. However, only a fraction of 53.0±15.9% of all apoptotic cells found in both analyzed 
E17.5 dcKO cortical areas was corresponding to the apoptotic GLAST positive AGPs (thus 47% of 
apoptotic cells were of another cell type). For comparison, 41.0±35.0% of apoptotic cells found in 
both analyzed areas of E17.5 WT cortex expressed GLAST. Similarly to E17.5, analysis of the 
abundance of apoptotic cells found in P0 dcKO and WT MCx and LCx, revealed increased 
percentages of dcKO DAPI and GLAST positive cells exhibiting CASP3 staining. Accordingly, in MCx of 
dcKO 1.4±0.3% of DAPI stained cells and 1.6±0.2% of GLAST positive cells expressed CASP3, whereas 
in dcKO LCx 1.3±0.05% of DAPI and 1.9±0.7% of GLAST expressing cells stained for CASP3 (Figure 24E 
and F). Comparing to the percentage values revealed for P0 WT MCx (0.05±0.02% of DAPI stained 
cells and 0.1±0.07% of GLAST positive cells expressed CASP3), as well as for P0 WT LCx (0.06±0.002% 
of DAPI stained cells and 0.2±0.03% of GLAST positive cells expressed CASP3), the apoptotic 
processes of P0 dcKO cortex seemed to be elevated (no statistical analysis due to the low numbers 
of investigated animals (for WT and dcKO n=2). Overall, these experiments indicated a slightly 
increased apoptosis in BAF complex depleted GLAST positive AGPs. However, even though elevated, 
the extent of the programmed cell death in dcKO AGPs was relatively low, as the percentage 
numbers of CASP3 positive found in dcKO at both investigated developmental stages did not exceed 
2% of all GLAST expressing cells. Thus, we conclude that it is unlikely that the apoptosis of AGPs 
deprived of BAF complex led to the deficits in the protoplasmic astrocytes pool observed in medial 
areas of dcKO cortex. 
Seeking for the answer we subsequently noticed that several literature reports indicated the
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Figure 24 | Slightly elevated apoptosis in murine DP affected by BAF complex KO. (A, B) Immunostaining 
analysis of coronal brain sections through WT and dcKO E17.5 (A) and P0 (B) murine MCx (developing M1 
area) and LCx (developing S1 area) stained with antibody to AGPs marker - GLAST (in green) together with 
apoptosis marker - CASP3. The nuclei of cells stained by DAPI (in blue). Four zoom in pictures in (A) are 
magnified insets of delineated area of dcKO MCx. Full arrowheads indicate examples of GLAST positive 
AGPs positive for CASP3 staining, empty arrowheads indicate examples of CASP3 positive/ GLAST 
negative cells. (C-F) Percentages of CASP3 positive cells per: (C and E) total number of GLAST expressing 
cells analyzed at (C) E17.5 and (E) P0; (D and F) per total number of DAPI positive. All bar graphs show 
data collected in the regions of MCx (developing M1 area) and LCx (developing S1 area). Data are 
averages ± σ of n=2-4 animals; **p≤0.01, in t student test, NA not applicable (n=2). CASP, CASP3; Cx, 
cortex; dcKO, double knockout; MCx, medial cortex (refers to developing M1 area); LCx, lateral cortex 
(refers to developing S1 area); NA, not applicable; WT, wild type. 
 
 
indispensable role of late born neuron derived cytokines in the activation of astrocytic genes within 
progenitor cells (Barnabe-Heider et al., 2005; Freeman, 2010; Miller and Gauthier, 2007). Thus, we 
reasoned that neuronal depletion occurring upon BAF KO could lead to impaired differentiation of 
cortical astrocytes (Figure 25). In order to investigate whether lack of development of ACSBG1 
positive protoplasmic astrocytes within MCx of dcKO may be caused by neuronal aberrations, we 
decided to reanalyze and compare the P3 WT and dcKO cortical distribution of GLAST stained AGPs 
(described in Figure 17), SATB2 stained late born neurons (details in Figure 20) and above described 
ACSBG1 stained protoplasmic astrocytes (Figure 23). As presented in micrographs of Figure 25A and 
bar graph of Figure 25B, the medio-lateral cortical distribution of GLAST expressing AGPs seemed to 
be homogenous (indicated by evenly distributed arrowheads) with similar percentage values of DAPI 
cells expressing GLAST found in medial (M1) and lateral (S1) parts of P3 WT as well as dcKO cortex. 
Thus, it is not due to the difference in AGPs distribution that ACSBG1 positive astroglia are not 
developed in medial cortical areas. Additionally, cells expressing SATB2 or ACSBG1 found in WT 
cortex of P3 mice displayed a similarly regular distribution (Figure 25C-F; pointed by evenly 
distributed arrowheads). However, in the brain of P3 dcKO mice SATB2 expressing late born neurons 
as well as ACSBG1 stained protoplasmic astrocytes exhibited specific medio-lateral cortical gradient 
of distribution (Figure 25C and E; pointed by unevenly distributed arrowheads). Overall, both of 
these cellular populations were diminished in medial cortical areas (M1) of dcKO mice; SATB2 
positive cell population to a lesser extent (Figure 25C and D), whereas ACSBG1 expressing astroglial 
population was not present at all (Figure 25E and F). In order to summarize, based on quantification 
data shown in bar graphs of Figure 25B, D and F, we generated a line graph (end of lines correspond 
to percentages of DAPI positive cells expressing given marker in MCx and LCx; Figure 25G) and 
corresponding scheme (gradient colour coded percentages of DAPI positive cells expressing given 
marker in MCx and LCx; Figure 25H) that allowed the comparison of the distribution of neurons vs 
glia in P3 dcKO cortex. Accordingly, in dcKO mouse brain GLAST positive AGPs were equally 
distributed through the cortex, whereas the amounts of SATB2 neurons and ACSBG1 astrocytes were
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Figure 25 | Neuronal and astroglial distribution differs between and within cortex of WT and dcKO 
mice. Coronal sections through P3 cortex of WT and dcKO mice stained with antibodies against astroglial 
progenitor marker - GLAST (in green, A), late born neuron marker – SATB2 (in magenta, B) and 
protoplasmic astrocytes marker – ACSBG1 (in green, C). The nuclear DAPI staining is blue. Full arrowheads 
indicate the areas of registered positive staining for given marker. (B, D and F) Percentages of given 
marker positive cells per total number of DAPI positive in the regions of MCx (M1 area) and LCx (S1 area) 
of P3 WT and dcKO DP. Data are averages ± σ of n=2-3 animals; ***p≤0.001; **p≤0.01, in t student test, 
NA not applicable (n=2). (G) Line graph representation of values shown by bar graphs from B, D and F 
indicating dynamic changes in the abundance of: GLAST positive cells (dashed green line), SATB2 positive 
cells (magenta line) and ACSBG1 positive cells (green line) between the areas of medial (MCx) and lateral 
(LCx) part of the cortex. (H) Scheme depicting medio-rostral distribution of analyzed markers in dcKO 
cortex. GLAST expressing AGPs were equally distributed through the cortex whereas the amounts of 
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SATB2 neurons and ACSBG1 astrocytes were found to be reduced in MCx (lighter colour) and partially 
reconstituted in LCx (darker colour). Colour intensity proportional to the percentage values found in B, D 
and F. Cx, cortex; dcKO, double knockout; MCx, medial cortex (refers to developing M1 area); LCx, lateral 
cortex (refers to developing S1 area); VP, ventral pallium; WT, wild type. 
 
 
found to be reduced in MCx and partially reconstituted in LCx. Thus, we found a correlation between 
the distributions of neurons and astrocytes, suggesting that low numbers of late born neurons may 
be responsible for the underdevelopment of protoplasmic astrocytes in medial areas of P3 dcKO 
mouse cortex, presumably through reduced concentration of late born neurons derived cytokines. 
This hypothesis will need to be confirmed in future experiments.  
Last but not least, abnormal migration of cortical progenitors could also possibly explain the scarcity 
of protoplasmic astrocytes in MCx of dcKO mice. In order to address this issue, we first decided to 
analyze the results of GO pathway evaluation in P3 dcKO/WT DP. We focused our analysis on known 
pathways connected to the regulation of migration. As indicated in Figure 26D, several transcripts 
significantly upregulated in P3 dcKO DP were related to the cell locomotion and migration or to the 
movement of subcellular compartments, indicating enhanced migration-related processes in dcKO 
DP. Encouraged by this finding we further traced the localization of the progenies of cortical RGCs 
found in lateral VZ of WT and dcKO mice. We electroporated LCx VZ cells of perinatal embryos with a 
pCAG-IRES-EGFP plasmid, enabling expression of EGFP in electroporated cells and their progenies. 
Subsequently we analyzed the localization of EGFP positive cells at P3 developmental stage (Figure 
26A). Unfortunately a mortality rate of 100% of embryos electroporated at E17.5 prevented us from 
tracing astrocytic RGCs and their progenies. Therefore we decided to trace daughter cells of 
intermediate (between neurogenic and astrogenic) RGCs from late E16.5 embryos. Furthermore, due 
to the fragile cortical structure of dcKO MCx we chose to electroporate LCx VZ cells instead. As 
indicated in Figure 26B and C, the progenies of WT RGCs electroporated at E16.5 mostly populated 
superficial layers of cortex (LII/III) postnatally (P3), indicating their neuronal fate. Additionally, a 
fraction of electroporated cells in WT was left behind still residing in VZ of LCx (as RGCs population) 
or migrating across the cortical layers (possibly as migrating neurons) towards the final destination. 
The distribution of EGFP traced cells of dcKO mice substantially differed from that of WT (Figure 26B 
and C). Only single EGFP expressing cells could be found close to the PS of LCx (arrowheads). 
However, the cellular morphology and distribution pattern of these cells was not similar to that of 
neurons. Additionally, some of the traced cells resided in the VZ of LCx. Since this area was 
electroporated, we assumed that these cells were RGCs. Besides, to our surprise, a substantial 
amount of EGFP expressing cells could be found in VP of dcKO, namely in the LGE and striatum 
(indicated by arrowheads). Importantly these observations stand true for 3 electroporated WT and 3 
electroporated dcKO brains (visual evaluation, no statistical analysis). We also considered the
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Figure 26 | The distribution of perinatal RGCs progenies differs between WT and dcKO brains. (A) 
Scheme explaining the principle of distribution studies conducted by means of EGFP plasmid in utero 
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injection and electroporation (IUE). Lateral ventricles of late E16.5 embryos were injected with pCAG-
IRES-EGFP and subsequently electroporated, directing plasmid DNA towards LCx VZ. Electroporated 
brains were assessed for EGFP (in green) expression at P3 postnatal stage. (B) Endogenous EGFP signal in 
P3 WT and dcKO coronal brain slices prepared from electroporated brains. Nuclear DAPI staining is blue. 
Lower boards of WT and dcKO are single channel images of EGFP. Full arrowheads indicate approximate 
localization of EGFP positive cells. (C) Scheme of the areas of P3 WT and dcKO brains in which EGFP 
positive cells were found after IUE at 16.5. Dashed green line indicates the injection and electroporation 
site. Green coloured area indicates brain regions with EGFP positive cells. Shades of green represent the 
approximate quantity of EGFP positive cells. (D) GO molecular pathway enrichment analysis indicating 
groups of transcripts related to migration and significantly upregulated in P3 DP hGFAP-Cre dcKO (E, F). 
Immunofluorescence analysis of P3 WT and dcKO murine cortical coronal sections stained with antibody 
to upper layer neurons marker – SATB2 (in magenta). DAPI stained by intercalation (in blue). (E) Overview 
pictures of WT and dcKO coronal brain sections indicating (by arrowheads) the areas exhibiting positive 
staining for SATB2. Delineated areas of LGE show regions of which inset images presented in (F) were 
taken. (F) LGE and striatum areas of WT and 3 independent dcKO mice exhibiting staining for SATB2. 
Arrowheads indicate cells positive for SATB2. The directions towards VZ and CPu are indicated by two 
headed arrow. com., compartment; CPu, caudate putamen; dcKO, double knockout; DP, dorsal pallium; 
IUE, in utero electroporation; LGE, lateral ganglionic eminence; sub., subcellular; VP, ventral pallium; VZ, 
ventricular zone; WT, wild type.  
 
 
influence of pronounced (at the stage of P3) anatomical differences in WT and dcKO brain 
architecture on the outcome of electroporation experiments. However comparing E16.5 brain 
structures of WT and dcKO mice we concluded that the degree of anatomical differences at this 
developmental stage is very low and unlikely to influence the results of electroporation (Appendix, 
Figure 47A and B). Thus, as presented in schemes of Figure 26C, RGCs of E16.5 WT LCx (Figure 26C, 
WT; dashed line) gave rise to progenies that postnatally resided in several areas of DP (Figure 26C, 
WT; green shade depicts areas of P3 WT brain in which EGFP positive cells were observed (n=3)). 
However, electroporated E16.5 dcKO LCx VZ cells (Figure 26C, dcKO; dashed line) and their progenies 
could be found in DP as well as VP of postnatal brain (Figure 26C, WT; green shade depicts areas of 
P3 dcKO brain in which EGFP positive cells were found (n=3)). These results seem to confirm our 
assumption that BAF depleted AGPs of DP may migrate out of the cortical areas to populate other 
regions of dcKO brain. Additionally, another line of evidence supporting this hypothesis comes from 
late born neurons studies. Careful investigation of SATB2 expression revealed a population of late 
born neurons that in dcKO brain resides in LGE and striatum (Figure 26E and F, arrowheads). This 
finding stands to the contrary of WT SATB2 positive cells distribution that solely populate upper 
layers of cortex with no single positive cell found in LGE or striatum (Figure 26F, arrowheads). As 
shown in Figure 26F, SATB2 positive cells could be found in LGE and striatum of 3 independent dcKO 
mice. In summary, it appears likely that BAF complex depleted AGPs of MCx are migrating towards 
presumably healthier ventral regions of dcKO brains and subsequently differentiate to ACSBG1 
positive protoplasmic astrocytes (Appendix, Figure 47C further described in upcoming section 3.4).  
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Overall, we could observe that ACSBG1 positive gray matter astrocytes exhibit a specific medio-
rostral gradient of distribution with lack of expression in MCx and elevated expression in LCx. This 
striking phenomenon in the medial areas of dcKO cortex could be due to the low numbers of late 
born neurons in this area and the ensuing impoverishment in cytokines promoting AGPs maturation. 
Lack of protoplasmic astrocytes in dcKO MCx could also be caused by aberrant migration of AGPs, 
prompting these to translocate from DP to LGE or striatum. It is less likely that lack of ACSBG1 
expressing protoplasmic astrocytes in MCx of dcKO is due to the premature differentiation of AGPs 
or their apoptosis. However, these possible explanations of the medio-lateral gradient in 
protoplasmic astrocytes numbers in dcKO need to be verified by further experiments. 
 
3.4 Ventral astroglial phenotype  
 
A comprehensive survey of dcKO cortical phenotype of perinatal mice revealed several interesting 
aspects of astrocytogenesis evidently affected by the mutation. It is crucial, however, to keep in 
mind that the hGFAP promoter used in this study targets not only dorsal but also ventral astroglial 
germinal zones (Chapter 3. Results. 3.2), thereby affecting ventral astroglial populations (Bayraktar 
et al., 2014; Tsai et al., 2012). Therefore, hGFAP-Cre driven loss of BAF complex in ventral and dorsal 
astrocytic RGCs mimics the reduction in BAF expression commonly observed in WT striatal AGPs (as 
described in Chapter 3. Results. 3.1). Additionally, the cortical gradient of protoplasmic astrocytes 
distribution as well as our migration studies suggest that ventral forebrain astrocytes may also be 
altered upon hGFAP-Cre driven BAF complex depletion. Thus, we decided to investigate the ventral 
astroglial phenotype of dcKO mice forebrain. Prompted by our previous observations we analyzed 
the possible changes within the cellular population of ACSBG1 expressing protoplasmic astrocytes. 
 
 Maturating astrocytes in BAF complex deprived VP 
Immunohistochemical analysis of ACSBG1 revealed an interesting cortical distribution pattern with 
diminished expression in medial and elevated expression in lateral parts of P3 dcKO cortex (Chapter 
3. Results. 3.3). Because hGFAP promoter allows to target both ventral astrocytic germinal zones 
(MGE and LGE) potentially affecting different astroglial populations (astrocytes of piriform cortex, 
striatum and ventral pallidum; see Figure 12), to gain further insights into protoplasmic astrocytes 
phenotype of BAF complex depleted VP, we examined the forebrain distribution  of ACSBG1 positive 
cells. For this purpose we immunohistochemically assessed the ASCBG1 expression in anterior and 
posterior coronal sections of P3 WT and dcKO brains. We used a custom-written Matlab routine to 
generate semi-quantitative heat maps (based on single sections) of WT and dcKO distribution of 
ACSBG1 positive cells. As shown in Figure 27 and 28, ACSBG1 positive astrocytes of WT mice were
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Figure 27 | Highly elevated astrogliosis in BAF complex deprived VP and lateral pallium (LP) (I). (A, 
B) Immunostaining of ACSBG1 in coronal brain sections through P3 WT and dcKO murine brain (in 
green) in the rostro-medial (A, anterior) and medio-caudal (B, posterior) brain regions. The nuclei of 
cells visualized by DAPI intercalation (in blue). Middle panels of each are single channel images of 
ACSBG1 staining. Full arrowheads indicate the areas of dcKO brain exhibiting increased density of 
astrocytes expressing ACSBG1. Extreme right boards of each are semi-quantitative distribution maps 
generated based on manual labeling of ACSBG1 positive cells in a single representative section. As 
indicated by scale bar (arbitrary units), red colour corresponds to high density whereas blue colour 
corresponds to low density of ACSBG1 positive cells. CANu, central amygdala nucleus; CPu, caudate 
putamen; dcKO, double knockout; MCx, medial cortex; LCx, lateral cortex; Th, thalamus.    
 
 
rather evenly scattered through anterior and posterior regions of brain. A slightly higher 
concentration of astrocytes could be observed in hippocampus and thalamus (Th) of posterior as 
well as in CPu of anterior WT sections (Figure 27A and B; distribution maps). A similar analysis 
performed for dcKO brain sections revealed several alterations in ACSBG1 expressing protoplasmic 
astrocytes distribution (Figure 27A and B; distribution maps, Figure 28A-E). First of all, we found a 
massive increase in ACSBG1 density (indicated in Figure 27 by arrowheads) in anterior and posterior 
regions of dcKO CPu (Figure 27A and B; distribution maps - red colour; Figure 28A) and LCx (Figure 
27A and B; Figure 28D) as well as in CANu (Figure 27B; Figure 28B) and Th (Figure 27B; Figure 28C). 
As depicted in Figure 28E, 14.1±2.4% of DAPI positive cells of the region of dcKO CPu expressed 
ACSBG1. For WT CPu cells positive for ACSBG1 amounted to 5.7±1.0% of all DAPI stained cells. 
Importantly, as revealed by statistical analysis, the amount of ACSBG1 expressing astrocytes found in 
CPu of several dcKO individuals significantly outnumbered that of WT (**p≤0.01). Similarly, the 
fraction of DAPI stained cells exhibiting ACSBG1 staining was significantly higher in the areas of dcKO 
CANu and Th compared to the corresponding areas in WT (**p≤0.01; for CANu: in WT 5.2±0.9% 
whereas in dcKO 13.6±2.6% of all DAPI positive stained for ACSBG1; for Th: in WT 6.3±0.8% whereas 
in dcKO 12.6±2.1% of all DAPI positive stained for ACSBG1). Importantly, this observation seems to 
minimally support our previous assumption that BAF complex depleted cortical ACSBG1 positive cells 
preferentially reside in ventral regions of dcKO brains (Appendix, Figure 47C). Additionally, despite 
the quantitative differences, dcKO affected protoplasmic astrocytes also exhibited qualitative 
discrepancies. As shown in Figure 28B (in magnified insets), protoplasmic astrocytes of dcKO VP 
manifested hypertrophic morphologies with highly enriched cellular ACSBG1 staining what clearly 
distinguishes them from protoplasmic astrocytes residing in WT VP areas. Furthermore, ACSBG1 
positive astrocytes found in enriched dcKO regions tended to group into clusters and were rarely 
found in isolation (Figure 28B, magnified insets). Overall, ACSBG1 immunostaining data indicated 
elevated amounts of protoplasmic astrocytes in VP of dcKO mice. 
In order to confirm this finding we decided to search for WT/dcKO transcriptome differences that 
could indicate elevated astrogliosis in BAF complex depleted VP. We sequenced RNA isolated from
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Figure 28 | Highly elevated astrogliosis in BAF complex deprived VP and LP (II). (A-D) Immunostaining of 
coronal brain sections through WT and dcKO murine P3 VP (A-C) and LP (D) for ACSBG1 (in green and 
gray) in the following areas: CPu (A), CANu (B), Th (C) and LCx – S2 (D). Cell nuclei are visualized by DAPI 
(in blue). Lower boards of WT and dcKO are single channel images. Full arrowheads indicate astrocytes 
expressing ACSBG1. Magnified views of ACSBG1 positive astrocytes from delineated areas of WT and 
dcKO CANu shown as small panels and grayscale images in B. (E) Bar graph representing percentage 
share of ACSBG1 positive cells in all DAPI positive cells in indicated areas of P3 WT and dcKO mouse 
VP. Quantifications for D shown in Figure 19. Data are averages ± σ of n=3-5 experimental replicates 
(WT/CPu: n=5, dcKO/CPu: n=5, WT/CANu: n=5, dcKO/CANu: n=5, WT/Th: n=3, dcKO/Th: n=3); 
**p≤0.01 in Mann Whitney Rank Sum test. (F) GO analysis indicating groups of genes related to astrocyte 
function and differentiation, significantly upregulated in P3 VP hGFAP-Cre dcKO. Bar graph represents –
Log of corresponding p value for each indicated GO category. (G) Bar graph representing Log2 fold change 
of astrocyte related transcripts abundance in VP of P3 dcKO animals. Transcriptome data are averages of 
n=4 animals. For all investigated transcripts p≤0.01. In GO pathway enrichment analysis Bonferroni 
corrected for p<0.05. CANu, central amygdala nucleus; CPu, caudate putamen; dcKO, double knockout; 
diff, differentiation; EC1, oxidoreductase; ET, electron transfer; GT, glutathione transferase; LCx, lateral 
cortex (refers to S2 area); SM, structural molecule; WT, wild type.  
 
 
P3 WT and dcKO VP tissue lysates (see Chapter 2. Materials and Methods. 2.8) and selected 
aberrantly upregulated genes for subsequent GO enrichment analysis. We then compared the 
outcome of the GO classification with the online available list of GO annotated astrocyte enriched 
molecular pathways (http://www.networkglia.eu (Cahoy et al., 2008; Doyle et al., 2008; Lovatt et al., 
2007)). As indicated in Figure 28F, several molecular pathways upregulated in P3 dcKO were 
previously annotated as astrocyte specific. Accordingly, by means of this analysis we could reveal 
that VP of dcKO upregulated transcripts known to be elements of molecular pathway of: structural 
molecule activity (GO: 0005198), oxidoreductase activity (GO: 0016491), electron transfer activity 
(GO: 0009055), RNA binding activity (GO: 0003723) as well as glutathione transferase activity (GO: 
0004364). All of these molecular pathways are typically enhanced in astroglial cells, which highlights 
the prominent astroglial phenotype of dcKO VP. In addition, several transcripts significantly elevated 
in P3 dcKO VP (**p≤0.01) were related to glial cell differentiation (GO: 0045687 and GO: 0045685), 
indicating enhanced glia development in dcKO VP compared to WT. Among those, Nkx6.1 as well as 
Nkx2.1 are known to induce astrocyte differentiation (Minocha et al., 2017; Minocha et al., 2015; 
Zhao et al., 2014). Furthermore, screening the literature for astrocytic markers allowed us to select 
14 the most upregulated transcripts known to be astrocyte related. Figure 28G illustrates their levels 
of upregulation where Log2 fold changes of chosen transcript correspond to its abundance 
compared to P3 WT VP). The relation of a given transcript to astroglial cell fate regulation is 
documented in Table 2. Importantly, the increase of ACSBG1 described above (Figure 27A-B and 
Figure 28A-E) was also apparent at the transcriptome level (Figure 28G).  
 
Overall, our transcriptome studies together with the ACSBG1 immunohistochemistry prompted us to 
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NAME FUNCTION REFERENCES 
Nkx2.6 Control of astrocyte specification and differentiation (Zhao et al., 2014) 
Pamr1 
Unknown. Transcript upregulated in 
human and murine astrocytes. An 
extracellular matrix molecule. 
(Molofsky et al., 2014; Zhang et al., 2016) 
Nkx2.2 Control of astrocyte specification and differentiation 
(Minocha et al., 2017; Minocha et al., 
2015) 
Gli1 Enhancement of astrocyte development (Garcia et al., 2010) 
Id3 
Promotes astrocytic differentiation and 
negatively regulates neuronal 
differentiation 
(Nakashima et al., 2001) 
Acsbg1 Gray matter astrocyte marker (Cahoy et al., 2008; Chaboub and 
Deneen, 2013) 
Romo1 Unknown. Transcript upregulated in murine astrocytes.  (Zhang et al., 2016) 
Vcam1 Unknown. Transcript upregulated in murine astrocytes. (Zhang et al., 2016) 
Nnat Unknown. Transcript upregulated in murine astrocytes.  (Zhang et al., 2016) 
Magoh Unknown. Transcript upregulated in murine astrocytes.  (Zhang et al., 2016) 
H3f3a 
Unknown. Transcript upregulated in 
murine astrocytes. Often mutated in 
astrocytomas 
(Michelucci et al., 2016; Zhang et al., 
2016) 
Dll1 Initiation of astrogliogenesis (Freeman, 2010) 
Rfx4 Unknown. Transcript upregulated in murine astrocytes. (Zhang et al., 2014) 
Vim Astrocyte enriched protein (Schnitzer et al., 1981) 
 
 
Table 2 | Selected astrocyte related transcripts upregulated in VP of P3 dcKO mice. The table describes 
14 transcripts considered as typical for astrocytes significantly upregulated in VP of P3 dcKO stating the 
function and corresponding literature source (references).  
 
 
assume that unlike in DP, VP of P3 dcKO mice exhibits prominent mature astrocyte phenotype. 
 
In order to confirm this assumption we decided to investigate the P3 VP expression of another 
protoplasmic astrocyte marker - GS (Anlauf and Derouiche, 2013) and compare it to that of ACSBG1. 
As shown in Figure 29A (overviews shown in Appendix, Figure 45B), immunostaining indicated a 
massive increase of the abundance of GS positive cells found in the area of LGE of dcKO VP. A 
quantification (Figure 29C) revealed that the fraction of DAPI stained cells exhibiting GS expression in 
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the LGE was significantly higher in dcKO than in WT (***p≤0.001; in WT 8.2±0.7% whereas in dcKO 
14.9±1.9% of all DAPI found in LGE stained for GS). Surprisingly, this elevated amount of GS 
expressing astrocytes seemed to decline in deeper areas of dcKO VP (Figure 29A and C; CPu). Even 
though still significantly outnumbering WT CPu residing cells (**p≤0.01; Figure 29C), GS positive 
astrocytes of dcKO CPu were not as numerous as in LGE (in WT 5.5±0.9% whereas in dcKO 9.3±1.3% 
of all DAPI found in CPu stained for GS). However, considering the total area of VP, GS expressing 
astrocytes found in dcKO brains were significantly more numerous than those of WT (Figure 29C; 
***p≤0.001; in WT 7.0±0.6% whereas in dcKO 12.7±1.3% of all DAPI found in VP stained for GS).   
 
 
 
 
 
Figure 29 | Area dependent upregulation of GS expression in BAF complex depleted postnatal VP. (A-B) 
Coronal tissue sections through WT and dcKO P3 mouse LGE and CPu stained with antibodies detecting 
astroglial markers; (A) GS (in magenta) and (B) GS (in magenta) together with Acsbg1 (in green). DAPI 
staining is blue. For LGE the directions towards VZ and CPu are indicated by two headed arrow. For (B) 
lower panels of CPu are magnified insets of delineated areas. Full arrowheads indicate CPu astrocytes 
positive for GS and ACSBG1, emptyones indicate astrocytes positive only for ACSBG1. Cell bodies of 
ACSBG1 positive/GS negative astrocytes outlined with dashed line. (C) Percentages of GS positive 
astrocytes per DAPI positive cells in the areas of LGE, CPu and total VP of WT and dcKO mice. Data are 
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averages ± σ of n=4 experimental replicates; ***p≤0.001, **p≤0.01 in t- student test. (D) Pie charts 
showing the degree of colocalization between ACSBG1 and GS in WT (upper panel) and dcKO (lower 
panel) P3 CPu. Light purple colour indicates percentages of ACSBG1 positive cells expressing GS, green 
colour indicates percentages of ACSBG1 positive cells negative for GS. Data are averages of n=3 (for WT: 
ACSBG1+/GS+=95.3, ACSBG1+/GS-=4.6% ±2.8%; for dcKO: ACSBG1+/GS+=61.0, ACSBG1+/GS-=39%±4.3%). 
CPu, caudate putamen; dcKO, double knockout; LGE, lateral ganglionic eminence; VP, ventral pallium; VZ, 
ventricular zone; WT, wild type.   
 
 
Furthermore, the ACSBG1/GS co-immunostaining indicated an interesting relationship between 
these two markers in dcKO CPu (Figure 29B). As indicated in Figure 29B (CPu; full arrowheads) and 
the pie chart (Figure 29D), the majority of ACSBG1 positive astrocytes of WT CPu exhibited GS 
staining (95% of all CPu ACSBG1 positive cells stained for GS). A Similar comparison of ACSBG1 and 
GS expression in dcKO mice indicated a reduced fraction of CPu ACSBG1 positive cells expressing GS 
(61% of all dcKO CPu ACSBG1 stained for GS, ACSBG1 positive that did not express GS indicated by 
empty arrowheads in Figure 29B). Importantly, several studies indicated that GS expression may not 
be confined to astrocytes and can be present in oligodendrocytes and common glial precursors 
(Cahoy et al., 2008; Derouiche and Rauen, 1995; Sun et al., 2017; Tansey et al., 1991). Thus, the 
highly enriched GS staining found in dcKO astroglial germinal zone (LGE) may indicate an increased 
production of common glial precursors. As expression of GS decays in deeper areas of dcKO VP (CPu) 
a visible decline in ACSBG1 positive cells may lead one to assume that GS positive dcKO glial 
precursors migrating out of the germinal zone loose GS expression and differentiate into astroglial 
cells (ACSBG1 was found to be exclusively enriched in astrocytes (Cahoy et al., 2008)). However, 
evidence supporting this is scarce and needs to be expanded by further experiments. 
 
Together, data from our marker analyses and transcriptome studies indicate that hGFAP-Cre driven 
loss of BAF complex evokes a massive increase in astrocyte abundance in VP of P3 murine brain.   
 
 AGPs in postnatal VP – dcKO versus WT phenotype 
As previously described, during WT mouse development expression of several BAF complex subunits 
decreased along with the transformation of astrocytic RGCs to AGPs. This stood true for cortical and 
striatal progenitors (see: Chapter 3. Results. 3.1). Accordingly, we showed that loss of BAF complex 
in astrocytic RGCs massively increases the abundance of cortical AGPs. However, it would be 
interesting to prove that the absence of BAF complex can positively influence the abundance of 
ventral AGPs. Having established that the amount of ventral protoplasmic astrocytes is increased in 
dcKO VP, we asked whether the numbers of ventral AGPs are also elevated upon BAF complex loss. 
Thus, using immunostaining we investigated the expression of the AGPs markers: NFiA, BLBP and 
GLAST (Chaboub and Deneen, 2013) (Figure 30). Because the highest numbers of GS and ACSBG1
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Figure 30 | Deficiency in BAF complex results in highly elevated astrocytic GP generation in postnatal 
striatum. (A-D) Immunofluorescence staining of WT and dcKO P3 mouse LGE and CPu coronal sections 
showing expression of GP and astrocyte markers: (A) NFiA (in magenta and gray), (B) GLAST (in magenta 
and gray), (C) BLBP (in magenta and gray, overview in Appendix, Figure 45), (D) NFiA (in magenta) and 
GLAST (in gray, overview in Figure 18). The nuclear DAPI staining is blue. For LGE area the directions 
towards VZ and CPu are indicated by two headed arrow. For A-C grayscale images are magnified insets of 
delineated areas of: (A,C) LGE and (B) CPu. Full arrowheads indicate GP positive for given marker. Lower 
boards in D are single channel images of WT and dcKO CPu. Full arrowheads indicate CPu GPs positive for 
NFiA and GLAST, empty arrowheads indicate progenitors positive only for NFiA. (E) Percentages of 
astrocytic GP marker positive cells per DAPI positive cells in the area of striatum of P3 WT and dcKO mice. 
Data are averages ± σ of n=3-4 experimental replicates (NFiA/WT: n=4, NFiA/dcKO: n=3, GLAST/WT: n=3, 
GLAST/dcKO: n=3, BLBP/WT: n=3, BLBP/dcKO: n=3); ***p≤0.001, **p≤0.01 in t student test. (F) Pie charts 
showing the degree of colocalization between NFiA and GLAST in WT (upper panel) and dcKO (lower 
panel) P3 CPu. Light purple colour indicates percentages of NFiA positive cells expressing GLAST, magenta 
colour indicates percentages of NFiA positive cells negative for GLAST. Data are averages of n=2-3 animals 
(for WT: n=2, NFiA+/GLAST+=43.2, NFiA+/GLAST-=56.8 ±0.9%; for dcKO: n=3, NFiA+/GLAST+=67.7, 
NFiA+/GLAST-=32.3 ±11.2%). CPu, caudate putamen; dcKO, double knockout; LGE, lateral ganglionic 
eminence; VZ, ventricular zone; WT, wild type.   
 
 
positive cells were observed in dcKO LGE and CPu, we decided to focus our analysis on these two 
areas of P3 VP. As showed in Figure 30A-C, compared to WT the LGE and CPu of dcKO P3 pups 
exhibited elevated staining for all investigated markers of AGPs. Accordingly, the quantifications 
performed for both analyzed areas (LGE and CPu pulled together and presented as VP; Figure 30E) 
indicated a significant increase in the amount of NFiA expressing cells found in VP of dcKO 
comparing to that of WT (***p≤0.001; in dcKO VP 24.7±1.7% of DAPI stained cells expressed NFiA, 
12.6±1.4% in WT). Interestingly, despite the increased general cell numbers, the expression pattern 
of dcKO NFiA cells was similar to that of dcKO GS positive cells with elevated staining found in LGE 
area that further seemed to decay in deeper VP regions (here shown in CPu). However, as in the case 
of GS, the elevated NFiA staining found in dcKO astroglial germinal zone (LGE) may indicate an 
increased production of common glial precursors. This assumption is supported by the literature, as 
it was described that in gliogenesis, NFiA initiates the induction of an oligodendrocyte/astrocyte 
genetic program (Deneen et al., 2006). Furthermore, cortical neurons are known to express NFiA 
(Bunt et al., 2017). Because we have already shown that cortical cells migrate aberrantly in dcKO 
(see Chapter 3. Results. 3.3) we could also assume that some of the NFiA positive cells found in dcKO 
LGE may be of cortical neuronal fate. Thus, we could not accept NFiA as an exclusive marker of dcKO 
astroglia and therefore, we decided to co-stain for NFiA and GLAST in CPu of P3 WT and dcKO and 
evaluate their colocalization (Figure 30D). These experiments revealed cells exclusively expressing 
NFiA (indicated by empty arrowheads) and cells that co-expressed NFiA and GLAST (indicated by full 
arrowheads) in both genotypes. However, as indicated in Figure 30F, the percentage of NFiA positive 
cells expressing GLAST was higher in CPu of dcKO mice (68% in dcKO and 43% in WT). This indicates 
that a substantial fraction of NFiA positive cells found in dcKO VP are of AGP fate. Additionally,
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Figure 31 |Single BAF170 subunit KO does not lead to increased astrogliosis in postnatal VP. (A, C, E, G) 
Coronal sections through P3 VP areas (CPu in A, E and G, CANu in C) of WT (in A and C), BAF170KO and 
dcKO (in A, C, E and G) mice, stained with antibodies to astrocyte and GP markers; (A and C) astrocyte 
marker – ACSBG1 (in green), (E) GP and astrocyte marker – BLBP (in magenta and gray) and (G) GP and 
astrocyte marker – GLAST (in magenta and gray). Nuclei of cells stained with DAPI (in blue). Lower panels 
are single channel images of the corresponding marker. Full arrowheads indicate cells positive for a given 
marker. (B, D, F and H) Bar graphs indicating percentages of astrocyte/GP marker positive cells per all 
DAPI positive cells in the areas of; (B) CPu, (D) CANu and (F and H) total VP of P3 WT, BAF170KO and dcKO 
pups. Data are averages ± σ of n=2-5 experimental replicates (ACSBG1/WT/CPu: n=5, 
ACSBG1/BAF170KO/CPu: n=2, ACSBG1/dcKO/CPu: n=5, ACSBG1/WT/CANu: n=5, ACSBG1/BAF170KO 
/CANu: n=2, ACSBG1/dcKO/CANu: n=5, BLBP/WT: n=3, BLBP/BAF170KO: n=2, BLBP/dcKO: n=3, 
GLAST/WT: n=3, GLAST/BAF170KO: n=2, GLAST/dcKO: n=3); for B and D: **p≤0.01 in Mann Whitney Rank 
Sum test, for F and H: ***p≤0.001, **p≤0.01 in t student test. For all NA not applicable (n=2). BAF170KO, 
BAF170 knockout; CANu, central amygdala nucleus; CPu, caudate putamen; dcKO, double knockout; GP, 
glial progenitors; NA, not applicable; VP, ventral pallium; WT, wild type.   
 
 
GLAST and BLBP positive cells of dcKO VP significantly outnumbered these of WT (Figure 30E; 
***p≤0.001; in WT 8.5±0.5% whereas in dcKO 17.0±0.8% of all DAPI found in VP stained for GLAST; 
**p≤0.01; in WT 9.7±0.4% whereas in dcKO 15.3±1.9% of all DAPI found in VP stained for BLBP) 
thereby indicating elevated amount of AGPs within BAF complex depleted VP.  
 
In summary, we showed that the loss of BAF complex in astrocytic RGCs causes a massive increase in 
the abundance of AGPs in cortex and striatum.  
 
However, in P0 WT mice, BAF complex subunits of striatal AGPs, even though declining, exhibited 
different levels of downregulation (Figure 8 and 10). Strikingly, the decay of BAF170 in striatal AGPs 
seemed to be faster and more pronounced than that of other investigated BAF complex subunits 
(only ~13% of AGPs expressed detectable levels of BAF170, and positive cells had low NFI). This could 
indicate that the downregulation of BAF170 expression itself promotes AGPs production. In order to 
test whether astrocytic RGCs differentiate to AGPs due to the decline in BAF complex as a whole or 
because of the reduction in BAF170 expression alone, we compared the abundance of AGPs and 
protoplasmic astrocytes in VP of WT, dcKO and BAF170KO (exhibiting loss of single BAF complex 
subunit – BAF170 (Tuoc et al., 2013b)) P3 mice (both KO driven by hGFAP-Cre; see Chapter 2. 
Materials and Methods. 2.1). Using immunohistochemistry, we compared the expression of the 
AGPs markers GLAST and BLBP as well as the protoplasmic astrocyte marker ACSBG1 in VP tissues 
(CPu and CANu) of WT, BAF170KO and dcKO P3 pups. The results are shown in Figure 31. As 
previously described, CPu and CANu of dcKO exhibited prominent upregulation of all investigated 
markers with respect to WT. To the contrary, neither GLAST and BLBP positive AGPs nor ACSBG1 
expressing protoplasmic astrocytes were upregulated in the corresponding ventral regions of 
BAF170KO brains. Moreover, the astroglial phenotype exhibited by CPu and CANu of BAF170KO mice 
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was similar to WT (Figure 31A and C), showing comparable percentage of DAPI stained cells positive 
for ACSBG1, BLBP and GLAST (Figure 31B, D, F and H). Additionally, astroglial cells found in 
BAF170KO VP showed a WT-like scattered distribution pattern (Figure 31A and C). Thus, these 
results demonstrate that in contrast to the elimination of complete BAF complex, KO of BAF170 
alone does not evoke the differentiation of astrocytic RGCs to AGPs or protoplasmic astrocytes. 
 
Altogether, we showed that the loss of the entire BAF complex forces astrocytic RGCs to 
differentiate to AGPs and to protoplasmic astrocytes in the developing mouse brain.  
 
BAF complex controls genesis of astrocytes in a cell-autonomous mechanism 
In order to trace the origin of the generated astrocytes in BAF complex deficit brain, we looked at 
the expression of ACSBG1 at different developmental stages (E17.5, P0 and P3) in hGFAP-Cre dcKO 
tdTomato mice (Chapter 2. Materials and Methods. 2.1).  
As indicated in Figure 32A and B, elevated amounts of ACSBG1 positive cells could be detected 
already in E17.5 CPu of dcKO mice. Importantly, the corresponding area of E17.5 WT brain did not 
exhibit cells stained for ACSBG1. Thus the amount of dcKO ACSBG1 positive cells found in E17.5 
brains significantly (**p≤0.01) outnumbered that of WT. Additionally, tracing experiments indicated 
that 99% of ACSBG1 expressing cells found in VP of E17.5 dcKO mice expressed tdTOM (upper most 
pie chart of Figure 32H). This suggests that these cells were affected by the mutation and possibly 
originated from hGFAP-Cre targeted astrocytic RGCs. The same experiment performed for CPu of P0 
WT and dcKO pups revealed a massive increase in the amount of ACSBG1 expressing astrocytes 
found in mutant tissue (Figure 32C, D and G). Importantly, these elevated amounts of ACSBG1 
positive cells significantly outnumbered that of WT (***p≤0.001). However the tracing analysis 
indicated that the fraction of ACSBG1 positive cells expressing tdTOM decreases to 91% (Figure 32C 
and H). This suggests that some of the protoplasmic astrocytes found in CPu of P0 dcKO originate 
from germinal zones unaffected by the mutation. Last but not least we subjected P3 CPu tissues of 
WT and dcKO brains to the same analysis. As shown in Figure 32E-G the amount of ACSBG1 positive 
astrocytes found in dcKO CPu was higher than that of P0 mutant mice or CPu (***p≤0.001). In 
addition 94% of ACSBG1 astrocytes stained in CPu of P3 dcKO mice exhibited tdTOM, demonstrating 
that they were affected by the mutation of the BAF complex (lowest pie chart of Figure 32H). Taken 
together, the numbers of ACSBG1 expressing astrocytes found in WT as well as dcKO CPu were 
escalating over developmental time (Figure 32G). Additionally, the amount of dcKO protoplasmic 
astrocytes always significantly exceeded that of WT. However, not all ACSBG1 positive cells found in 
CPu of postnatal dcKO mice were tdTOM positive, implying that a small fraction was not affected by 
BAF complex mutation. Still, the vast majority of ACSBG1 positive cells were, suggesting that the
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Figure 32 | Deficiency in BAF complex leads to intensified VP astrocyte production during embryonic 
development and postnatally. (A, C, E) Immunofluorescence analysis of WT and dcKO (hGFAP-Cre dcKO 
tdTomato) mouse coronal sections of brain tissue isolated at: (A) E17.5, (C) P0, (E) P3 and immunostained 
for ACSBG1 (in green). The nuclear DAPI staining is blue, the endogenous tdTOM signal is red (only for 
dcKO sections). Overview of E17.5 sections stained for ACSBG1 provided in Appendix, Figure 46. Lower 
boards of WT and dcKO are single channel images of ACSBG1 staining. Right panels of dcKO are magnified 
views of ACSBG1 positive astrocytes from delineated VP areas of dcKO brains, shown together with an 
endogenous tdTOM signal. Cells expressing ACSBG1 and tdTOM are astrocytes with an active hGFAP 
promoter, presumably affected by BAF complex knockout. For WT and dcKO overview pictures full 
arrowheads indicate astrocytes positive for ACSBG1, for magnified panels full arrowheads indicate dcKO 
ACSBG1 positive astrocytes exhibiting endogenous tdTOM signal, empty arrowheads indicate dcKO 
ACSBG1 positive astrocytes negative for tdTOM expression. (B, D, F) Bar graphs representing percentages 
of ACSBG1 positive cells among all DAPI cells in WT and dcKO VP of (B) E17.5, (D) P0 and (F) P3 mice. (G) 
Scatter plots with polynomial regression lines juxtaposing the quantifications for all analyzed 
developmental stages represented in bar graphs in (B, D, F). Regression line for WT is gray, regression line 
for dcKO is black. For (B, D, F, G) data are averages ± σ of n=3-5 experimental replicates (E17.5/WT: n=3, 
E17.5/dcKO: n=3, P0/WT: n=3, P0/dcKO: n=3, P3/WT: n=3, P3/dcKO: n=5); for E17.5 and P3: **p≤0.01, 
***p≤0.001 in Mann Whitney Rank Sum test, for P0: ***p≤0.001 in t student test. (H) Pie charts 
representing the degree of colocalization between ACSBG1 tdTOM in VP of dcKO brains harvested at; 
E17.5 (upper graph), P0 (middle graph) and P3 (bottom most graph). Red colour indicates percentages of 
ACSBG1 positive cells expressing tdTOM, green colour indicates percentages of ACSBG1 positive 
astrocytes negative for tdTOM. Data are averages of n=2 (for E17.5: ACSBG1+/tdTOM+=99.1, 
ACSBG1+/tdTOM-=0.9±1%; for P0: ACSBG1+/tdTOM+=91.1, ACSBG1+/tdTOM-=8.9±2.1%; for P3: 
ACSBG1+/tdTOM+=94.3, ACSBG1+/tdTOM-=5.7±1.4%). dcKO, double knockout; tdTOM, tdTomato; VP, 
ventral pallium; WT, wild type.   
 
 
abundance of astrocytes is due to the BAF complex mutation.  
 
Keeping in mind that hGFAP-Cre drives recombination in all astrocytic RGCs of the forebrain (Figure 
12), we subsequently asked whether every astrocytic germinal zone serves as a source for the 
abundant astroglial cells found in dcKO. It is most likely due to the BAF complex KO within cortical 
germinal zone that the cortex of dcKO mice exhibits highly elevated numbers of AGPs. Additionally, 
based on our IUE experiments we may assume that at least a fraction of ACSBG1 positive astrocytes 
found in CPu of dcKO mice could originate from cortical astrocytic RGCs (see Chapter 3. Results. 3.3). 
This assumption seems to be supported by the observation of ACSBG1 positive astrocytes in dcKO 
CPu as early as at E17.5. As indicated by tracing experiments, the hGFAP-Cre driven recombination 
within ventral astrocytic RGCs starts relatively late comparing to cortex (E13.5, E15.5 and E17.5 for 
cortical VZ, MGE and LGE respectively). Thus, we decided to investigate whether depletion of BAF 
complex within ventral astrocytic RGCs alone would result in an increased amount of astrocytes as in 
hGFAP-Cre dcKO brains. Accordingly, we assessed the expression of ACSBG1 in Olig2-Cre driven dcKO 
and compare it to that of WT and hGFAP-Cre driven dcKO (Figure 33). We chose to use Olig2-Cre as a 
driver of dcKO mutation, as it is known to exclusively target ventral germinal zones in developing 
forebrain (Zawadzka et al., 2010). As Olig2-Cre dcKO animals were dying at birth, we were forced to
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Figure 33 | Olig2-Cre congruous to hGFAP-Cre driven BAF complex KO leads to increased 
astrogliogenesis in affected LP and VP areas. (A) Immunofluorescence analysis of P0 WT as well as 
hGFAP-Cre and Olig2-Cre dcKO mouse brain sections stained with antibody to astroglial marker – ACSBG1 
(in green). The nuclear DAPI staining is blue. First row represents overview brain pictures of WT (left 
panel), hGFAP-Cre dcKO (middle panel) and Olig2-Cre dcKO (right panel) animals. Full arrowheads 
indicate the areas of dcKO LP, Th and VP exhibiting increased amount of ACSBG1 signal. Second and third 
row show magnified views of ACSBG1 positive astrocytes from delineated in overview areas of WT, 
hGFAP-Cre dcKO and Olig2-Cre dcKO CANu. Full arrowheads indicate astrocytes expressing ACSBG1. (B) 
Percentages of ACSBG1 positive cells per total DAPI positive cells in VP of WT, hGFAP-Cre and Olig2-Cre 
dcKO mice. Data are averages ± σ of n=2-3 animals (WT: n=3, hGFAP-Cre dcKO: n=3, Olig2-Cre dcKO n=2); 
***p≤0.001 in t student test, NA not applicable (n=2). (C-D) Sum up schematics showing astrocytic 
germinal zones affected by recombination (gray dots) together with the populations of ACSBG1 positive 
astrocytes (green dots) that differ from WT in the increase of amount in: (C) hGFAP-Cre dcKO and (D) 
Olig2-Cre dcKO P0 brains. CANu, central amygdala nucleus; dcKO, double knockout; DP, dorsal pallium; 
NA, not applicable; RGCs, radial glial cells; Th, thalamus; VP, ventral pallium; WT, wild type. 
 
 
perform ACSBG1 immunostaining on brain slices of P0 mice. Immunohistochemistry revealed that 
the amount of ACSBG1 positive cells found in Th, VP and LP of both mutants was visibly elevated 
comparing to that of WT. However the quantitative analysis performed for the area of CANu 
indicated that the ACSBG1 positive cells found in hGFAP-Cre dcKO were more numerous than that of 
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Olig2-Cre dcKO (Figure 33B). Thus, despite the lack of statistical significance, this results suggests 
that hGFAP-Cre driven BAF complex depletion is more thorough. However, as indicated in summary 
schemes, the aberrant expression of ACSBG1 was found in VP regions of all brain sections from 
hGFAP-Cre dcKO and Olig2-Cre dcKO mice (Figure 33C and D, targeted RGCs shown in gray, aberrant 
protoplasmic astrocytes shown in green). The only observed difference was in the density and 
cortical localizations of cells, namely cells aberrantly expressing ACSBG1 found in hGFAP-Cre dcKO 
appeared denser, and in contrast to those in Olig2-Cre dcKO, they could often be found in S1 cortical 
area.  
 
Taken together, our data indicate that the vast majority of the abundant astroglia found in dcKO 
derives from dorsal as well as ventral astrocytic RGCs affected by BAF complex depletion.  
  
 Proliferation of BAF complex depleted protoplasmic astrocytes of VP  
Considering that BAF complex depleted AGPs of postnatal DP are highly proliferative, we next 
investigated the proliferation of astroglia in VP of dcKO mice.  
We first evaluated proliferation by immunostaining of Ki67 within BLBP positive AGPs as well as 
ACSBG1 enriched protoplasmic astrocytes (Figure 34A-C) in P3 brains, focusing on the CPu. As 
indicated in Figure 34B and C, some of WT BLBP and ACSBG1 expressing cells found in CPu did 
exhibit Ki67 staining (pointed by full arrowheads), indicating active local proliferation of AGPs and 
maturating protoplasmic astrocytes in postnatal VP. Quantitatively, Ki67 was expressed by 
18.6±1.2% of BLBP and 13.2±2.9% of ACSBG1 positive cells in P3 WT CPu (Figure 34E). Strikingly, the 
BLBP positive AGPs as well as ACSBG1 enriched protoplasmic astrocytes of dcKO CPu exhibited 
prominent staining for Ki67 as well. Quantitatively, 39.6±5.3% of BLBP positive AGPs and 59.0±4.6% 
of ACSBG1 enriched protoplasmic astrocytes stained for Ki67 in dcKO. These were significantly 
higher fractions than in WT (*p≤0.05 and ***p≤0.001 for BLBP and ACSBG1 respectively; Figure34E). 
We next investigated the proliferation of ACSBG1 positive protoplasmic astrocytes by another 
method - EdU labeling. For this purpose EdU was IP injected into WT/dcKO P3 pups 30 min before 
brain collection (Figure 34A). In order to quantify ACSBG1 expressing protoplasmic astrocytes that 
incorporated EdU, coronal brain slices from injected mice were subjected to immunostaining of 
ACSBG1 and EdU (Figure 34D). Overall, large amounts of cells that incorporated EdU were found in 
CPu of WT as well as dcKO (Figure 34D full and empty arrowheads). However, in dcKO EdU mostly 
labelled ACSBG1 expressing cells whereas in WT EdU positive cells were commonly of other types. 
Moreover, the fraction of ACSBG1 expressing cells exhibiting EdU labelling was significantly higher in 
dcKO than in WT (**p≤0.01; in WT 6.5±1.5%; in dcKO 23.3±4.6% of all ACSBG1 stained for EdU). 
However, the numbers of mice in these experiments were quite low, and further repetitions should
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Figure 34 | High proliferation capacities of BAF complex depleted ventral astrocytes. (A) Scheme 
explaining the principle of proliferation analysis by Ki67 expression investigation and thymidine analogue 
(EdU) injection. Ki67 (magenta) is expressed during all active phases of the cell cycle whereas IP injected 
EdU (red) incorporates to DNA during the S phase allowing for proliferative cells labelling. (B-C) Coronal 
tissue sections through WT and dcKO P3 mouse CPu stained with antibodies detecting astroglial markers; 
(B) ACSBG1 (in green) and (C) BLBP (in green) together with proliferation marker Ki67 (in magenta). The 
nuclear DAPI staining is blue. Cells expressing ACSBG1 or BLBP together with Ki67 are proliferative 
astrocytes. For (B) lower boards of each are magnified insets of delineated areas. For (C) lower panels of 
each are double channel images. Full arrowheads indicate proliferative astrocytes, empty arrowheads 
indicate non-proliferative astrocytes. (D) Immunofluorescence analysis of mouse P3 CPu WT and dcKO 
sections detecting ACSBG1 positive astrocytes (in green) and EdU (in red) that incorporated into DNA of 
cells after 30 minutes pulse IP injection. Cells expressing ACSBG1 positively stained for EdU are 
proliferative astrocytes. Lower boards of each are magnified insets of delineated areas. Cell bodies of EdU 
positive outlined with dashed line. Full arrowheads indicate EdU positive cells expressing ACSBG1, empty 
arrowheads indicate EdU positive/ACSBG1 negative cells. (E) Percentages of proliferative astrocytes in 
the areas of P3 WT and dcKO murine CPu. Upper graph illustrates percentages of ACSBG1 positive 
astrocytes and BLBP positive astrocytes expressing Ki67. Lower graph indicates the percentage of ACSBG1 
expressing astrocytes positive for EdU after 30 minutes from injection. Data are averages ± σ of (A) n=4 
experimental replicates; ***p≤0.001, *p≤0.05 in t- student test; (B) n=3 experimental replicates; 
**p≤0.01 in Mann-Whitney Rank Sum test. (F) Expression profile of significantly upregulated 
glioma/astrocyte proliferation related transcripts (in black) juxtaposed with all cell proliferation related 
transcripts (in red) upregulated in ventral pallium of P3 hGFAP-Cre dcKO versus WT mice. Scatter plot 
represents Log2 fold change of transcript abundance together with –Log of corresponding p value for all 
significantly upregulated proliferation related transcripts. Pie chart shows the percentage of 
glioma/astrocyte proliferation related transcripts among all significantly upregulated proliferation 
associated transcripts. The exact transcript number shown in brackets. Black colour refers to the 
glioma/astrocyte proliferation related transcripts, red colour refers to other upregulated proliferation 
related transcripts. The Log2 fold change level of upregulation as well as names of glioma/astrocyte 
proliferation related transcripts represented as black dots in scatter plot are shown in G. Transcriptome 
data are averages of n=4 animals. For all investigated transcripts p≤0.01. In GO pathway enrichment 
analysis, used for proliferation related transcripts detection, Bonferroni-corrected for p<0.05. CPu, 
caudate putamen; dcKO, double knockout; IP, intraperitoneal injection; WT, wild type.   
 
 
be performed in the future. Still, taken together our Ki67 immunostaining and EdU incorporation 
experiments highlight the elevated proliferative capacities of BAF complex depleted, BLBP positive 
AGPs as well as ACSBG1 expressing protoplasmic astrocytes found in CPu of postnatal mice.  
To confirm this finding we searched for transcriptome differences between genotypes that would 
indicate elevated proliferation in BAF complex depleted VP. Thus, we subjected all genes found to be 
aberrantly overexpressed in RNA-seq experiments of VP of P3 dcKO mice (see Chapter 3.  Results. 
3.4) to GO enrichment analysis. As this procedure highlighted several overexpressed genes from the 
group of proliferation regulators (regulation of cell proliferation - GO: 0042127; -Log –p value=3.1), 
we decided to investigate their involvement in astrocyte or glioma proliferation (Figure 34F and G, 
Table 3). Thus, as previously, we screened the literature for information on the precise function of 
92 proliferation related transcripts that were upregulated in dcKO VP. We found that 15 of these 
(17%, Figure 34F) were related to the proliferation of astrocyte and/or glioma. The detailed results 
indicating significant upregulation of these transcripts are shown in scatter plot (Figure 34F). 
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NAME LOG2 FOLD CHANGE P VALUE 
ASTROCYTES/GLIOMA 
PROLIF. RELATED  REFERENCES 
S100a6 1.61 1.27E-12 astrocytes and glioma (Yamada and Jinno, 2012, 2014) 
Ccnd1 1.33 1.26E-21 glioma (Cao et al., 2017) 
Hmgn5 1.15 5.88E-14 glioma (Cao et al., 2017) 
Rac2 1.07 6.66E-09 glioma (Lai et al., 2017) 
Fas 1.06 0.000251 glioma (Barca et al., 2013; Bechmann et 
al., 2000; Runic et al., 1996) 
Btk 0.94 0.000246 glioma (Yue et al., 2017) 
Gli1 0.89 3.15E-08 astrocytes and glioma (Clement et al., 2007; Garcia et al., 
2010; Pitter et al., 2014) 
Hpse 0.85 0.000692 glioma (Kundu et al., 2016) 
Ifitm1 0.76 0.005193 astrocytes and glioma (Arakelyan et al., 2014; Seyfried et 
al., 2008; Yu et al., 2011) 
Atf3 0.75 0.003528 glioma (Ma et al., 2015) 
Syk 0.71 0.000436 glioma (Moncayo et al., 2018) 
Hdac1 0.71 2.55E-05 glioma (Li et al., 2018b) 
Fezf1 0.71 0.003581 glioma (Yu et al., 2018) 
Cdc7 0.70 4.52E-07 glioma (Erbayraktar et al., 2016; Li et al., 
2018a) 
Spry1 0.65 1.93E-08 glioma (Park et al., 2018; Walsh et al., 
2015) 
 
 
Table 3 | Astrocyte/glioma related transcripts upregulated in VP of P3 dcKO mice. The table describes 
15 transcripts related to astrocyte/glioma proliferation significantly upregulated in VP of P3 dcKO stating 
the level of upregulation (log2 fold change), significance (p value), involvement in astrocyte and/or 
glioma proliferation (astrocytes/glioma prolif. related) and corresponding literature source (references). 
Transcripts in red were also found to be upregulated in DP of P3 dcKO. Prolif., proliferation.  
 
 
Additionally, the names and the Log2 fold changes of all 15 genes related to astrocyte and/or glioma 
proliferation whose expression was upregulated are shown in Figure 34G and Table 3. As indicated in 
Table 3, only 3 of 15 selected genes were known to regulate astrocyte proliferation. These were: Gli1 
(Garcia et al., 2010; Pitter et al., 2014), S100a6 (Yamada and Jinno, 2012, 2014) and Ifitm1 
(Arakelyan et al., 2014). However, as mentioned previously, our transcriptome analysis was hindered 
by the scarcity of literature about the molecular control of astrocyte proliferation. In this context, 
even few upregulated transcripts may be considered as already sufficient proof supporting our 
immunostaining data. Additionally, several transcripts were also upregulated in DP of P3 dcKO brain 
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(Table 2, Table 3 - marked in red). This suggests that similar proliferative processes are at work in 
both areas of postnatal dcKO brain.   
 
Taken together, these results indicate that BAF complex depleted AGPs and protoplasmic astrocytes 
found in postnatal VP as well as DP are highly proliferative. Additionally, proliferation evoked by 
hGFAP-Cre driven BAF loss were accompanied by upregulation of several glioma related proliferation 
regulators. Overall, taking into account the recent state of knowledge, we are one few scientific 
groups that could show a possible way of astrocyte proliferation regulation during early postnatal 
brain development. 
 
 The case of fibrous astrocytes and reactive astrogliosis 
Our GO classification revealed that several inflammation related transcripts were upregulated in DP 
and VP of P3 dcKO animals (Figure 35A). Inflammation as well as neuronal degeneration triggers 
reactive astrogliosis (Anderson et al., 2014). Upon activation, reactive astrocytes become 
hypertrophic and highly proliferative (Robel et al., 2011; Sofroniew, 2015). Bearing this in mind, we 
asked whether the proliferative astroglial phenotype observed in DP and VP of postnatal dcKO mice 
is due to the activation of astrocytes rather than a loss of BAF complex. Importantly, the fibrous 
astrocytes marker, GFAP is considered as one of a hallmarks of reactive astrocytes (RAs) (Liddelow 
and Barres, 2017; Robel et al., 2011). Thus, as a next step we sought to assess the expression of 
GFAP in coronal brain slices isolated from P3 WT and dcKO mice by immunohistochemistry. As 
shown in Figure 35B, several regions of WT brain prominently expressed GFAP. By contrast, GFAP 
expression seemed to be reduced in P3 dcKO mice. In order to further assess the reactive astrogliosis 
of the abundant protoplasmic astrocytes of dcKO brains we performed co-immunostaining of GFAP 
and ACSBG1 in the developing S1 area of P3 WT and dcKO mice (ACSBG1 positive astrocytes were 
already reported to be upregulated in dcKO; see Chapter 3. Results. 3.3, Figure 23). The results of 
this staining are shown in Figure 35C. None of the ACSBG1 positive cells found in WT or dcKO CP of 
S1BF expressed GFAP (pointed by full arrowheads, empty arrowheads indicate another stained 
cells). Importantly, in order to confirm that our antibody against GFAP reliably stains RAs, we evoked 
reactive astrogliosis in S1BF area of adult mice (by stab injury, see Chapter 2. Materials and 
Methods. 2.1) and subsequently performed GFAP staining in stabbed brains. As indicated in Figure 
35D and E, injured mice exhibited prominent GFAP staining at every investigated DPI. To the 
contrary and similarly to WT and dcKO P3 tissues, S1BF area (CP) of P60 control mouse (Figure 35D, 
extreme left images) rarely stained for GFAP.  
 
Despite the morphological similarities between RAs and hypertrophic protoplasmic astrocytes of
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Figure 35 | Fibrous astrocytes and reactive astrogliosis in BAF complex depleted postnatal brain. (A) GO 
biological process enrichment analysis indicating groups of genes related to inflammation significantly 
upregulated in P3 Cx hGFAP-Cre dcKO. Bar graph represents –Log of corresponding p value for each 
indicated GO category. (A, B) Coronal tissue sections through WT and dcKO P3 mouse brain stained with 
antibodies detecting astroglial markers; (B) GFAP (in green) and (C) GFAP (in green) together with 
ACSBG1 (in pseudo colour gray) in the area of S1BF. The nuclear DAPI staining is blue. The pictures 
presented in C are magnified insets of areas delineated in B. Full arrowheads indicate cells positive for 
ACSBG1, empty arrowheads indicated other cells stained by GFAP antibody (D) Coronal tissue sections 
through healthy (control) and injured (at 2, 4 and 7 DPI) S1BF area of P60 WT mice stained with antibody 
to fibrous astrocytes – GFAP (in green). Nuclear DAPI staining is blue. Full arrowheads indicate examples 
of reactive astrocytes stained for GFAP. (E) Example morphologies of GFAP positive astrocytes found in 
healthy (control) and injured (at 2, 4 and 7 DPI) S1BF area of P60 WT mice. (F) Example morphology of 
ACSBG1 positive astrocyte found in S1BF area of P3 dcKO brain. Middle panel shows lack of GFAP 
expression in these astrocytes. Cell body delineated by dashed line. For E and F arrowheads indicate 
abnormally elongated process of astrocyte. Cx, cortex; dcKO, double knockout; DPI, days post injury; I, 
innate; inflam., inflammation; L, leucocyte; LY, lymphocyte; WT, wild type.  
 
 
dcKO (Figure 35E and F) as well as the visibly increased inflammation processes, ACSBG1 expressing 
protoplasmic astrocytes of mutant mice did not express GFAP. We can thus conclude that astrocytes 
of dcKO mice were not proliferative because of their reactivity, but directly because of BAF complex 
depletion.  
 
3.5 BAF dependent molecular trigger of astrocyte proliferation 
 
One of the most important finding of this study is that BAF complex depleted AGPs and protoplasmic 
astrocytes exhibit elevated proliferative capacities, resulting in an increase in their numbers (see 
Chapter 3. Results. 3.3). In other words, the elimination of BAF complex de-represses certain 
factor(s) that trigger the proliferation of astroglia. Moreover, the upregulation of this (these) BAF-
dependent factor(s) may be responsible for the generation of aberrant quantities of astrocytes, with 
implications for several neurological disorders (Alcantara Llaguno et al., 2009; Molofsky et al., 2012; 
Sofroniew and Vinters, 2010; Stiles and Rowitch, 2008). Thus, as a final step, we sought to find which 
molecular effector/pathway triggers abnormal astrocyte proliferation upon the BAF complex 
depletion.  
 
 Selection of the potential BAF dependent proliferation regulator 
Previous studies from other groups have proposed that enhanced canonical WNT signaling, SHH/GLI 
signaling or NOTCH signaling may promote proliferation of astroglial cells (Alqudah et al., 2013; 
Araujo et al., 2014; Pierfelice et al., 2011; Pitter et al., 2014; Rush et al., 2010; Ugbode et al., 2017; 
Yang et al., 2012). The GO analysis performed on genes significantly overexpressed in DP of E17.5 
dcKO mice (see Chapter 3. Results. 3.3) showed that all 3 signaling pathways were aberrantly 
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upregulated in BAF complex mutants at the onset of cortical astrogliogenesis (Figure 36A). As shown 
in Figure 36A and B, elements of WNT signaling pathway were most prominently overexpressed and 
constituted 25% of all proliferation related transcripts that were upregulated in DP of E17.5 dcKO 
mice. Among upregulated genes, 16 were involved in SHH/GLI signaling pathway, representing 20% 
of all overexpressed proliferation regulators (Figure 36B). Finally, only 5 elements of the NOTCH 
signaling pathway were upregulated in DP of E17.5 dcKO mice (6% of all proliferation related, Figure 
36A and B). Having established that all these 3 pathways are upregulated in BAF complex depleted 
DP of E17.5 brains, we searched for the expression of their receptors/effectors that had previously 
been linked to astrocyte and glioma proliferation, namely β-catenin (CTNNB1; WNT signaling (Yang 
et al., 2012)), glioma associated oncogene 1 (GLI1; SHH/GLI1 signaling (Araujo et al., 2014; Clement 
et al., 2007; Garcia et al., 2010; Pitter et al., 2014)) and neurogenic locus notch homolog protein 3 
(NOTCH3; NOTCH pathway (Alqudah et al., 2013; Pierfelice et al., 2011)). As indicated in Figure 36B, 
all 3 investigated effectors were present among the upregulated proliferation related transcripts. 
However, the level of upregulation of Gli1 was the highest and the most significant compared to the 
other 2 factors (relatively high Log2 fold change of transcript abundance as well as –Log of p value, 
scatter plot, Figure 36B). In addition, the -Log of p values corresponding to the fold change of Ctnnb1 
and Notch3 were rather low and close to the threshold of significance (**p≤0.01, indicated by 
dashed line). Nevertheless, we recognized these features insufficient for the selection of a final 
candidate that triggers abnormal astrocyte proliferation. Believing that the overexpression of the 
proliferation regulator must be initiated early but also must persist further in postnatal brain (as the 
high proliferative capacities of BAF depleted DP and VP astroglia have been confirmed for postnatal 
stages) we then expanded our analysis to the other upregulated proliferation related transcripts of 
DP and VP of P3 dcKO mice (see Chapter 3. Results. 3.3 and 3.4). To find proliferation regulators 
commonly upregulated in E17.5 and P3 dcKO brains, we compared the expression of all proliferation 
associated transcripts found to be significantly upregulated in at least 1 of all 3 locations of E17.5 
and P3 brains: Dorsal E17.5, Dorsal P3 and Ventral P3 of dcKO brains. Thus, as indicated in Figure 
36C, we generated a binomial colorimetric matrix illustrating the expression of proliferation related 
genes that were either significantly upregulated (in red) or unchanged (downregulated or exhibiting 
not significant changes, in blue) found in E17.5 DP, P3 DP and P3 VP of dcKO mice. It is worth 
stressing that each listed transcript was significantly upregulated at least in one of the analyzed 
locations. This analysis allowed us to select 15 proliferation related genes that were overexpressed 
in all 3 investigated locations (the top most transcripts of colorimetric matrix, red rectangle for all 3 
investigated conditions). Importantly, Gli1 was present among these 15 transcripts (Figure 36C, bold 
names shown in red, Figure 36D). Notably, Ctnnb1 and Notch3, involved in WNT and NOTCH 
signaling pathways, were among the group of proliferation regulators overexpressed only in DP of
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Figure 36 | Astrocyte proliferation related gene expression profile of BAF complex depleted mouse 
brain. (A) Astrocyte proliferation inducing signaling pathways significantly upregulated in DP of E17.5 
hGFAP-Cre dcKO versus WT transcriptome. (B) Expression profile of significantly upregulated WNT (upper 
panel), SHH/GLI (middle panel) and NOTCH (lower panel) pathway related transcripts associated with 
proliferation induction juxtaposed with all cell proliferation related transcripts upregulated in DP of E17.5 
hGFAP-Cre dcKO versus WT mice. Scatter plots represent Log2 fold change of transcript abundance 
together with –Log of corresponding p value for all significantly upregulated proliferation related 
transcripts. For each pathway, the regulator of astrocyte/glioma proliferation (CTNNB1, GLI1, NOTCH3) is 
highlighted in red. Pie charts show the percentages of the corresponding pathway related transcripts 
among all significantly upregulated proliferation associated transcripts. The exact transcripts numbers 
shown in brackets. Light red colour refers to the corresponding pathway related transcripts, dark red 
colour refers to other upregulated proliferation related transcripts. (C) Binomial expression profile 
analysis of all proliferation associated transcripts significantly upregulated at least in 1 of all 3 
investigated hGFAP-Cre dcKO vs WT transcriptomes; E17.5 DP, P3 DP and P3 VP. Red colour refers to 
significantly upregulated expression level, blue colour refers to unchanged (downregulated or non-
significantly upregulated) expression level. For each pathway from A and B the key astrocyte proliferation 
regulator (CTNNB1, GLI1, NOTCH3) is highlighted in red. (D) Dynamic expression profile of 15 proliferation 
related genes significantly upregulated in all 3 investigated hGFAP-Cre dcKO vs WT conditions. Heat map 
shows Log2 fold change of transcript abundance. Dendrogram depicts existing relation between astrocyte 
proliferation regulator – GLI1 and other upregulated proliferation related transcripts. Data are averages 
of n=3-4 animals (E17.5DP; hGFAP-Cre dcKO: n=3, WT: n=4; P3 DP and VP; hGFAP-Cre dcKO: n=4, WT: 
n=4). For all investigated transcripts p≤0.01. In GO pathway enrichment analysis Bonferroni-corrected for 
p<0.05.  
 
 
E17.5 dcKO (Figure 36C, bold names shown in red). Thus we excluded these two candidates from 
further analysis.  
As indicated in Figure 36D (representing Log2 fold change of given transcript abundance), the 
selected transcripts exhibited a dynamic expression pattern with their abundance visibly increasing 
with time (for majority, comparing Dorsal E17.5 to Dorsal P3). Interestingly, the literature screening 
and online gene set enrichment analysis (Liberzon et al., 2015; Liberzon et al., 2011; Subramanian et 
al., 2005) about the pathway affiliation of these genes revealed that some of them may act 
upstream, downstream or be related to SHH/GLI1 signaling (Figure 36D). Accordingly, Fuz (Szabo-
Rogers et al., 2010; Zhang et al., 2011) and Lgals3 (Kang et al., 2016) could act as upstream genes. 
Pitx2 (Satheesha et al., 2016; Subramanian et al., 2005), Ccnd1 (Kasiri et al., 2017; Mathew et al., 
2014; Wang et al., 2016b), Tgif (Subramanian et al., 2005) and Adamts1 (Oliver et al., 2003; 
Subramanian et al., 2005) were indicated as possible downstream factors. And yet others were 
shown to be related to SHH/GLI1 signaling (C3ar1 (Pun et al., 2011), Lhx1 (Zhao et al., 2007) and 
Gpnmb (Zahreddine et al., 2014)) (Figure 36D).  
 
In summary, we found that the proliferation regulator Gli1 was overexpressed in dorsal and ventral 
brain regions of perinatal and postnatal dcKO brains. The upregulation of Gli1 was accompanied by 
aberrant overexpression of other proliferation regulators related to the SHH/GLI signaling pathway. 
Thus, we decided to select GLI1 as a candidate trigger of astrocyte proliferation in dcKO mice.  
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De-repressed GLI1 as a candidate trigger of astrocyte proliferation in dcKO mice 
Seeking further support for our choice, we evaluated the upregulation of Gli1 transcript by in situ 
hybridization. Using digoxigenin (DIG)-labelled probes, we detected Gli1 mRNA in brain tissues of 
E17.5 WT and dcKO mice. As shown in Figure 37A and C, the staining of WT cortex revealed low 
levels of Gli1 mRNA confined mostly to the VZ, with isolated cells found outside in CP (depicted by 
distribution plots). The VZ of WT VP also exhibited faint Gli1 mRNA staining (Figure 37A and B). To 
the contrary, the BAF complex deficient DP and VP showed prominent Gli1 mRNA labelling (Figure37 
A-C). Additionally, as presented in distribution density plots, unlike in control, the Gli1 mRNA 
staining of dcKO DP exhibited scattered distribution reminiscent of that observed for GLAST or BLBP 
positive AGPs in dcKO cortex (see Chapter 3. Results. 3.3, Figure 16). Furthermore, quantitative 
studies performed for Gli1 mRNA stained tissues of E17.5 and P3 WT and dcKO animals (results of P3 
in situ hybridization shown in Appendix, Figure 48) indicated a massive upregulation of the Gli1 
transcript in dcKO mice of both developmental stages (Figure 37D-F).  
Accordingly, the densities of Gli1 mRNA stained cells found in dcKO brains significantly exceeded 
these of WT (***p≤0.001, **p≤0.01), which held true in cortex (Figure 37F), VP (Figure 37E) as well 
as in the brain section as a whole (Figure 37D). Thus, our in situ hybridization confirms the 
upregulation of Gli1 mRNA in BAF complex depleted DP and VP.  
Next, we asked whether the upregulation of Gli1 leads to the overexpression of its target genes. 
Therefore, using an online tools for TF binding site profiling (Lachmann et al., 2010; Liberzon et al., 
2015; Liberzon et al., 2011; Subramanian et al., 2005; Yun et al., 2017) we found a list of all potential 
GLI1 target genes and inquired how many of these were upregulated in DP of E17.5 as well as DP 
and VP of P3 dcKO mice. The outcome of this analysis is shown in Figure 37I. We identified several 
GLI1 target genes whose overexpression level increased over developmental time (from 
Dorsal/E17.5 to Dorsal/P3). Importantly, VP and DP of P3 dcKO mice exhibited similar sets of 
upregulated GLI1 targets. This might indicate similarities in the molecular regulation of dorsal and 
ventral proliferative astroglial phenotype.   
Having established that GLI1 and its targets are potently upregulated in BAF complex depleted 
perinatal and postnatal brains we asked whether the observed overexpression of Gli1 is directly 
evoked by BAF complex elimination. Previous studies showed that a BAF complex subunit, BRG1, 
binds to the regulatory regions of Gli1, directly repressing its transcription (Figure 37G) (Zhan et al., 
2011). This may be taken as evidence that the observed upregulated Gli1 levels are due to the loss of 
BRG1 evoked by elimination of the entire BAF complex (see Chapter 3. Results. 3.2). However, it is 
well known that the expression of Gli1 can be triggered by the externally secreted morphogen SHH 
(Dahmane et al., 2001; Palma et al., 2005). Importantly, it has been shown that externally released 
SHH protein can trigger proliferation of astrocytes upon neurodegeneration (Ugbode et al., 2017). In
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Figure 37 | De-repression of Gli1 in embryonic and postnatal dcKO brains caused by elimination of BAF 
complex. (A, C) In situ hybridization of coronal brain sections through WT and dcKO E17.5 murine Cx 
(developing M1 area) stained Gli1 mRNA. (A) Overview pictures of WT and dcKO stained brain sections 
(B-C) Magnified insets of (B) ventral germinal zones of ganglionic eminence and (C) developing M1 area - 
delineated in (A). Full arrowheads indicate Gli1 mRNA positive cells. For (C) line graphs represented in the 
extreme right boards of each (WT and dcKO) are distribution density plots generated for Gli1 mRNA in 
whole cortical column (divided for 16 the same size bins). Average plots for n=3 animals shown as thick 
brown colour lines, plots for individual animals shown as thin beige colour lines). Each graph represents 
bin no. (0-16) juxtaposed with corresponding cell density found in cubic mm. PS area corresponds with 
bin no. 1, VZ area corresponds with bin no. 15 (both marked with dashed lines). Distribution of Gli1 
mRNA expressing cells in the WT cortex shows clear peak in VZ area, whereas Gli1 mRNA positive cells in 
dcKO exhibited distribution scattered across the cortical column. (D-F) Densities of cells expressing Gli1 
mRNA found in cubic mm of (D) complete brain slice, (E) VP and (F) cortex. Data are averages ± σ of n=3 
experimental replicates; ***p≤0.001, **p≤0.01 in t student test. (G) BRG1 binding sites around the region 
of mouse Gli1 gene. Reproduced from Zhan et al., 2011. (H) In situ hybridization of coronal brain sections 
through WT and dcKO P3 murine Cx (developing M1 area) stained Gli1 mRNA (in red) and Shh mRNA (in 
blue).  Pictures are pseudo-colored mergers of consecutive sections. Full arrowheads indicate cells 
expressing Gli1 mRNA, empty arrowheads indicate cells expressing Shh mRNA. Contours of brain tissues 
delineated with dashed lines. Bottom bar graph indicates Log2 fold change level of downregulation of Shh 
and upregulation of Gli1 revealed by RNA-seq of DP transcriptome of P3 WT and dcKO mice (I) Dynamic 
expression profile of potential/confirmed GLI1 target genes unchanged (in white) or significantly 
upregulated in 3 investigated hGFAP-Cre dcKO vs WT conditions. Heat map shows Log2 fold change of 
transcript abundance. Chr., chromosome; Cx, cortex; dcKO, double knockout; den., density; GE, 
ganglionic eminence; PS, pial surface; VZ, ventricular zone; WT, wild type.   
 
 
order to exclude the possibility that the upregulated Gli1 levels found in dcKO brains are due to the 
external action of SHH we opted for in situ hybridization for Gli1 and Shh. We performed this 
analysis on cortical sections of P3 WT and dcKO brains. As shown in Figure 37H and in agreement 
with the literature, layer IV and layer V of WT cortex exhibited Shh mRNA staining (empty 
arrowheads, in blue) (Courchet and Polleux, 2012). At the same time, Gli1 mRNA was mostly present 
in DW with some positive cells scattered across the cortical thickness (full arrowheads, in red). To 
the contrary, the cortex of dcKO mice did not display any staining for Shh mRNA despite the 
prominent Gli1 labelling. These results were supported by RNA-seq data, which indicated a 
significant downregulation of Shh transcript DP of P3 dcKO mice. Thus Gli1 overexpression is not due 
to the SHH but rather to the elimination of the BAF complex.   
 
In summary, our data confirmed that the elimination of BAF complexes causes de-repression of Gli1. 
 
 Restoration of WT-like phenotype by direct inhibition of GLI1 in dcKO mutants 
In order to determine whether de-repressed GLI1 promotes astrocyte proliferation in dcKO mice we 
opted for a rescue experiment. We blocked GLI1 mediated transcription by administering an 
inhibitor (Figure 38). Starting from E15.5, pregnant mice were given daily IP injections of the GLI1 
antagonist - GANT61 (Lauth et al., 2007). Injections were carried out for 4 consecutive days and the
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Figure 38 | Direct inhibition of GLI1 rescues proliferative astrocytic phenotype of BAF complex depleted 
VP. (A) Scheme explaining the experimental plan for GLI1 antagonist – GANT61 injection. Starting from 
E15.5, pregnant mice were administered a daily dosage of GANT61. The injections were carried for 4 
consecutive days and the brain tissues were isolated at late E18.5. Isolated tissues were subsequently 
subjected to immunohistochemical analysis of ACSBG1 and Ki67 expression. (B) Scheme illustrating the 
way of GANT61 action. GANT61 antagonizes GLI1 blocking transcription of GLI1 target genes. (C, F) 
Coronal tissue sections through WT, dcKO and inhibitor treated dcKO E18.5 mouse brains stained with 
antibodies detecting: (C) ACSBG1 expressing protoplasmic astrocytes (in green) as well as (E) ACSBG1 
expressing protoplasmic astrocytes (in green) together with proliferation marker Ki67 (in magenta). The 
nuclear DAPI staining is blue. Cells expressing ACSBG1 and Ki67 are proliferative astrocytes. For (C) top 
panels are overview pictures. Arrowheads point the area of VP with strongest ACSBG1 staining found in 
untreated dcKO animals. For magnified insets full arrowheads indicate ACSBG1 expressing astrocytes. For 
(E) full arrowheads indicate proliferative astrocytes, empty arrowheads point to astrocytes that were not 
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proliferative. (D, F) Percentages of: (D) DAPI cells expressing ACSBG1 and (E) proliferative astrocytes 
quantified in the areas of CANu of late E18.5 WT, dcKO and inhibitor injected dcKO mice. Data are 
averages ± σ of n=2 experimental replicates; NA, not applicable (n=2). CANu, central amygdala nucleus; 
dcKO, double knockout; NA, not applicable; WT, wild type.  
 
 
brain tissues were isolated at late E18.5 (Figure 38A and B). Subsequently, we assessed the astroglial 
phenotype within treated and untreated dcKO and WT brain sections. First, by means of 
immunostaining, we investigated ACSBG1 positive protoplasmic astrocytes. As shown in Figure 38C, 
the VP of untreated dcKO mice exhibited prominent staining for ACSBG1 (middle panel images). 
Strikingly the VP phenotype of dcKO mice treated by GANT61 reverted to WT-like pattern (Figure 
38C, extreme left and right panels). Accordingly, the ACSBG1 expressing protoplasmic astrocytes of 
injected dcKO mice were scattered throughout the brain tissue as single individuals and unlike these 
of untreated dcKO, did not tend to group into clusters of hypertrophic cells. Additionally, the amount 
of ACSBG1 positive cells found in VP of GANT61 treated animals was similar to that of WT and visibly 
lower than in untreated dcKO (Figure 38D).  
Next, we sought to investigate the proliferation of the above described astrocytes. Using staining we 
analyzed the expression of the proliferation marker Ki67 in ACSBG1 positive protoplasmic astrocytes 
found in VP of treated and untreated dcKO as well as WT mice (Figure 38E). As expected, we found a 
prominent staining for Ki67 within numerous ACSBG1 positive astrocytes of untreated dcKO mice 
(pointed by full arrowheads). To the contrary and similarly to the WT condition, only few ACSBG1 
expressing cells found in VP of GANT61 treated dcKO mice stained for Ki67. Moreover, the amount 
of ACSBG1 positive cells expressing Ki67 found in VP of treated dcKO mice was similar to that of WT 
and definitely lower than the fraction of ACSBG1 expressing cells exhibiting Ki67 staining found in VP 
of untreated dcKO mice (Figure 38F).  
 
Taken together, these results indicate that direct inhibition of Gli1-dependent transcriptional activity 
rescues the abnormally proliferative astrocytic phenotype of BAF complex depleted VP. In other 
words, the elimination of BAF complex de-represses GLI1 that triggers proliferation within mutation 
affected astroglia. This confirms that BAF complexes control the proliferation of astrocytes by 
repressing GLI1 activity.   
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Chapter 4 
 
Discussion 
 
 
 
In the present study, we investigated the role of BAF complex in the development of neuronal and 
astroglial lineages. We found that the composition of the BAF complex depends on the cellular 
lineage as well as the developmental stage. Furthermore, the analysis of our hGFAP-Cre driven dcKO 
of BAF155 and BAF170 revealed that the loss of BAF complex results in a tremendous depletion of 
neurons and an abundance of massively overproliferative astroglia. Finally, we demonstrated that 
the overproliferation of astroglia was mediated by the mitogen GLI1, which was de-repressed in cells 
lacking BAF complex. In this chapter, we will discuss the interpretation and significance of these 
findings. 
 
4.1 Dynamic expression pattern of BAF complex subunits during astrogliogenesis: lessons from 
brain development 
 
BAF chromatin remodeling complexes utilize energy from the hydrolysis of ATP to orchestrate 
changes in the structure of chromatin (Cairns, 2007; Hargreaves and Crabtree, 2011; Sokpor et al., 
2017). This chromatin altering activity endows BAF complexes with the capacity to execute 
transcriptional activation and/or repression (Sokpor et al., 2017; Wu, 2012). Functional competence 
of different BAF complexes has been attributed to their specific subunit composition (Ho and 
Crabtree, 2010). Precisely, the particular subunit assemblies of BAF complex determine which 
genomic areas it can target and its interaction with specific factors (Ho and Crabtree, 2010; Wu, 
2012). Therefore, reshuffling the subunits of BAF complexes during development initiates unique 
transcriptional programs that regulate developmental events such as cellular proliferation or 
differentiation (Bachmann et al., 2016; Ho et al., 2009; Kadoch and Crabtree, 2015; Lessard et al., 
2007; Mashtalir et al., 2018; Yoo et al., 2009). These processes are naturally involved in 
astrogliogenesis, from the initial astrocytic RGCs self-renewal, subsequent specification to AGPs, 
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transient amplification and final maturation to astrocytes (Kriegstein and Alvarez-Buylla, 2009; 
Molofsky and Deneen, 2015).  
 
In this study we shed light on the BAF complex assemblies within astroglial cells. For the first time 
we showed that BAF complex expression pattern correlates not only with cell type (namely neurons 
versus astroglia) but also with different levels of specification within the astrocytic lineage (namely 
astrocytic RGCs versus AGPs).  
 
Technical considerations 
Our findings about BAF complexes were based chiefly on immunohistochemical assessment of the 
expression of 5 chosen BAF subunits (namely: BRG1, BAF155, BAF170, BAF60a and BAF250a). 
Considering that cell-specific BAF complexes are multimeric assemblies of at least 15 different 
subunits (Lessard et al., 2007; Narayanan et al., 2015; Sokpor et al., 2017; Wu et al., 2007), such an 
approach may at first glance appear insufficient to infer anything about the entire complex 
assembly. However, early studies describing BAF complex purification posited that all subunits must 
be incorporated into the complex (Chen and Archer, 2005; Doan et al., 2004; Goldberg, 2003; 
Kadoch and Crabtree, 2015; Wang et al., 1996). This implies that the presence of single subunits 
testifies to the assembly of the entire BAF complex. Our choice of method was grounded in this 
reasoning. On the other hand, it has been shown that under certain circumstances BAF subunits can 
be found as unbound to the complex. Accordingly, in destabilized BAF complex, some subunits 
degrade faster than other, hinting at differences in the temporal expression of free BAF elements 
(Sohn et al., 2007). Unbound subunits could also be found as maturating proteins adopting correct 
folding before their incorporation to the complex (Chen and Archer, 2005). Additionally, single 
subunits of BAF complexes were found in cells as monomeric fraction (Kadoch and Crabtree, 2015). 
It has been also proposed that the methylation of core subunits can destabilize entire BAF complex, 
suggesting the presence of solely methylated BAF elements (Panamarova et al., 2016). However, 
these findings were described only for 4 subunits out of 15 (BAF155, BAF57 as well as β-actin and 
BAF53a) (Chen and Archer, 2005; Kadoch and Crabtree, 2015; Sohn et al., 2007). Thus, on the whole, 
it does not seem unreasonable to extrapolate the state of the BAF complex from the co-expression 
of only 5 of its constituents.  
 
Additionally, it is not without good reasons that we chose to investigate these particular 5 BAF 
subunits (BRG1, BAF155, BAF170, BAF60a and BAF250a). This choice was dictated by their 
functionality within the complex. Indeed, three of these subunits are elements of the core of BAF 
complex (one catalytic ATPase - BRG1, and two invariable scaffolding subunits: BAF155 and BAF170) 
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(Ho and Crabtree, 2010; Phelan et al., 1999). The remaining two are variant subunits: BAF60a and 
BAF250a. These were shown to be present within npBAF complex as well as neuronal - nBAF 
complex (Chen et al., 2012; Ho and Crabtree, 2010; Lei et al., 2015; Li et al., 2010; Meng et al., 2018; 
Oh et al., 2008). As the distinct variant subunits integrate into the core and scaffolding proteins 
(Mashtalir et al., 2018; Narayanan and Tuoc, 2014b; Ronan et al., 2013), this specific selection 
covered a broad range of subunit functions and therefore allowed us to infer the integrity of the 
complex. 
 
In addition, it is obvious that coimmunoprecipitation under stringent conditions (Wang et al., 1996) 
followed by mass spectrometry measurements would provide more accurate evaluation of the 
complete complex assembly. However this experiment involves the purification of AGPs population 
which due to the lack of exclusive markers is not possible to this day (Schiweck et al., 2018). Thus, 
overall, our immunohistochemical approach seems reasonable given the current state of knowledge.  
 
Dynamic expression of BAF subunits during astrogliogenesis  
Our immunostaining studies have enabled us to reveal the spatio-temporal dynamics of BAF 
complex expression pattern within the astroglial lineage. We found that all tested BAF subunits were 
ubiquitously expressed in astrocytic RGCs of all astroglial germinal zones of developing forebrain. 
However, BAF170 alone stood as an exception to this rule. Indeed, a small fraction (~11-16%) of 
astrocytic RGCs in any area did not express this subunit. This loss of BAF170 may be a sign that the 
RGCs are transitioning towards a more advanced state of differentiation, that of AGPs. In support of 
this hypothesis, we observed that astrocytic RGCs that detach from the AS of VZ practically lose the 
expression of BAF170. It is well established that astrocytic RGCs delaminate as they differentiate 
towards AGPs (deAzevedo et al., 2003; Ge and Jia, 2016; Noctor et al., 2004; Voigt, 1989). It thus 
appears that changes within BAF170 expression and detachment from the VZ are two sides of the 
same coin. In fact, we suspect that the loss of BAF170 is causal to the detachment of astrocytic RGCs. 
Some support for this hypothesis comes from the observation that BAF170 depleted adult NSCs 
detach from the subgranular zone (SGZ) and mis-position to the outer layers of DG (Tuoc et al., 
2017).  
 
Once astrocytic RGCs have differentiated to AGPs, the composition of the BAF complex does not 
remain static but undergoes deep and characteristic changes. Our immunostaining studies have 
revealed that the expression of investigated subunits decreased within delaminated AGPs. A bold 
hypothesis hence leaped to our minds: the downregulation of BAF complex expression could be 
necessary for the initiation of some AGPs characteristics. One such characteristic is a high rate of 
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proliferation (Ge and Jia, 2016; Ge et al., 2012; Molofsky and Deneen, 2015). Several groups have 
described BAF complex as a proliferation limiting factor that inhibits mitogens e.g. GLI1 (Narayanan 
et al., 2015; Nguyen et al., 2018; Panamarova et al., 2016; Wu, 2012; Zhan et al., 2011). Thus one 
may speculate that the downregulation of BAF subunits abundance is causing or at least enabling 
AGPs proliferation.  
Although compelling, this assumption was frustrated by the fact that unlike all other subunits, 
BAF155 expression levels remained high in AGPs. This does not suffice to disprove our hypothesis 
and can in fact be explained quite simply. Indeed, on the one hand it has been shown that the 
elimination of BAF170 increases the expression of BAF155 (Tuoc et al., 2013b). On the other hand, it 
is known that high levels of methylated BAF155 destabilize the BAF complex (Panamarova et al., 
2016), possibly leading to downregulation of other subunits. It is therefore conceivable that the 
strong expression of BAF155 that we observed in AGPs corresponds to its less competent, 
methylated form, which has no bearing on our hypothesis. High levels of methylated BAF155 and 
low levels of BAF170 would exert a powerful destabilizing effect on the entire BAF complex 
(Narayanan et al., 2015; Panamarova et al., 2016; Poston et al., 2018), explaining the decrease in 
expression of other subunits that we have observed within AGPs. However, the experimental proof 
for this statement is parsimonious and further investigations (e.g. addressing methylation of 
BAF155) need to be performed in the future.   
 
The final step of astrogliogenesis is differentiation of AGPs into postmitotic astrocytes (Kriegstein 
and Alvarez-Buylla, 2009; Tabata, 2015). Remarkably, our immunostaining confirmed the presence 
of 4 subunits absent from AGPs in adult astrocytes: BAF170, BRG1, BAF60a and BAF250a (Appendix, 
Figure 44). Alas we could not determine whether BAF155 was also present because we failed to 
successfully stain adult tissue; however, we presume that this was the case. It thus appears that the 
pattern of BAF subunit expression in adult astrocytes differs substantially from AGPs and recovers an 
astrocytic RGCs-like character. This result further supports the notion that BAF subunits expression 
levels may control the rate of astroglia proliferation. We hypothesize that downregulated levels of 
BAF complex enable AGPs (premature astroglia) proliferation while their elevation immobilizes the 
cell into a quiescent state.    
 
Different expression levels of BAF subunits in cortical neurons and AGPs 
In addition to the astroglial lineage we also investigated BAF subunit composition in cortical neurons 
and found marked differences with astrocytic RGCs and AGPs. Our immunohistochemical analysis 
revealed that BRG1, BAF170, BAF60a and BAF250a were highly expressed in neurons. BAF155 on the 
other hand was only present at low levels. In other words, the BAF subunit composition in neurons is 
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the mirror opposite of that in AGPs, where BAF155 was more strongly expressed than any other 
subunit. Thus, the BAF complex subunit composition is not only specific for a given stage of 
differentiation within a defined cellular lineage, but it is also cell type specific. From there, one can 
extrapolate that BAF complex influences cell fate specification in addition to its role in the regulation 
of proliferation.  
 
Revealed pattern of BAF subunits expression - summary 
In summary, our results indicate that the expression pattern of BAF subunits differs between various 
cells of astrocytic lineage as well as between neuronal and astroglial cell types (Figure 39A).  
 
 
 
 
 
Figure 39 | Changes of BAF complex subunits composition in relation to various neural cell fates. (A) 
Scheme depicting our findings. The cartoon shows that astrocytic RGCs of all astrocytic germinal zones 
(VZ of Cx, LGE and MGE; indicated in the of drawing of perinatal murine brain section) assemble BAF 
complex and its expression tends to decline as they detach from the surface of VZ in the form of AGPs 
(process pointed by red arrow; this was showed for all subunits except for BAF155, expression of which 
was elevated). To the contrary, expression of subunits downregulated within AGPs was highly elevated in 
neurons populating CP (surpassing that of astrocytic RGCs as well; this was true for all subunits except 
BAF155, whose expression was lowered). The colour of the nuclei of a given cell population is 
proportional to the average expression levels of all tested subunits (*in (A) scale bar refers to the 
expression of all tested subunits except for BAF155, problem discussed above). (B) Proposed hypothetical 
model of described BAF composition reshuffles showed for postmitotic neurons (upper panel) and 
AGPs (lower panel). Postmitotic neurons expressed high levels of BRG1, BAF170, BAF60a and 
BAF250a. BAF155 expression was rather moderate (comparing to that of astrocytic RGCs and AGPs). 
This could be caused by high expression levels of BAF170 (discussed previously). High expression 
levels suggest assembly of BAF complex within postmitotic neurons and its action as activator of 
transcription of genes allowing for neuronal terminal differentiation. On the other hand postmitotic 
neuronal BAF complex can act as transcriptional repressor of genes coding for astrocytic marks and 
proliferation promotion. AGPs exhibited declining abundance of BRG1, BAF170, BAF60a and 
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BAF250a; however, levels of BAF155 were elevated. Considering that high expression levels of 
BAF155 were evoked by drastic downregulation of BAF170 and assuming that BAF155 could be 
silenced by posttranscriptional modification (e.g. methylation) this observation may indicate the 
destabilization of the entire BAF complex within proliferative astrocytic precursors - AGPs. This 
destabilization could evict BAF complex from previously regulated places abolishing its activator and 
repressor functions and therefore allowing for inhibition of neuronal differentiation and activation of 
astrogliogenesis (in sense of detachment of astrocytic RGCs from AS in form of AGPs), and 
proliferation. The colour of tested subunits matches the scale shown in (A). Subunits coloured in 
gray are not covered by the study. AGP, astroglial progenitor; AS, apical surface; CP, cortical plate; 
Cx, cortex; Me, methylation; MGE, medial ganglionic eminence; as RGCs, astrocytic radial glia; LGE, 
lateral ganglionic eminence; VZ, ventricular zone.  
 
 
We found that astrocytic RGCs of all germinal zones assemble BAF complex and that its expression 
tends to decline as cells detach from the surface of VZ in the form of AGPs. We could also show that 
previously diminished BAF elements reconstitute within mature, quiescent protoplasmic astrocytes. 
Thus, these results suggest that the depletion of BAF complex elements may be correlated with the 
proliferation of astroglial cells. Additionally, we established that BAF complexes expression is 
generally lowered within astroglial lineage and highly elevated in neurons. This suggests that the 
downregulation of BAF complex abundance could be crucial for astrogliogenesis and astrocyte 
proliferation. It thus appears that affecting astrocytic RGCs by BAF complex KO and subsequently 
conducting further experiments aiming at investigation of astrogliogenesis within impacted 
forebrain regions was fully justified. The summary of our observations, as well as a hypothetical 
model of BAF complex reshuffles in neurons, astrocytic RGCs and AGPs of perinatal forebrain are 
presented in Figure 39. 
 
4.2 Our mouse model with hGFAP-Cre driven KO of BAF complex, the lesser evil 
 
Having established that the declining abundance of BAF complex could be crucial for astrogliogenesis 
and astrocyte proliferation we can turn our attention to the subject of the animal model selected for 
testing this hypothesis. In the present study we used a transgenic mutant mouse with specific hGFAP 
promoter driven, Cre dependent dcKO of BAF155 and BAF170 (Narayanan et al., 2015; Nguyen et al., 
2018; Zhuo et al., 2001). The choice of this model allowed us to effectively eliminate the entire BAF 
complex from the affected astrocytic RGCs. Despite this clear advantage, this model also suffered 
from several drawbacks. Both of these will be discussed in the present subchapter.  
 
hGFAP promoter driven recombination, pros and cons 
hGFAP-Cre driven tdTOM fluorescence have enabled us to confirm the activity of hGFAP promoter 
within all known dorsal and ventral forebrain astrocytic germinal zones (Bayraktar et al., 2014; Tsai 
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et al., 2012). This observation was in agreement with previously published work (Anthony and 
Heintz, 2008). Such activity at first glance appears to be in favour of our designs. Precisely, it allowed 
us to test the impact of BAF complex depletion on dorsal as well as ventral astrogliogenesis. As 
described previously (see Chapter 4. Discussion. 4.1), a gradual decline of the majority of 
investigated BAF subunits could be observed in both cortical and striatal AGPs of perinatal WT 
forebrain. It is known that astrocytes of cortex and corpus callosum originate from cortical astrocytic 
RGCs. At the same time astrocytes populating the striatum and ventral pallidum as well as striatum 
and piriform cortex derive from RGCs of MGE and LGE respectively (see Chapter 3. Results. 3.2. 
Figure 12D-F) (Tsai et al., 2012). Thus the use of this mouse model allowed us to imitate the decline 
of BAF complex that we have previously proposed as necessary for the initiation of cortical and 
striatal AGPs characteristics. 
   
The data obtained from our and other’s (Anthony and Heintz, 2008) tracing experiments indicated 
that the developmental stage during which the activity of hGFAP promoter was initiated, differed 
between astrocytic germinal zones, preceding or succeeding the start of astrogliogenesis. 
Accordingly, cortical activity of hGFAP promoter started relatively early (around E13.5), affecting 
neuronal RGCs of medial areas of cortex (Kwan et al., 2012) and further spreading to lateral cortical 
VZ (active at E15.5). Importantly, this activity persisted over development, allowing the manipulation 
of cortical astrocytic RGCs (residing in VZ of E17.5 murine cortex). Such gradual recombination 
starting during the neurogenic period and spreading from medial to lateral areas of cortex has 
numerous consequences, helpful or otherwise. First of all, it opens the possibility of testing what 
influence the loss of BAF complex exerts on cortical neurogenesis and astrogliogenesis. Therefore, by 
use of the same animal model we could verify that BAF complex acts as an activator of neuronal 
differentiation and repressor of astrogliogenesis and astroglial proliferation (see Chapter 4. 
Discussion. 4.1. Figure 39). On the other hand, affecting neurons carried a risk of indirect 
manipulation of astroglial phenotype through a reduction in neuron-derived cytokines and 
proliferation of reactive astrocytes (detailed description in Chapter 4. Discussion. 4.3) (Anderson et 
al., 2014; Barnabe-Heider et al., 2005; Freeman, 2010; Miller and Gauthier, 2007). Furthermore, 
because of gradual spread of hGFAP promoter activity, medial and lateral areas of cortex were 
unequally affected by driven mutation. This forced us into a separate analysis of both cortical 
regions.  
 
Although we could trace the activity of hGFAP promoter within ventral astrocytic germinal zones, 
our results did not fully match the literature. Our studies indicated that in E15.5 forebrain, only a 
subpart of MGE was affected by hGFAP-Cre driven recombination. This observation is somewhat at 
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odds with published data indicating that RGCs of E15.5 MGE as well as LGE exhibit the activity of 
hGFAP promoter (Anthony and Heintz, 2008). Moreover, it was shown that this activity starts within 
few astrocytic RGCs residing in VZ of MGE, as early as at E14.5. Such minimal discrepancy may be 
explained by the difference in the tracing techniques used to detect the activity of hGFAP promoter 
(the promoter controlled expression of β-galactosidase and X-gal staining used in (Anthony and 
Heintz, 2008) could be more sensitive than the tdTOM reporter used in our studies). The exact time 
point of the initiation of astrogliogenic switch within ventral RGCs remains unclear (Minocha et al., 
2017). However, it has been reported that astroglia originating from MGE may be produced as early 
as at E14.5 (Minocha et al., 2015). Thus, considering published data as well as our findings we could 
assume that the hGFAP promoter is active within ventral astrocytic RGCs that produce astrocytes.  
 
Affecting dorsal and ventral astrocytic germinal zones within the same forebrain led to difficulties in 
the evaluation of the origin of the revealed upregulated astroglial cells. Based on previously 
published tracing studies, we could follow forebrain astrocyte populations that exhibited hGFAP-Cre 
driven recombination (Tsai et al., 2012). However, our data indicated that BAF complex elimination 
possibly changes the migratory behaviour of affected cells, likely directing them to the regions of 
forebrain different than in WT animals (detailed description in Chapter 4. Discussion. 4.3). Thus 
despite the use of tdTOM tracing we could not fully discern whether the upregulated AGPs and 
astrocytes originate from dorsal or ventral astrocytic germinal zones. This drawback of the hGFAP-
Cre dcKO forced us to diversify our approach by using another animal model generated by in utero 
electroporation and Olig2-Cre recombination (see Chapter 4. Discussion. 4.3).  
 
BAF complex elimination, whistling past the graveyard 
The elimination of all known BAF complex subunits (and thus extinction of the entire BAF complex) 
can be evoked solely by the dual loss of BAF155 and BAF170 (Narayanan et al., 2015). Indeed, 
astrocytic RGCs of our hGFAP-Cre driven dcKO model were deprived of all tested BAF complex 
subunits (namely BAF155, BAF170, BRG1 and BAF60a). Similarly, ventral protoplasmic astrocytes of 
postnatal dcKO mice did not express BAF complex elements (Appendix, Figure 43B). Thus despite the 
relatively late initiation of hGFAP-Cre activity within MGE and LGE, ventral astroglial cells could still 
be affected by BAF complex KO.   
 
Finally, as we have reported, the post-partum mortality of dcKO animals was sorely high, limiting 
their average lifespan to P3-4. This is due to difficulties with feeding, as these mutants were 
displaying motor deficits and therefore could not compete for food with their littermates. This was a 
clear disadvantage of hGFAP-Cre dcKO as a model for abnormal astrogliogenesis and astroglial 
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proliferation. Accordingly, cortical astrogliogenesis has been reported to begin around E17.5 
(Kriegstein and Alvarez-Buylla, 2009). However, the whole process of astrogliogenesis (including 
AGPs migration, local proliferation, terminal differentiation to post mitotic astrocytes and their 
integration to the neural circuitry) takes place over weeks of postnatal development (Bandeira et al., 
2009; Ge and Jia, 2016; Ge et al., 2012; Miller and Gauthier, 2007). Therefore, our animal model 
limited our study to the early steps of astrogliogenesis influenced by BAF complex depletion. 
Namely, the high juvenile mortality of dcKO mice prevented the investigation of later stages of 
astrocytes development.  
 
 hGFAP-Cre driven KO of BAF complex, the lesser evil 
A better strategy to target specific lineages could help us avoid the drawbacks described above. 
Literature reports indicate diverse methods that allow to perturb the expression of chosen genes 
within the astroglial lineage (Anthony and Heintz, 2008; Casper et al., 2007; Jahn et al., 2015; 
Srinivasan et al., 2016; Xie et al., 2015). Among these, several Cre driver lines have been shown to 
target astrocytes and their progenitors. However, all described mouse models display shortcomings 
(e.g. early induction, lack of specificity, etc.) (Casper et al., 2007; Foo and Dougherty, 2013). For 
instance GLAST or BLBP promoter driven recombination, albeit reported to be astrocyte specific, 
have been shown to start in E10.5 cortex, thereby affecting early and late neuronal RGCs as well as 
astrocytic RGCs (Anthony and Heintz, 2008; Casper et al., 2007). Perhaps viral delivery of Cre to 
BAF155fl/fl_ BAF170fl/fl brain could serve as an alternative method of BAF155 and BAF170 KO within 
astrocytes of adult animals. While such an approach appears promising at first glance, the damage 
caused by injection of a viral vector could itself trigger a proliferation of astroglia, evoking reactive 
astrogliosis at the place of capillary insertion (reaction to the injury, described in (Casper et al., 
2007)). Therefore, this method cannot be considered as appropriate for investigation of regulators 
of astroglia proliferation, as in the case of BAF complex.   
 
In conclusion, our results show that hGFAP-Cre driven dcKO affects all forebrain astrocytic germinal 
zones and allows an effective elimination of the entire BAF complex from the affected astrocytic 
RGCs. Thus, this animal model, albeit not perfect, still serves our purpose, allowing us to mimic the 
reduction in BAF subunits expression observed for WT AGPs (see Chapter 4. Discussion. 4.1).  
 
4.3 Phenotype of BAF complex depleted forebrain – favoring astroglia over neurons 
 
Functional competence of mammalian brain depends on cooperation of many distinct cell types 
(McKenzie et al., 2018; Sloan and Barres, 2014). Among these, the joint action of neurons and 
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astrocytes has emerged as pivotal in the coordination of neural circuit development and 
performance (Clarke and Barres, 2013; Khakh and Sofroniew, 2015; Martin et al., 2015; Sloan and 
Barres, 2014). Importantly, accomplishment of an appropriate astrocyte to neuron ratio has been 
indicated as crucial for proper brain function (Gallo and Deneen, 2014; Perea et al., 2014; von 
Bartheld et al., 2016). Tight control of neuronal and astroglial quantities is determined, no doubt, by 
the molecular events underpinning brain development (Miller and Gauthier, 2007; Sloan and Barres, 
2014; Tien et al., 2012).  
 
Our previous studies (see Chapter 4 Discussion. 4.1) led us to propose that the developmental 
regulation by BAF complex may control the establishment of balanced numbers of neurons and 
astroglial cells. Accordingly, we hypothesized that the diminished abundance of BAF complex could 
be crucial for the promotion of astroglia and disruptive for neurogenesis. Thus we generated the 
hGFAP-Cre dcKO mouse model, which enabled us to eliminate the entire BAF complex form the 
germinal zones of late developing forebrain and thus made it possible to test our hypothesis.  
 
Notably, this in vivo deletion of BAF complex led to quantitative alterations in the cellular 
composition of the forebrain, with visibly increased numbers of astroglia and reduced numbers of 
neurons. In this subchapter we will discuss the promoted astroglial phenotype found in hGFAP-Cre 
dcKO forebrain, taking all analyzed areas of DP and VP into account (see Chapter 3. Results. 3.3 and 
3.4).  
 
Technical considerations 
The methods used for revealing the characteristics and the abundance of AGPs in WT and dcKO 
forebrain may encounter some words of criticism that need to be addressed and hopefully defused 
before unveiling our final conclusions. 
 
First of all, to the best of our knowledge, so far there are no known universal markers of AGPs. Thus 
the markers used here for the evaluation of AGPs phenotype (GLAST, BLBP, NFiA and SOX9) are 
commonly expressed by astrocytic RGCs (Hartfuss et al., 2001; Kang et al., 2012; Molofsky et al., 
2012; Nagao et al., 2016; Scott et al., 2010; Shibata et al., 1997). There is therefore a risk of 
confusing these two cell types. However, it is widely accepted that astrocytic RGCs are differentiated 
AGPs as soon as they leave astrocytic germinal zones (Minocha et al., 2015; Mission et al., 1991; 
Pixley and de Vellis, 1984; Schmechel and Rakic, 1979). Thus, our analysis focuses not only on the 
expression of certain astroglial markers, but also on the spatial distribution of stained cells. In 
addition, unlike in VP, due to anatomical defects it was not possible for us to reveal VZ of dcKO 
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cortex. Thus, we chose to evaluate the attachment of given cells to the AS of cortical VZ as a final 
criterion to distinguish astrocytic RGCs from AGPs. We took this step because it has been well 
established that differentiated AGPs detach from the VZ and subsequently migrate outside of 
germinal zones (Cameron and Rakic, 1991; Ge et al., 2012; Guillemot, 2007; Marshall and Goldman, 
2002; Minocha et al., 2015; Mission et al., 1991; Molofsky and Deneen, 2015; Rowitch and 
Kriegstein, 2010). Importantly, we could exclude oRGPs fate of delaminated cells by confirming their 
expression of typically astroglial NFiA (Deneen et al., 2006; Kang et al., 2012) (see Chapter 3. Results. 
3.3). Overall, the simultaneous investigation of astroglial markers expression and the location of 
stained cells enabled us to specifically study the formation of AGPs in WT and dcKO forebrain.     
 
Secondly, striking anatomical differences between WT and dcKO cortex, especially pronounced in 
the reduced thickness of its medial areas, may have influenced the interpretation of the AGPs 
quantifications. Precisely, due to reduced neuronal numbers the amount of DAPI cells revealed for 
medial area of dcKO was visibly lowered, hence artificially increasing the percentages of dcKO AGPs 
(quantified per DAPI cells). However this potential confounder could not have been avoided by any 
other method of investigation. In addition, the absolute numbers of AGPs expressing BLBP revealed 
for dcKO were higher than these of WT, suggesting that the actual increase in AGPs abundance is 
directly evoked by the deletion of BAF complex within these cells and is not due to the quantification 
artifacts.    
 
BAF complex - a guardian of balanced abundance of neurons and astroglia 
Overall, the most striking features of dcKO forebrain phenotype were: tremendously increased 
amount of AGPs, elevated numbers of protoplasmic astrocytes and reduced numbers of late born 
neurons. Taken together these results inspired the model that we proposed above. 
 
We investigated the numbers of late born neurons in postnatal DP of WT and dcKO mice using a 
staining against SATB2 (Britanova et al., 2008). Our analysis showed severely reduced SATB2 positive 
neurons. This held true for medial area of cortex and, to a lesser extent, lateral areas. This indicates 
that the impairment of late neurogenesis is a cortex wide phenomenon but exhibits a gradient in 
severity, with medial areas being most affected. This gradient mimics hGFAP-Cre activity (see 
Chapter 3. Results. 3.2. Figure 12) and is likely to be fully explained by it. These results were 
confirmed by our RNA-seq analysis, which revealed a massive downregulation of transcripts related 
to neurogenesis, late born neurons and neuronal cellular component. Importantly, the neuronal 
deficits appeared even more severe at P3 than at E17.5, indicating that there was no postnatal 
compensation for the impaired embryonic neurogenesis. Therefore, deprivation of BAF complex in 
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developing cortex results in a pronounced and irreversible loss of upper layer neurons. These results 
are in good agreement with the model that we have proposed before. Indeed we observed that in 
WT animals neurons were characterized by high expression levels of BAF subunits. As the KO of 
BAF155 and BAF170 causes deletion of the entire BAF complex (Narayanan et al., 2015), it was 
impossible for RGCs to reach the elevated levels of BAF complex that would allow differentiation to 
neurons (Nguyen et al., 2018). Besides, these results are not surprising given that appropriate BAF 
complex assembly was shown to be critical for proper neurogenesis (Bachmann et al., 2016; 
Narayanan et al., 2015; Nguyen et al., 2018; Tang et al., 2013; Tuoc et al., 2013b). 
 
Furthermore, we evaluated the AGPs population in embryonic and postnatal DP of WT and dcKO 
mice using a range of markers: GLAST, BLBP, NFiA and SOX9 (Hartfuss et al., 2001; Kang et al., 2012; 
Molofsky et al., 2012; Nagao et al., 2016; Scott et al., 2010; Shibata et al., 1997). Our analysis 
indicated a greatly increased abundance of cortical AGPs. This was already visible at early stages of 
cortical astrogliogenesis (at E17.5) as well as at postnatal stages (P3) when astrogliogenesis is known 
to be in full swing (Freeman, 2010; Gallo and Deneen, 2014; Ge and Jia, 2016; Ge et al., 2012; Gotz 
and Barde, 2005; Kriegstein and Alvarez-Buylla, 2009; Rowitch and Kriegstein, 2010). Moreover, the 
AGPs population expanded over developmental time. As in the case of late born neurons, the 
numbers of AGPs exhibited a medio-lateral cortical gradient. However, this gradient was mirrored 
when compared to neurons, with higher numbers of AGPs in medial cortical area and lower in lateral 
area. In addition, our transcriptome analysis at least partly confirmed our immunohistochemistry 
results, indicating increased gliogenic process within embryonic and postnatal DP of dcKO. These 
observations were not only pronounced in DP but also in VP indicating again that altered production 
of AGPs is a common feature of our BAF complex depleted forebrain. Surprisingly, earlier studies 
yielded conflicting results, indicating that the loss of a single BAF subunit, BRG1, leads to a decrease 
in numbers of AGPs (Matsumoto et al., 2006). However, the results described there were chiefly 
focusing on S100β and CD44 expressing AGPs of spinal cord, and thus do not fully reflect our 
research model. Accordingly, these results seem to confirm the model we previously postulated. 
Thus, we propose that the downregulated expression of BAF complex subunits in developing WT 
forebrain and their absence in the dcKO mutants promotes the differentiation of astrocytic RGCs 
into AGPs.  
 
We also investigated the maturation of protoplasmic astrocyte populations in gray matter (Cahoy et 
al., 2008; Li et al., 2012; Oberheim et al., 2012). By means of immunostaining against ACSBG1 (Cahoy 
et al., 2008; Chaboub and Deneen, 2013; Li et al., 2012; Naka-Kaneda et al., 2014) we could reveal an 
increased abundance of protoplasmic astrocytes in postnatal dcKO VP. This finding is anything but 
133 
 
surprising. Since we found elevated numbers of AGPs in dcKO brains it seems logical to expect higher 
abundance of maturating astrocytes as well (Tabata, 2015). This is indeed what we found also in LCx, 
however, we were puzzled that protoplasmic astrocytes numbers were dramatically reduced in 
medial cortical areas where hGFAP-Cre driven BAF KO was most precocious and where we found 
high numbers of AGPs. Thus, at first glance this observation seemed to contradict our predictions. 
However, several lines of reasoning lead us to believe that such is not necessarily the case.  
First of all, it is possible that AGPs born in MCx die before differentiating to protoplasmic astrocytes. 
However, our evaluation of cell death contradicted this idea showing that only negligible numbers of 
DP AGPs were apoptotic. Therefore, there must be another reason for the lack of astrocytes in 
medial cortical areas. 
It is possible that AGPs were first born in MCx, later migrate to healthier areas such as LCx and 
subsequently differentiate there. This idea seems to be supported by our EGFP tracing performed by 
means of in utero electroporation. Here we could show that dorsal progenitors were highly mobile. 
Accordingly, a couple of days after electroporation in cortex, labeled cells could be found in more 
lateral as well as ventral areas of dcKO forebrain. Moreover, our RNA-seq analysis seems to confirm 
high migratory abilities of BAF complex depleted cells. Indeed, several transcripts upregulated in 
postnatal dcKO DP are involved in enhancement of cell locomotion and migration. Additional 
evidence supporting this idea comes from studies on regional allocations of astrocytes (Tsai et al., 
2012). It has been shown that the distribution of astroglia is dictated by VZ-patterning. This implies 
that astroglial cells expressing ventral markers would be restricted into more lateral and ventral 
areas of forebrain (see Chapter 3. Results. 3.2. Figure 12D-F). Our RNA-seq analysis of postnatal 
dcKO DP revealed a massive upregulation of markers known to be attributes of ventral areas (e.g. 
Gli1, data not shown) (Tsai et al., 2012; Yu et al., 2009). Thus it could be that these markers trigger 
aberrant migration of DP AGPs towards more lateral and ventral regions of dcKO forebrain. 
Incidentally, this effect would not exclude the contribution of BAF complex depleted astrocytic RGCs 
of MGE and LGE in the production of the increased numbers of VP protoplasmic astrocytes. We 
could confirm it by observing increased numbers of ACSBG1 expressing astrocytes in VP of Olig2-Cre 
dcKO mice, as in this model we affected only ventral astrocytic RGCs by BAF complex depletion 
(Zawadzka et al., 2010).     
Additionally, it has been shown that late born neuron derived cytokines are necessary for 
differentiation of astrocytes (Barnabe-Heider et al., 2005; Freeman, 2010; Miller and Gauthier, 
2007). Although the numbers of late born neurons were drastically reduced in dcKO DP, this effect 
was less pronounced in lateral areas. Thus, it is possible that sufficient amounts of late born neurons 
survived in lateral cortical areas of dcKO to allow the development of protoplasmic astrocytes, 
whereas this was not the case in MCx. 
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However, overall the experimental data explaining the observed lack of protoplasmic astrocytes in 
MCx of dcKO are parsimonious and further investigations addressing, for instance, the role of 
cytokines or patterning markers need to be performed in the future.   
Rather than contradicting our model, these observations allowed us to refine it.  Accordingly, it may 
be an oversimplification to assume that more AGPs should lead to an increase in numbers of 
maturating astrocytes. In fact, we propose that BAF complex depletion merely drives the 
proliferation of AGPs, without causing their maturation towards astrocytes. Thus, one could expect 
that lowered levels of BAF complex within maturating astrocytes will also lead to their uncontrolled 
proliferation, what could eventually explain their elevated numbers within VP of dcKO (more details 
described below).  
 
 
   
 
Figure 40 | Increased numbers of astroglia and reduced numbers of neurons in forebrain affected 
by BAF complex depletion. Scheme depicting our findings. The cartoon shows that in normally 
developing brain all astrocytic RGCs express BAF complex. In WT animals (shown on the left side) cortical 
neurogenesis precedes astrogliogenesis and allows for development of neurons that are rich in BAF 
complex expression. When neurogenesis ceases BAF complex expressing astrocytic RGCs start to 
delaminate from the AS of VZ (marked by rounded red arrows) and subsequently migrate, proliferate and 
differentiate to astrocytes (marked by straight red arrows). Notably, the fate of proliferative AGPs 
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corresponds to downregulated levels of BAF complex within this cell line and the downregulated BAF 
complex subunits are reconstituted within mature astrocytes Overall, we could reveal the presence of 
neurons, astrocytic RGCs, AGPs and astrocytes in perinatal (E17.5 and P3, results merged in one cartoon) 
WT cortex. We could also observe moderate numbers of AGPs and astrocytes in VP of perinatal (P3) WT 
forebrain indicating active astrogenesis within ventral astroglial germinal zones. BAF complex depletion 
within dcKO forebrain (showed on the right side) led to decrease in cortical neurogenesis and massive 
delamination of affected astrocytic RGCs in form of AGPs. In addition the numbers of AGPs found in DP as 
well as VP of BAF depleted forebrain were tremendously elevated. Strikingly we could reveal increased 
abundance of protoplasmic astrocytes in several areas of postnatal VP whereas these cells were not 
present in MCx of dcKO. Centrally placed scale bar refers to the revealed average expression of BAF 
complex. AGP, astroglial progenitor; AS, apical surface; DP, dorsal pallium; as RGC, astrocytic radial 
glial cell; VP, ventral pallium. 
 
 
Overall, all these experimental results can be explained by the model we propose. Thus, it seems 
plausible that BAF complex plays a crucial role in maintaining a proper ratio of astroglial cells to 
neurons. Figure 40 summarizes all described findings.  
 
4.4 GLI1 triggered proliferation of astroglia is under tight control of BAF complex 
 
One of the final steps of mammalian brain development that allows the establishment of a proper 
neuron to astrocyte ratio lies in astroglia proliferation. Indeed it has been shown that during the first 
postnatal weeks, the abundance of rodent astroglia increases up to 8-fold (Bandeira et al., 2009). 
Exciting reports of 2-photon imaging and BrdU labelling experiments indicated locally proliferative 
astroglia as a major source for this expansion (Chaboub and Deneen, 2013; Ge et al., 2012; Tien et 
al., 2012). However, the little is known about the molecular underpinnings controlling initiation and 
termination of this process.  
 
Our previous studies (see Chapter 4 Discussion. 4.1) suggested that the developmental regulation by 
BAF complex may control the establishment of balanced numbers of neurons and astrocytes. 
Indeed, we could show that the loss of BAF complex from germinal zones of late developing brain 
causes a dramatic unbalance in populations of neural cells, lowering the abundance of neurons and 
increasing that of astroglia. Moreover, our model indicates that except for initiation of 
astrogliogenesis (allowance for detachment of astrocytic RGCs in the form of AGPs), downregulation 
of BAF complex expression may have a permissive role in astroglial multiplication. In fact several 
groups have described BAF complex as a proliferation limiting factor that inhibits mitogens e.g. GLI1 
(Jagani et al., 2010; Narayanan et al., 2015; Nguyen et al., 2018; Panamarova et al., 2016; Wang et 
al., 2014; Wu, 2012; Zhan et al., 2011). Thus, we have speculated and further confirmed that the 
elevated numbers of astroglia deprived of BAF complex are due to their uncontrolled proliferation 
driven by GLI1. In this subchapter we will discuss the increased proliferation of astroglia found in DP 
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and VP of hGFAP-Cre dcKO forebrain (see Chapter 3. Results. 3.3 and 3.4). At the end, we will focus 
on the proposed mitogen trigger of astroglia proliferation in the absence of BAF complex – GLI1 (see 
Chapter 3. Results. 3.5).  
 
Increased proliferation accompanies abundant astroglia 
Highly elevated proliferative capacity was a common feature of AGPs and protoplasmic astrocytes of 
dcKO forebrain and VP, respectively. As we have speculated that downregulated expression of BAF 
subunits enables astroglia proliferation, this observation confirms our assumptions.  
 
We assessed the proliferation of AGPs and protoplasmic astrocytes by two independent methods: 
immunostaining of Ki67 (Scholzen and Gerdes, 2000) and IP injection of thymidine analogue - EdU 
(Chehrehasa et al., 2009; Flomerfelt and Gress, 2016; Vega and Peterson, 2005).   
The results of the immunostaining showed that a large fraction of BAF complex depleted AGPs and 
VP protoplasmic astrocytes expressed Ki67, indicating that these were proliferative. This finding was 
confirmed for both cell types by EdU incorporation assay.  
Furthermore, the results of RNA-seq revealed that a number of transcripts related to proliferation of 
astrocytes and glioma were significantly upregulated in postnatal DP and VP of dcKO. Moreover, 
proliferation-related transcripts were already highly elevated in BAF complex depleted DP at E17.5 
(showed here and in (Nguyen et al., 2018)).  
 
Importantly, it has been described that neuronal loss triggers inflammation and proliferation of 
astroglia and astrogliosis (Anderson et al., 2014; Ben Haim et al., 2015; Sofroniew, 2015). Therefore, 
there is a risk that the elevated numbers of proliferative astrocytes result from reactive astrogliosis, 
evoked indirectly by BAF complex deletion. In fact, we could find some evidence to that effect: our 
RNA-seq data showed a notable upregulation of inflammation-related transcripts in cortex. 
However, immunohistochemistry revealed that BAF complex depleted proliferative astrocytes did 
not overexpress GFAP, a hallmark of reactive astrogliosis (Liddelow and Barres, 2017; Robel et al., 
2011). Therefore reactive astrogliosis is an unlikely explanation of our results.  
 
Taken together, these findings highlight the abnormally high proliferation levels of astroglia in our 
dcKO mouse model, demonstrating that BAF complex is a powerful regulator of astroglia 
multiplication. We have found evidence that when BAF complex levels are low, astroglial cells are 
proliferative. Furthermore, we propose that when BAF complex expression increases, cells exit their 
proliferative cycles and are eased towards terminal differentiation and quiescence.      
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BAF complexes regulate proliferation of astroglia via mitogen GLI1 
The findings discussed so far clearly show that BAF complex has a powerful influence on astroglia 
proliferation. In addition, as little is known on the subject (Ge and Jia, 2016; Tien et al., 2012), we 
sought to investigate which effector that triggers this proliferation could be targeted by BAF complex 
inhibition. Our RNA-seq data indicated that the mitogenic TF Gli1 and its downstream targets, 
several of which are known triggers of proliferation (e.g. cyclin D1 (Ccnd1) (Dahmane et al., 1997; 
Klein and Assoian, 2008; McCubrey et al., 2014; Nilsson et al., 2000), were constitutively upregulated 
in the brain of E17.5 and P3 dcKO. As the GLI1 is known to be implicated in aberrant proliferation of 
astroglia (e.g. in glioma) (Clement et al., 2007; Garcia et al., 2010; Pitter et al., 2014), it seems a 
plausible candidate as a target of inhibition by BAF complex. We could confirm increased levels of 
Gli1 mRNA by in situ hybridization, the results of which showed a massive increase in the number of 
labeled cells in dorsal and ventral areas of dcKO forebrain. Granted, this chromogenic in situ 
hybridization did not allow us to confirm the identity of the cells in which Gli1 mRNA was 
upregulated. But given that the dcKO cortex is populated mostly by aberrantly proliferating astroglia, 
it is very likely that these cells accounted for much, if not most, of the upregulation of Gli1 that 
emerged from our RNA-seq and in situ hybridization data.   
 
Importantly, the upregulation of Gli1 could also be due to its activation by SHH (Dahmane et al., 
2001; Palma et al., 2005), indirectly by loss of BAF complex. Two of our findings argue against this 
possibility. First of all, our RNA-seq data did not show a concomitant increase in Shh, which was 
downregulated instead. Secondly, in situ hybridization for Shh indicated a lower number of positive 
cells in dcKO cortex. It thus appears that SHH cannot have caused the upregulation of Gli1 in our 
model, making it all the more plausible that BAF complex deletion was its source. In support of this 
hypothesis, previous studies have shown that the BAF complex subunit BRG1 binds to the regulatory 
regions of Gli1, directly repressing its transcription (Zhan et al., 2011). In fact, this reciprocity has 
been proposed to be involved in the regulation of proliferation of cancer cells (Jagani et al., 2010). 
We have demonstrated the loss of BRG1 in dcKO, providing a convincing mechanism by which GLI1 
disinhibition occurs in affected astroglia.  
 
But the most conclusive evidence comes from our experiments with direct inhibition of the GLI1 
dependent transcription. Indeed, we could prevent aberrant overproliferation of astrocytes, thereby 
lowering their numbers in the ventral area of dcKO forebrain, by direct blockade of GLI1 using its 
antagonist, GANT61 (Lauth et al., 2007). Albeit this experiment warrants further repetitions (the n 
numbers are low), it identifies GLI1 as a promising candidate trigger of astroglia proliferation.    
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Therefore, our data does not only indicate that BAF complex deletion causes overproliferation of 
astroglial cells, but also that this effect is achieved through de-repression of the mitogen, GLI1.  
 
 BAF complex controlled GLI1 triggered proliferation of astroglia. Possible scenarios 
Proliferation of astroglia may be considered as a good or bad feature for development. On the one 
hand, it has been shown that it is due to the amplification processes that mammalian astrocyte 
population expands postnatally (Ge and Jia, 2016; Ge et al., 2012). This expansion enables the brain 
to achieve appropriate ratios of astroglia to neurons, a prerequisite for proper function (Ge et al., 
2012; Herculano-Houzel, 2014; Sloan and Barres, 2014). On the other hand, aberrant 
overproliferation of astroglia leads to pathological states of brain, such as tumor (e.g. glioma) 
(Furnari et al., 2007; Irvin et al., 2017).  
Despite the fact that several factors have been shown to trigger proliferation of gliomas (Wang et al., 
2000; Xu et al., 2013; Yang et al., 2012), little is known about the molecular underpinnings regulating 
multiplication of astroglia during development (Ge et al., 2012; Tien et al., 2012).    
Here we could show that BAF complex inhibits proliferation of astroglia, possibly by repressing 
transcription of the proliferation-enhancing mitogen, GLI1 (Figure 41). As we could also observe 
downregulated expression of BAF subunits (including Gli1 repressing BRG1) in premature astroglia 
(AGPs) of WT mice, we suggest that this could initiate GLI1 transcription within these cells. Overall, 
this can serve as a causal molecular mechanism for the early postnatal expansion of astrocytic 
populations (Figure 41A, left panel). In support of this hypothesis, postnatally proliferative astrocytes 
divide symmetrically, which has been shown to be the primary mode of division upon BAF complex 
deletion in early RGCs (Ge and Jia, 2016; Nguyen et al., 2018). Besides, overexpression of GLI1 has 
been also associated with symmetric cellular division (Ferent et al., 2014).  
Furthermore, we speculate that the reestablishment of BAF complex within proliferative astroglia 
could serve as a mechanism that represses Gli1 transcription thereby restraining their proliferative 
capacities and enforcing terminal differentiation and quiescence (Figure 41A, right panel). However, 
the present work does not fully confirm such a mechanism, thus additional experiments probing BAF 
controlled GLI1 activation/repression within WT AGPs/quiescent astrocytes respectively need to be 
performed in the future.     
Additionally, aberrant lack of Gli1 transcription repression caused by BAF complex mutation (or lack 
of BAF complex expression, as in case of our dcKO) could also be involved in enabling astroglial 
overproliferation, leading to tumorigenicity and glioma generation (Figure 41B). In support of this 
hypothesis, reciprocity between GLI1 and BAF complex (BRG1) has been proposed to induce the 
proliferation of malignant rhabdoid tumors (Jagani et al., 2010). Thus further studies should also 
139 
 
 
 
Figure 41 | Proposed model of BAF complexes dependent regulation of astroglia proliferation via 
mitogen GLI1. (A) In normally developing brain downregulation of BAF complex may lead to derepression 
of Gli1 transcription increasing amount of mitogenic GLI1, which further induces upregulation of 
proliferation inducing factors (e.g. known to promote AGPs proliferation – S100A6 (Yamada and Jinno, 
2014) or CCND1) thereby enabling perinatal premature astroglia proliferation (left panel). The 
reestablishment of BAF complex within proliferative astroglia could serve as a mechanism that 
represses Gli1 transcription thereby restraining their proliferative capacities and enforcing terminal 
differentiation and quiescence (right panel). (B) Aberrant lack of Gli1 transcription repression caused 
by elimination of BAF complex (dcKO) enables astroglial overproliferation, leading to pathological 
states of brain and tumorigenicity. dcKO, double conditional knockout.   
 
 
investigate the role of the BAF complex and the GLI1 signaling pathway in models of astroglioma. 
 
Overall the model presented in Figure 41 may be erroneous and further investigations are needed to 
verify it. Still, it serves as a helpful guide for future experimental work.   
 
4.5 Conclusions and perspectives 
 
It is important for proper brain function that appropriate ratios of cell types are achieved (McKenzie 
et al., 2018; Nedergaard et al., 2003; Robertson, 2013; Sloan and Barres, 2014). Among these, 
adequate quantitative relation between neurons and astrocytes has been proposed as pivotal for 
brain performance and large departures from this balance have been involved in 
neurodevelopmental and psychiatric disorders as well as brain tumors (Clarke and Barres, 2013; 
Dimou and Gotz, 2014; Gallo and Deneen, 2014; Khakh and Sofroniew, 2015; Martin et al., 2015; 
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O'Brien et al., 2013; Perea et al., 2014; Sloan and Barres, 2014; von Bartheld et al., 2016). 
Unquestionably, the basics of the brain cellular composition have the origin in the developmental 
processes (Bandeira et al., 2009; Kriegstein and Alvarez-Buylla, 2009).  
Chromatin regulators, such as BAF complex, exert an influence on cell proliferation and 
differentiation, making significant contribution to the endeavour of brain development (Narayanan 
and Tuoc, 2014b; Sokpor et al., 2017; Son and Crabtree, 2014). For instance BAF complex is known to 
orchestrate neurogenesis and neuronal migration as well as NSCs proliferation and maintenance 
(Bachmann et al., 2016; Lessard et al., 2007; Matsumoto et al., 2006; Narayanan et al., 2018; Nguyen 
et al., 2018; Tuoc et al., 2013b; Wiegreffe et al., 2015). Albeit crucial for proper neuronal numbers 
and functionality, the role of BAF complex in astroglia development has not been extensively 
investigated to this day. In fact only few sources have addressed this topic, focusing on 
astrogliogenesis during embryonic developmental stages (Matsumoto et al., 2006) or in adulthood 
(Ninkovic et al., 2013; Tuoc et al., 2017). However, these studies describe the role of only single BAF 
complex subunits and therefore are not sufficient to provide information on the dependence of 
astrogliogenesis on the entire BAF complex assembly. Accordingly, little is known about the general 
role of BAF complexes in the processes controlling proliferation and differentiation of cells within 
the astroglial lineage.   
 
We investigated the involvement of BAF complexes in the establishment of balanced neuronal and 
astroglial numbers by analyzing the phenotype of a mouse model in which two core elements of BAF 
complex, BAF170 and BAF155 were deleted, leading to the destruction of the entire complex 
(Narayanan et al., 2015). Applying a combination of genomic and proteomic approaches as well as 
advanced imaging and cellular quantification methods, we could show that BAF complex deletion 
resulted in a tremendous depletion of neuronal populations as well as aberrantly increased 
abundance of proliferative astroglia. As mentioned before, earlier studies have stressed the 
importance of appropriate BAF complex assemblies for proper neurogenesis, thus our findings 
consolidate these notions. However our results describing an increased astrogliogenesis driven by 
massive delamination of AGPs followed by aberrant astroglia proliferation are, to our knowledge, 
completely novel. On the other hand, a high rate of multiplication upon BAF deletion is not 
surprising as such, as several groups have indicated the BAF complex as a proliferation limiting factor 
(Narayanan et al., 2015; Nguyen et al., 2018; Panamarova et al., 2016; Wu, 2012). Furthermore, our 
RNA-seq experiments, in situ hybridization and pharmacological inhibition implicated de-repression 
of the mitogen GLI1 as a trigger of increased astroglia proliferation upon BAF complex deletion.  
 
We therefore propose a model in which BAF complex regulates the ratio of neurons to astroglia in 
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normally developing brain. In this model, BAF complex acts upon the balance of neurons and 
astroglial cells in two ways. First of all, BAF complex promotes neurogenesis. Second, when 
downregulated, it also acts upon detachment of astrocytic RGCs from the AS of VZ, enabling their 
differentiation into AGPs. BAF complex also regulates the proliferation of astroglia by repressing the 
transcription of the proliferation-enhancing mitogen GLI1. Furthermore, the downregulation of BAF 
complex in premature astroglia can serve as a causal mechanism for the early postnatal expansion of 
astrocytic populations. This model also indicates a potential mechanism in pathological astroglial 
overproliferation such as glioma, hinting at a potential role of BAF complex in tumorigenicity. 
Further studies should investigate the role of the BAF complex and the GLI1 signaling pathway as a 
potential target for the development of therapeutic drugs, such as the GLI inhibitor GANT61 used in 
this study. 
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Summary 
 
 
In the human central nervous system, astrocytes vastly outnumber neurons and regulate a host of 
physiological processes critical to its function. Astrocytes form a functional syncytium tiling the brain 
with minimal overlap between individual cells. This anatomical organization implies that a balanced 
numbers of neurons and astrocytes must be generated during brain development. In spite of this, 
very little is known about the molecular events governing proliferation and differentiation in the 
astroglial lineage that culminate in the establishment of adequate numbers of astrocytes.  
 
In recent years, the chromatin remodeling BAF (Brg1/Brm Associated Factors) complex, a 
conglomerate of at least 15 protein subunits, has emerged as a key regulator of different steps of 
neurogenesis, from proliferation of progenitors to differentiation into mature neurons, thus 
profoundly affecting brain development. However, its functions in astrogliogenesis are largely 
unknown.    
 
Here, we investigated the involvement of BAF complex in the regulation of cellular proliferation and 
differentiation in the astroglial lineage of perinatal mouse brain.  
We first assessed the expression of several BAF complex subunits in cells of both neuronal and 
astroglial lineages, and found that the composition of the BAF complex was cell type dependent.  
Next, we examined the phenotype of a mouse model in which hGFAP-Cre driven conditional 
knockout of BAF155 and BAF170, two scaffolding subunits, results in the deletion of the entire BAF 
complex within radial glial progenitors during late neurogenesis and astrogliogenesis. Performing 
phenotype and gene expression profile analyzes, we found that loss of BAF complex at this 
developmental stage causes a tremendous depletion of neuronal cells as well as an aberrantly 
increased abundance of proliferative astroglia in ventral and dorsal telencephalon. Furthermore, we 
identified an upregulated expression of GLI1 as a causal mechanism of abnormal overproliferation of 
astroglial cells following BAF complex depletion. This could be demonstrated by inhibition of GLI1 by 
injection of GANT61, which abolished the aberrant proliferation caused by loss of BAF complex. 
 
We thus propose that cell lineage dependent rearrangements of the composition of the BAF 
complex play a crucial role in regulating the relative numbers of neurons and astrocytes generated 
during brain development. This effect is achieved in part by BAF complex dependent repression of 
the proliferation-enhancing mitogen GLI1 in the astroglial lineage.         
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Appendix 
 
 
 
 
 
 
 
Figure 42 | Expression of BAF complex subunits in AGPs of perinatal murine brain. (A-B) 
Immunofluorescence analysis of P0 mouse WT coronal brain sections stained with antibodies to astroglial 
progenitor markers; GLAST (in green) and NFiA (in red) together with antibodies detecting BAF complex 
subunits (in blue, pseudo coloured): BAF155 (A) and BAF170 (B). Magnified picture taken in the 
delineated areas no 1 are shown in Figure 7 and 9. Pictures of areas no 2 are presented in Figure 8 and 
10. Figure 11 focuses on analysis of area no 3. WT, wild type.  
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Figure 43 | Loss of BAF complex subunits in ventral astrocytes affected by BAF155/BAF170 dcKO. (A-B) 
Immunofluorescence analysis of P3 mouse WT (A) and dcKO (B) coronal brain sections of CPu stained 
with antibodies to protoplasmic astrocyte marker ACSBG1 (in green) together with antibodies detecting 
BAF complex subunits: BAF170 (in red) and BAF60a (in magenta). ACSBG1 positive astrocytes expressing 
(in WT, A) or lacking the expression (in dcKO, B) of investigated BAF subunits pointed by arrowheads. 
dcKO, double conditional knockout; WT, wild type.  
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Figure 44 | Expression of BAF complex subunits in cortical protoplasmic astrocytes of adult mice. (A-D) 
Immunofluorescence analysis of P60 mouse WT coronal cortical sections stained with antibodies to 
protoplasmic astrocyte marker ACSBG1 (in green) together with antibodies detecting BAF complex 
subunits (in blue, pseudo-coloured): BRG1 (A), BAF170 (B), BAF60a (C) and BAF250a (D). For each right 
panels are single channel grey scale images of corresponding BAF subunit staining. Bottom panels of each 
are magnified insets of delineated areas. ACSBG1 positive astrocytes expressing given BAF subunit 
pointed by arrowheads. Cx, cortex; WT, wild type.  
 
 
 
 
162 
 
 
 
 
Figure 45 | Expression of astroglial markers in P3 WT and dcKO brains. Pictures are overviews 
supplementing Figure 17 (A) and Figure 29. CPu, caudate putamen; dcKO, double conditional knockout; 
MCx, medial cortex (refers to the M1 area); LCx, lateral cortex (refers to the S1 area), LGE, lateral 
ganglionic eminence, WT, wild type.  
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Figure 46 | Expression of ACSBG1 positive protoplasmic astrocytes in E17.5 WT and dcKO brains. 
Pictures are overviews supplementing Figure 23 and Figure 32A. Arrowheads indicate cortical regions. 
None of genotypes exhibited ACSBG1 positive astrocyte staining in DP. Note the prominent ACSBG1 
staining in ventral areas of dcKO brain. dcKO, double conditional knockout; WT, wild type.  
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Figure 47 | The distribution of perinatal RGCs progenies differs between WT and dcKO brains 
(supplementary to Figure 26). (A) Scheme explaining the principle of distribution studies conducted by 
means of EGFP plasmid in utero injection and electroporation (IUE). (B) Anatomy and GLAST expression in 
E16.5 WT and dcKO brains. Arrowheads point the place aimed for electroporation (note: GLAST 
expression was preserved in LCx of dcKO brains). (C) LGE and striatum areas of WT and 3 independent 
dcKO mice exhibiting staining for SATB2 and ACSBG1. Arrowheads indicate cells positive for SATB2. The 
directions towards VZ and CPu are indicated by two headed arrow. CPu, caudate putamen; dcKO, double 
knockout; DP, dorsal pallium; IUE, in utero electroporation; LGE, lateral ganglionic eminence; VP, ventral 
pallium; VZ, ventricular zone; WT, wild type.  
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Figure 48 | Upregulation of Gli1 transcript in P3 dcKO brain (supplementary to Figure 37). (A, C) In situ 
hybridization of coronal brain sections through WT and dcKO P3 murine Cx (developing M1 area) staining 
Gli1 mRNA. (A) Overview pictures of WT and dcKO stained brain sections (B-C) Magnified insets of (B) 
developing M1 area and (C) CPu - indicated in (A). Full arrowheads indicate Gli1 mRNA positive cells. (D) 
Densities of cells expressing Gli1 mRNA found in cubic mm of complete brain slice, cortex and VP. Data 
are averages ± σ of n=3 experimental replicates; ***p≤0.001, **p≤0.01 in t student test. Cx, cortex; dcKO, 
double knockout; VP, ventral pallium; WT, wild type.  
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Conference posters 
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Teaching experience  
 
 
2015 Method course for students of the first year of International Max Planck 
Research School (IMPRS) MSc/PhD Neuroscience Program 
 Georg-August University, Göttingen, Germany  
 
   Preparation of immunohistological brain sample and imaging 
 
 
2015   Supervision of the lab rotation of Killian Vasco Hinze, 
   student of Developmental, Neural and Behavioral Biology Program  
   Georg-August University, Göttingen, Germany 
 
Project: “Investigation of apoptotic processes in BAF complex depleted 
mouse brain” 
 
 
2015   Supervision of the lab rotation of Tizibt Ashine Bogale, 
   student of IMPRS MSc/PhD Neuroscience Program 
   Georg-August University, Göttingen, Germany 
 
Project: “The role of BAF complex in reactive astrogliosis and glial scar 
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2011 Method course for students of the first year of Biochemistry MSc Program  
 Jagiellonian University, Kraków, Poland  
 
Transformation and maintenance of bacterial strains. Plasmid DNA 
extraction by minipreparation 
 
 
Activities  
 
 
2017 Main organizer of the 4th biennial Neuroscience Symposium “ENCEPHALON” 
Göttingen, Germany 
 
 
2015 Participation in workshop “Manipulation and visualization of physiological 
and pathophysiological functions of glia“ 
Bilbao, Spain 
 
 
2013   Inter alia co-founder of Biochemistry Students Society “NZYME” 
   Kraków, Poland  
 
 
2011 – 2012  Tutoring volunteer for primary school, gymnasium and high school students  
 
 
2011 – 2012  Many scientific and didactic biochemical shows 
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Additional informations 
 
 
Certificates  FELASA certificate, function ABD  
(accreditation to perform animal experiments, since April 2015;  
accreditation to design procedures and projects, since February 2019) 
 
 
Diploma of pedagogical training 
(accreditation to teach biology and chemistry in primary school, gymnasium 
and high school, since June 2012) 
 
 
Computer skills  Microsoft Office, CorelDRAW Graphics Suite, Adobe Illustrator and 
Photoshop, ImageJ, Zeiss Zen, Neurolucida, LasX, SigmaPlot, basic 
knowledge of R and MatLab  
 
 
Languages  Native speaker of Polish; fluent in English; intermediate in German (B1); 
intermediate in French (B1); knowledge of Latin 
 
